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1 Stem cells in health and in diseases 
 
1.1 Emergence of the stem cell concept 
The term "stem cell" (German stammzelle) emerged with the German biologist Ernst Haeckel 
in 1868 to designate the origin of all cell types. After Darwin, who at the same time proposed 
his theory on the common origin of species, Haeckel used the term stem cells to refer to the 
fertilized egg that is the source of all the organism's cell types. In 1892, Theodor Boveri and 
Valentin Hacker expanded the definition of stem cells to include primordial germ cells (PGC), 
since germ cells maintain unaltered genetic material and transmit it to the next generation. At 
the same time, the hematologist Pappenheim used the word stem cell to denote common 
precursors that can generate both myeloid and lymphoid cells. Hematopoietic stem cells were 
then established as a prototype of stem cells according to two criteria: the capacity to proliferate 
indefinitely and the ability to generate differentiated cells (Ramalho-Santos and Willenbring, 
2007). 
 
1.2 Adult stem cells 
Tissue homeostasis is the process by which a robust structural organization and function are 
maintained, in the face of varying internal and environmental conditions. This stability is 
accomplished by the activity of tissue-specific populations of non-differentiated cells, called 
adult stem cells (SCs), which have three distinguishing features. First, compared to the short-
lived differentiated cells that insure tissue function, adult stem cells are long-lived to regenerate 
tissue damages throughout the adult life. Second, they divide to generate new SCs and maintain 
their pools. Third: they are able to differentiate into a limited range of cell types that build the 
tissue in which they reside; hence, adult stem cells are multipotent. 
The rate of tissue renewal is very variable depending on the intrinsic characteristics of each 
organ. For instance, it is very high for blood cells (Seita and Weissman, 2010) or the gut 
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epithelium (Eastwood, 1977; Leblond, 1981) which is entirely renewed every week in humans. 
Some other tissues display a low rate of cell renewal, such as the brain (Ihunwo et al., 2016) , 
kidney (Little and McMahon, 2012) or heart (Doppler et al., 2017). In the case of lesions or 
other stresses (infections, injuries), these organs yet display increased regenerative capacities 
necessary to replace dead cells. In the heart, an organ less exposed to external aggressions, cell 
renewal can occur by the dedifferentiation of mature cells that will proliferate to repair the 
injury (Szibor et al., 2014). The study of adult stem cell behavior has become a major topic for 
the following reasons:  
1. Given their potential to differentiate into various cell types, SCs have tremendous 
potentials for the treatment of human diseases (Kiskinis and Eggan, 2010). 
2. Reduced SC function and/or homeostasis can trigger degenerative diseases and is 
involved in ageing (Clevers, 2011; Jones and Rando, 2011). 
3. Deregulated growth of SCs may lead to tumors and adult stem cells share many 
similarities with the so-called cancer stem cells (CSCs) (Visvader and Lindeman, 2008). 
  
1.3 Cancer stem cells 
The discovery of cancer stem cells  
The development of tumors and their metastatic potential depend on the activity of rare cancer 
stem cells (CSCs), or tumor-initiating cells. As for adult stem cells, CSCs have the capacity to 
proliferate in order to produce more CSCs and to give rise to committed malignant cells. 
The concept of CSCs has first emerged in the thirties, from the work of Furth and Kahn (Furth, 
1935) showing that individual cells derived from mouse leukemia could generate new tumors 
when engrafted in a healthy recipient mouse. Lapidot et al later hypothesized that a population 
of CSCs sustains leukemic clones, since myeloid cancer cells have a restricted proliferative 
capacity (Lapidot et al., 1994). Cancer cells were sorted based on the differential expression of 
cell surface markers and then transplanted into immune deficient mice. Cells that are able to 
initiate new tumors in recipient mice were considered as CSCs (Lapidot et al., 1994). 
Furthermore, CSCs were also identified in solid tumors, such as in brain (Singh et al., 2004) 
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and breast cancers (Al-Hajj et al., 2003) using the same transplantation approach. Subsequently 
CSCs were identified in many solid cancers including colon, pancreas and lung among others 
(Tirino et al., 2013). 
Origin of cancer stem cells  
Despite numerous evidence of the importance of CSCs in tumors, their origin remains 
controversial. It was hypothesized that transformed cells can fuse with normal stem cells; the 
resulting fusion cells thus possess both self-renew and transformed abilities. The fusion may be 
accompanied by chromosomal loss further favoring CSC formation (Ogle et al., 2005). In 
addition, mutations in somatic cell’s DNA lead to apoptosis and DNA fragmentation. The 
fragmented DNA can be taken up by a recipient cell leading to nuclear reprogramming and 
tumor initiation (Camargo et al., 2004; O'Malley and Scott, 2004; Pomerantz and Blau, 2004). 
The resulted genomic instability such as chromosomal rearrangement and mutations within 
stem cells thus lead to their transformation to CSCs (Bergsmedh et al., 2001; Holmgren et al., 
2002). 
An alternative model suggests that CSC arise from tumor cells that undergo multiple changes 
that favor a stem-like phenotype, including loss of cell-cell adhesion molecules such as E-
cadherin, alteration of apical basal polarity, and the gain of motility. This reversible process 
known as epithelial to mesenchymal transition (EMT) permits CSCs invasion to new sites 
where they seed micro tumors by reverse mesenchymal to epithelial transition (MET) (De 
Craene and Berx, 2013). In addition to generating CSCs and inducing metastasis, EMT governs 
multiple normal processes including tissue remodeling during embryogenesis, organ 
development and tissue regeneration (Thiery et al., 2009).  
The EMT program is induced by a series of transcription factors (TFs) mainly Snail, Slug, Twist 
and Zinc finger E-box binding Homeobox 1 (Zeb1 and Zeb2) collectively called EMT-inducing 
factors. The expression of these TFs is induced by signaling cues emanating from tumor-
associated stroma, including Transforming Growth Factor Beta (TGF-β), Notch and Wnt 
signaling (Peinado et al., 2007; Polyak and Weinberg, 2009).  
Under normal conditions, micro-RNA composed of 20-22 nucleotides silences the expression 
of EMT-TF by binding to 3’UTR of target mRNA (Lewis et al., 2005). miR-200 and miR-205 
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act as EMT repressors by targeting Zeb1 and Zeb2 mRNA, thus their downregulation facilitates 
early steps of metastasis (Cano and Nieto, 2008). Moreover, the downregulation of Zeb1 in 
some cancer types lead to an upregulation of miR-200 expression, pointing to a negative 
feedback loop between Zeb and miR-200. miR-200 also acts in a zeb-independent manner, 
through the regulation of various stemness-related genes, and Zeb factors are regulated by 
additional micro-RNAs less characterized than miR-200. Another regulatory feedback loop also 
exists between miR-34, miR-203 and the EMT-inducing TF Snail. Conversely, both Zeb and 
Snail target miR-34 expression providing a tight crosstalk between the miR-200/Zeb and miR-
34/Snail networks (Diaz-Lopez et al., 2014). 
Since the discovery of CSCs in solid tumors, many studies have focused on the mechanisms 
that induce EMT, based on the hypothesis that this process is at the origin of metastasis (Nieto 
et al., 2016). In contrast, recent findings suggest that tumor cells that contain both mesenchymal 
and epithelial features have the strongest metastatic potential. The screening for the factors that 
inhibit EMT have led to the identification of the transcription factor OvoL, as a crucial 
gatekeeper of the epithelial state (Roca et al., 2014; Watanabe et al., 2014). However, most 
studies that characterized OvoL functions in EMT-TF inhibition were performed using cultured 
cells. Thus, it is crucial to find a suitable in vivo model system to decipher OvoL mechanisms 
of action, in both physiological and pathogenic conditions.  
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2 The fly gut as a model system of stem cell function and 
dysfunction 
 
For over a century, the "fruit fly" Drosophila melanogaster has been a powerful model for many 
areas of research, such as genetics, development, evolution and diseases. Notably, six Nobel 
prizes were awarded to Drosophila researchers. Starting from 2006, Drosophila has now 
emerged as an attractive model system to study intestinal stem cells (ISCs) and gut regeneration. 
The intestine is one of the largest and most active organs of the adult body. Beside its function 
in food processing and nutrient absorption, the gut epithelium constitutes an efficient line of 
defense against a wide variety of ingested pathogens in both mammals and Drosophila (Buchon 
et al., 2014; Chassaing et al., 2014). The gut is also a major source of hormones that modulate 
the functions of other organs, such as pancreas and brain in mammals (Bewick, 2012). Thus the 
gut is not simply a passive digestive tract but it is a vital organ implicated in multiple 
physiological functions. 
The Drosophila adult midgut epithelium is a simple structure that shares anatomical and 
functional similarities with its mammalian counterpart, the small intestine (Liu et al., 2017). 
Adult flies feed on decayed fruits and are therefore continually exposed to ingested pathogens, 
which can have detrimental impacts in the absence of an effective defense mechanism. To deal 
with these challenges, damaged cells are constantly replaced by new cells, through the activity 
of intestinal stem cells (ISCs) (Micchelli and Perrimon, 2006; Ohlstein and Spradling, 2006). 
In the following section, I will describe the structural and cellular organization of the fly 
digestive tract. I will focus on ISCs of the posterior midgut, the region of interest in my PhD 
work. In a second part, I will present key findings regarding the molecular mechanisms that 
regulate both ISC differentiation and proliferation in steady state and stress conditions. In the 
final part, I will summarize similarities between Drosophila and mammalian digestive tracts, 
in both structural and cellular organization, as well as the key role of signaling pathways in 
normal homeostasis and tumor development. 
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2.1 Structural and cellular organization of Drosophila adult digestive tract  
2.1.1 The structural organization of the adult fly intestine  
The adult Drosophila digestive system is subdivided into three main regions: the foregut, the 
midgut and the hindgut (Royet, 2011). The foregut originates from the ectoderm. It is a short 
tube-like structure composed of the esophagus, which connects to the salivary glands and to the 
crop, a bi-lobed structure responsible for temporary food storage before its transition into 
midgut lumen (For review see (Miguel-Aliaga et al., 2018)). The midgut represent the 
functional equivalent of the mammalian small intestine. It originates from the endoderm and is 
responsible for food digestion and absorption. The anterior midgut extremity, called 
proventriculus, is responsible for the initiation of the mechanical breakdown of the ingested 
food (King, 1988). The proventriculus synthesizes a chitin-containing membrane called 
peritrophic matrix (PM) that lines the midgut epithelium and separates it from the food bolus. 
The PM is thus analogous to mucous secretion in the mammalian intestine and constitutes a 
physical barrier that protects the epithelium from harmful microbes and food particles (Kuraishi 
et al., 2011). The midgut is enclosed by visceral muscles (VM), nerves, as well as trachea which 
communicate with the epithelium by signaling molecules regulating intestinal homeostasis. The 
hindgut derives from the ectoderm and is in charge of water and electrolytes uptake, before 
discharging the waste into the rectum. The boundary between the midgut and the hindgut is 
where branching tubules called Malpighian tubules (MTs) are connected. MTs the Drosophila 
renal system are responsible for adjustment of hemolymph ionic concentrations, through the 
absorption of electrolytes and their subsequent release into the hindgut. It is interesting to note 
that distinct populations of stem cells residing in each region maintain the overall integrity of 
the digestive tract throughout adult life (Zeng et al., 2013) (Figure 1). 
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Figure 1: Adult Drosophila gut organization 
The Drosophila adult gut is folded into a 3D structure within the abdomen. It is composed of three mains regions: the foregut 
containing the esophagus, the proventriculus and the crop; the midgut, the main site of digestion and the hindgut. Malpighian 
tubules (MT) are attached to the midgut/hindgut boundary. The midgut epithelium is composed of Enterocytes (blue), 
Enteroendocrine cells (pink), intestinal stem cells (green) and enteroblast precursor cells (orange).  
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2.1.2 The midgut cellular composition and molecular markers  
The Drosophila midgut epithelium is a cell monolayer, composed of two types of differentiated 
cells, responsible for its physiological functions, and stem cells and progenitors cells that ensure 
the replacement of damaged differentiated cells (Figure 2).  
Enterocytes (ECs) are large polyploid absorptive cells that constitute 90% of the midgut 
epithelium. ECs are positive for the transcription factor Pdm1, also known as Nubbin (Beebe 
et al., 2010; Lee et al., 2009; Mathur et al., 2010; Tang et al., 2018), which is homolog to the 
mammalian Pou/Oct proteins (Holland et al., 2007; Tantin). Enteroendocrine cells (EE), are 
small secretory cells interspersed between ECs, and characterized by the expression of the pan-
neural TF Prospero (Figure 2c). EE cells can be subdivided in four different classes, marked by 
the expression of specific neuropeptides named Allatostatine (Ast), Tachykinin (Tk) and 
diuretic hormones (DH) (Beehler-Evans and Micchelli, 2015). Class I (AstB+, AstC+) and class 
II (AstC+) EE cells are present in the anterior part of the posterior midgut, whereas classes III 
(AstA+, AstC+) and IV (Tk+, Dh+) are localized in the remaining part of the midgut. 
Stem cells of the adult Drosophila midgut have initially been identified by the Perrimon and 
Spradling labs (Micchelli and Perrimon, 2006; Ohlstein and Spradling, 2006). In order to 
identify proliferating cells within the adult midgut, the researchers traced cells that incorporate 
Bromodesoxyuridine (BrdU) and thus synthetize DNA. They showed that both small diploid 
cells and large polyploid cells are BrdU-positive, but only diploid cells are positive for 
phosphorylated Histone 3 (on a serine at position 10, PH3), a specific marker of mitotic cells. 
Lineage tracing approaches demonstrated that PH3+ cells are able to both self-renew and give 
rise to differentiated intestine cells (Micchelli and Perrimon, 2006; Ohlstein and Spradling, 
2006). The small diploid cells are thus intestinal stem cells (ISCs) and larger BrdU-cells 
represent their daughter post-mitotic progenitors, called enteroblasts (EBs). 
ISC and EB are characterized by the expression of the zinc finger TF escargot (Esg), the 
Drosophila counterpart of the mammalian genes Snail/Slug, and are found as duplets along the 
basement membrane (Micchelli and Perrimon, 2006; Ohlstein and Spradling, 2006). In 
addition, ISCs specifically express Delta (Dl), a ligand of the Notch signaling pathway that 
binds to the Notch receptor present at the cellular surface of the newly formed EB. Consistently, 
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activation of Notch within EB cells is attested by the expression of the Su(H)-Gbe-LacZ reporter 
(Ohlstein and Spradling, 2007) (Figure 2c) . 
2.1.3 The midgut development: origin of ISCs  
During embryonic development, the endodermal primordia from both sides of the embryo 
invaginate and some cells undergo epithelial to mesenchymal transition (EMT) to form loosely 
organized mesenchymal mass containing Adult Midgut Progenitors (AMPs) (Hartenstein et al., 
1992). Mesenchymal cells then migrate toward each other’s and undergo reverse MET 
transition in order to produce EC. This is initiated when endodermal cells enter in contact with 
mesodermal cells. At this stage, the midgut is composed exclusively of ECs and AMPs closely 
associated to visceral muscles (Jiang and Edgar, 2009). The embryonic midgut is conserved 
until pupal stage. During metamorphosis, AMP daughter cells fuse together to form the adult 
midgut (Jiang and Edgar, 2009; Mathur et al., 2010). Lineage tracing demonstrated that AMPs 
give rise to all cells of the adult midgut, including ISCs, ECs and EEs (Mathur et al., 2010). 
During midgut development, AMPs undergo either symmetric or asymmetric division. During 
early larval stages, dispersed AMPs divide symmetrically to increase their number as the midgut 
increases in size. Later at mid-larval stage, AMPs undergo one asymmetric division generating 
a differentiated cell called Peripheral cell (PC), which wraps around clusters of AMP and 
inhibits their differentiation (Mathur et al., 2010). AMPs continue to divide within islets under 
the control of mitogenic signaling such as epidermal growth factor Receptor (EGFR) (Jiang and 
Edgar, 2009). AMPs behavior is also regulated by the ecdysone hormone during larval stages 
(Micchelli et al., 2011). During pupariation, PCs are lost by apoptosis and AMPs become free 
to differentiate (Mathur et al., 2010) (Figure 2a-b). 
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Figure 2 : Adult midgut progenitors at the origin of ISC  
(A) During early larval development Adult Midgut Progenitors (AMPs) express the Notch ligand Delta (Dl) and divide 
symmetrically in order to increase their number. Later on, AMPs divide asymmetrically and give rise to Su (H)+ peripheral 
cells (PC), which serve as niche. PC cells inhibits AMP differentiation and induce their self-renewal. 
(B) During metamorphosis, PC cells degenerate and AMPs start to differentiate.  
(C) AMPs give rise to ISC that divide asymmetrically to a generate a new ISC and a committed EB (orange) or EEP (pink) 
progenitor, that will further differentiate into EE or EC cells, respectively. 
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2.1.4 The Drosophila adult midgut regionalization  
The midgut was initially subdivided into three regions namely the anterior, the middle and the 
posterior midgut (Demerec, 1950; Hakim et al., 2010). This subdivision was based on the 
discovery in the middle region of acid secreting cells called “copper cells” (Dubreuil, 2004). 
These cells confer a high acidity for the middle midgut, similarly to the mammal’s stomach. In 
contrast, the luminal content of both the anterior and the posterior midgut are mildly alkaline 
(Dubreuil, 2004). 
Recently, work from two independent groups have resulted in the establishment of a nose-to-
tail atlas of the Drosophila adult midgut compartmentalization (Buchon et al., 2013; Marianes 
and Spradling, 2013). Morphometric analyses conducted by Buchon et al. have revealed the 
presence of six constrictions that split the midgut into five main chambers named R1-R5. These 
domains were further subdivided into eight subregions based on EC morphology. Next, they 
performed transcriptome analysis that unveil an unprecedented compartment-specific gene 
expression and led to a fine-grained division of the midgut into 14 subregions. Interestingly, 
this high level of regionalization seems to be very robust since it remains intact independently 
of diet fluctuations or gut damage. This regionalization is governed by a complex regulatory 
network involving TFs that were used for midgut development during embryogenesis (Buchon 
et al., 2013). Marianne and Spradling also subdivided the midgut into 10 regions contained 
within the 14 regions identified by Buchon et al. They also revealed the existence of region-
specific expression profiles by performing transcriptome analysis, region-specific microarrays 
and RNA-seq experiments (Buchon et al., 2013; Marianes and Spradling, 2013). Marianne and 
Spradling also uncovered a partial role for ISC in establishing midgut regionalization. They 
showed that ISC of different subregions have both different morphology and mitotic activity. 
ISCs of the posterior midgut region P1-P3 (R4) are the most rapidly dividing cells, with a 
division rate of once per day, the rate of division is less important in the anterior part. 
Importantly, ISC daughter cells residing near a region boundary always give rise to the same 
cell lineages and, even in rare cases where they cross the boundaries , they keep cellular memory 
of their region of origin (Marianes and Spradling, 2013) (Figure 3).  
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Figure 3 : Drosophila adult midgut regionalization 
Based on anatomical features the midgut is divided into 5 different regions (R1-R5). These regions are further divided to 8 
subregions containing EC cells with different morphologies (histological level). Gene expressing patterning has led to an 
additional level of regionalization (14 subregions ) (Buchon et al., 2013). Marianes and Spradling demonstrated the presence 
of 9 different regions contained within the 14 subregions found by Buchon et al. (Marianes and Spradling., 2013). (Adapted 
from Osman and Buchon., 2015) 
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2.1.5 The Drosophila adult Malpighian tubules 
In addition to digestion and nutrient absorption, ionic concentrations should be tightly regulated 
in order to maintain a healthy organism. This function is achieved by the Malpighian tubules 
(MT) attached to the midgut/hindgut junction. MT are also renewed by adult stem cells called 
Renal Nephric Stem cells (RNSC). In the following section, I will describe MT structural and 
physiological organization with emphasize on RNSC origin and regulatory mechanisms. I have 
to note that the first paper of this manuscript concern RNSC maintenance.  
2.1.5.1 Malpighian tubules structural organization  
Each adult gut is attached to two pairs of MTs: one pair is projected toward the anterior part of 
the digestive tract whereas the second one is oriented posteriorly. Each MT is divided into two 
regions: the lower tubules attached to the midgut through the ureters, and the upper tubules 
distant from the gut and further divided into main, transitional and initial segments (Sozen et 
al., 1997). As for gut regionalization, MT subregions can be defined based on differential genes 
expression (Sozen et al., 1997). MT are composed of two types of polyploid differentiated cells: 
principal cells (PC) distributed all along the tubules, and stellate cells (SC) located in the upper 
MT (Denholm et al., 2003). 
2.1.5.2 Malpighian tubules functions  
MT are immerged in the hemolymph, the circulatory system of Drosophila. They ensure water 
reabsorption, ionic and acid/base equilibrium, as well as the elimination of metabolic waste. In 
addition, MT participate to innate immunity by acting as autoimmune sensor. A deprivation of 
nutrients and water (desiccation) induces the expression of the peptidoglycan recognition 
protein-LC (PGRP-LC). PGRP-LC is known for its role in bacterial detection and induction of 
the immune response, with an increased production of anti-microbial peptides (AMPs) in order 
to protect the animal from bacterial loads (Zheng et al., 2018).  
2.1.5.3 Renal Nephric stem cells: origin and regulation 
 Similar to the midgut, MT are renewed by stem cells called Renal Nephric stem cells (RNSC) 
known as “tiny cells” due to their small size and to their diploid nuclei (Sozen et al., 1997). 
RNSC are located in the lower tubules and can divide to maintain their pool. They also give 
rise to committed progenitors called renalblasts (RBs) that further differentiate into PCs or SCs 
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(Singh et al., 2007). In contrast to differentiated cells, already present in the MT during 
embryogenesis, RNSC are specific to the adult stage. At the pupal stage, intestinal AMPs 
migrate from the midgut and form the ureter in order to attach the midgut to the MT (Takashima 
et al., 2013). The remaining undifferentiated AMPs then become RNSCs (Takashima et al., 
2013). RNSCs conserve the expression of esg, already present in AMP but express an additional 
TF called Krüppel (Kr) (Denholm et al., 2003; Singh et al., 2007), required for normal MT 
formation during embryogenesis. Thus, migrating AMPs are reprogrammed within MTs to 
acquire novel characteristics different from those of ISC. In addition, RNSC are well 
individualized and their number is reduced compared to this of ISC (350 RSCs compared to 
1000 ISCs approximatively). 
Although RNSCs were identified about ten years ago, the mechanisms that regulate their 
activity remains poorly understood. Similarly to ISC, RNSC express Dl, which activates the 
Notch pathway in the RBs to initiate their differentiation into reabsorbing cells, CPs and SCs 
(Li et al., 2014). RNSCs proliferation is regulated by both EGFR and JAK/STAT signaling 
pathways (Li et al., 2015; Singh et al., 2007) .In contrast, Hippo pathway loss of function leads 
to an overproliferation of RNSCs (Doggett et al., 2011; Verghese et al., 2012; Yang et al., 2015; 
Zeng et al., 2010). 
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2.2 Molecular mechanisms governing ISC behavior in the adult midgut 
Following the ISC discovery, many studies have focused on deciphering the molecular mechanisms that 
determine the choice between EC and EE fates, as well as the regulation of ISC proliferation. In the 
following paragraph, I will present our understanding of ISC regulation by both signaling pathways and 
transcription factors. I will next discuss recent findings concerning mitogenic signaling pathways 
required for ISC proliferation in both normal and stress conditions. 
2.2.1 ISC differentiation by Notch and JAK/STAT signaling pathways 
The generation of absorptive enterocytes (EC) requires high levels of Notch activity within 
EBs, whereas weaker Notch activation leads to the production of EE cells (Ohlstein and 
Spradling, 2007). In the absence of Notch, ISC cannot differentiate and continue to proliferate 
leading to tumoral masses (Ohlstein and Spradling, 2007). Conversely, constitutive activation 
of the Notch pathway by expressing the Notch Intra cellular Domain (NICD) forces the 
differentiation of ISCs into ECs. Moreover, the activation of Notch within EB cells seems to be 
dependent of ISC-EB interaction mediated by E-Cadherin molecules, also required for cell 
shape maintenance (Maeda et al., 2008). 
ISC identity is maintained, at least in part, by Daughterless (Da) a basic helix loop helix (bHLH) 
transcriptional activator that sustains Delta expression and self-renewal capacity (Bardin et al., 
2010). In addition, Hairless (H) and Suppressor of Hairless (Su(H) act within ISCs to repress 
the expression of a main Notch target gene, Enhancer of split (E-(spl)-C, (Bardin et al., 2010)). 
Notch activation in EBs triggers the expression of E(spl)-C that, in turn, represses Da 
expression thus enabling cell cycle exit to generate an EC cell (Bardin et al., 2010) (Figure 4). 
Interestingly, the commitment of ISC to EB also requires the activation of Notch but at a very 
high level compared to level of Notch signaling required for terminal differentiation of EB to 
EC (Perdigoto et al., 2011). It was suggested that this differential level is required for the 
protection of ISCs from their loss through differentiation. 
An alternative model for cell fate choice suggested that EE cells arise from another type of 
progenitors that do not activate Notch. This hypothesis is based on the fact that EE cell 
progenitors are negative of Su(H)-GBE reporter and that Notch mutant tumors still contain EE 
cells (Biteau and Jasper, 2014; Guo and Ohlstein, 2015; Zeng and Hou, 2015). This model is 
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further refined by recent observations demonstrating that EBs are able to produce a small 
population of class II EE cells (Beehler-Evans and Micchelli, 2015). 
In addition to Notch, the signaling pathway Janus Kinase/signal transducer and activator of 
transcription (JAK/STAT) is also required for terminal differentiation of both ECs and EEs. 
JAK/STAT inhibition in progenitors leads to the accumulation of undifferentiated cells and 
Notch mutant clones lacking JAK/STAT components are devoid of EE cells (Beebe et al., 2010; 
Jiang et al., 2009). Epistasis genetic analyses revealed that Stat92E, the TF downstream of 
JAK/STAT, acts in parallel or downstream to Notch to induce both EC and EE specification 
(Beebe et al., 2010; Jiang et al., 2009). On the other hand, JAK/STAT induces Dl expression in 
ISCs (Buchon et al., 2009b; Jiang et al., 2009), suggesting that JAK/STAT can act both 
downstream and upstream of Notch. Additional functions for JAK/STAT signaling in the 
maintenance of the Drosophila midgut homeostasis are discussed below (section 2.2.3.) 
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Figure 4 : Notch signaling pathway in Drosophila adult midgut  
In ISC Suppressor of Hairless (Su(H)) in association with Hairless bind to the regulatory region of Enhancer of split (E(spl)-
C) and inhibit its expression. In the absence of E(spl)-C the proneural factor Daughterless (Da) is expressed and induces the 
expression of Delta, thus maintaining ISC properties. Delta binds to the Notch receptor expressed at the cellular membrane of 
EBs. Notch intra cellular domain (NICD) translocate to the nucleus where it destabilizes Hairless and binds to Su(H), which 
leads to E(spl)-C derepression, Da repression and EB differentiation (Bardin et al., 2010). 
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2.2.2 Implication of Transcription factors in cell lineage  
Besides signaling pathways, a couple of transcriptional factors are known to determine the cell 
fate choice between EC and EE cells. In the following, I will describe the positive and the 
negative regulators of the EE cell fate determination. 
2.2.2.1 Specific EE fate regulation program 
Bardin et al. have revealed a key role for the proneural bHLH factors of the Achaete-Scute 
complex (AS-C) in the generation of EEs. The deletion of AS-C leads to a complete depletion 
of EEs, whereas the overexpression of either Asense or Scute in ISC/EB is sufficient to expand 
the population of Prospero+ cells (Bardin et al., 2010). Moreover, it has been proposed that 
Scute, a mitogenic factor is transiently expressed in ISCs and leads to their asymmetric division 
producing a new ISC and an EE progenitor (EEP) (Chen et al., 2018). EEPs divide once before 
the accumulation of Prospero causes cell cycle exit and EE differentiation (Chen et al., 2018). 
Numb, an inhibitor of Notch signaling pathway, is asymmetrically dispatched between ISC 
daughter cells during mitosis (Salle et al., 2017). Notch signaling is inhibited in cells that 
inherits Numb, consequently Asense and Scute expression is derepressed and Prospero is 
expressed (Salle et al., 2017).  
In addition to factors required for EE differentiation, negative regulators of this cell fate are 
also detected such as the transcriptional repressor Tramtrack 69 (Ttk69) that inhibits EE cell 
fate (Wang et al., 2015) and disrupts their hormone producing capacity (Wang and Xi, 2015).  
Interestingly EE cells are also able to regulate their number autonomously. Newly formed EE 
expresses the ligand Delta and activates Notch signaling in the apically located ISC. This 
activity blocks EE cell production and maintains ISC multipotency thus they revert to producing 
EC (Guo and Ohlstein, 2015). EE cells autoregulate their number by secreting a ligand called 
Slit. Slit is transduced by Roundabout receptor/leak receptor (Robot2/leak) present at the cell 
surface of intestinal precursor cells. Slit/robot pathway inhibits Prospero expression within ISC 
specifically and then inhibits the generation of new EE (Biteau and Jasper, 2014) (Figure 5).  
33 
 
 
 
 
Figure 5 : EE cell fate regulation 
The achaete-scute complex (AS-C) required for prospero expression and subsequently EE cell production is transiently 
activated in dividing ISC (green) and leads to the generation of a new ISC and enteroendocrine progenitor cell (EEP)(light 
pink). EEP divide once before starting to accumulate prospero protein. In addition, the newly formed EEP inherits the protein 
Numb that inhibits Notch signaling and thus depresses AS-C genes. 
EE cell generation is negatively regulated by the transcriptional repressor tramtrack69 (Ttk69) that inhibits AS-C in parallel to 
Notch. Newly formed EE (dark pink) cells express Delta ligand and activates Notch in the apically located ISC that switches 
to the production of EC cells rather than EE. EE autoregulate their production also by secreting the ligand Slit that activates 
Roundabout receptor/leak receptor (Robot2/leak) present at the surface of ISC leading to the inhibition of prospero expression. 
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2.2.3 Regulation of ISC proliferation and survival  
In addition to a proper differentiation, midgut homeostasis requires a tight regulation of ISC 
proliferation in order to replace damaged cells, but also to prevent excessive ISC proliferation 
that can lead to tumor development. 
In the following section, I will describe our current knowledge of the role of diverse signaling 
pathways in the regulation of ISC proliferation under both homeostatic and stress conditions. 
2.2.3.1 The Wnt/Wingless signaling pathway in Drosophila adult midgut 
In Drosophila midgut (Figure 6, for the canonical Wnt pathway), Wingless (wg) is the only 
ligand that has a functional role in intestinal homeostasis (Cordero et al., 2012; Lin et al., 2008). 
The first evidence about a central role for Wnt signaling in regulating ISC behavior in the 
posterior midgut was reported by Lin et al. (Lin et al., 2008). wg expression was initially 
detected in the muscle layer surrounding the midgut. By generating clones lacking components 
of the Wnt pathway such as the receptor Frizzled, they observed a reduction of ISC proliferation 
rate that continue to produce EC and EE (Lin et al., 2008). Consistently the overexpression of 
wg in esg+ cells was sufficient to induce an expansion of esg+ Dl+ cells. This study led to the 
conclusion that Wnt signaling is necessary and sufficient to maintain ISC self-renewal and that 
the surrounding VM may serve as ISC niche (Lin et al., 2008). 
Other studies brought different results about the source of Wnt ligands and the site of Wnt 
signaling activation. Takashima et al detected Wg in epithelial cells at the midgut hindgut 
junction (Takashima et al., 2008). Buchon et al. have observed an enrichment of Wnt signaling 
reporter genes expression at the different midgut boundaries (Buchon et al., 2013); this 
expression decreases within the different midgut compartments. Tian et al demonstrated that 
EC cells rather than ISC cells are the primary site of Wnt signaling activation within Drosophila 
adult midgut (Tian et al., 2016). This activity is required to inhibit growth factors release from 
EC such as Upd2 and Upd3 that act as paracrine signals and activate ISC proliferation (Tian et 
al., 2016).  
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Figure 7 : Canonical JAK/STAT signaling in Drosophila  
(Arbouzova and Zeidler, 2006).  
 
 
Figure 6 : Canonical Wnt signaling in Drosophila 
The β-catenin protein known as Armadillo (Arm) in Drosophila is a key effector in the Wnt signaling cascade. In normal 
conditions, β-catenin is kept in the cytoplasm where it is phosphorylated by a “destructive complex” composed of four kinases: 
Axin, Adenomatous polyposis Coli (APC), Glycogen Synthase Knase 3 (GSK3) and Casein Kinase 1α (Ck1α) (Kishida et al., 
1998). This phosphorylation induces the ubiquitination of β-catenin that is then targeted to proteasome degradation. Upon Wnt 
binding to Frizzled (FZD) and lipoprotein receptor related protein 6 (LRP6), the receptor complex is endocytosed and the 
protein Dishevelled (Dvl) form polymers at the cytoplasmic domain of the receptors. Together, LRP6 FZD and Dvl form the 
Wnt signalosome that sequestrates and inactivates the destruction complex. β-cat thus reaches the nucleus where it acts in 
collaboration with Pangolin (a.k.a. TCF/LEF) to induce the expression of Wnt target genes (Korinek et al., 1997; Morin et al., 
1997) (adapted from Clevers et al; 2012). 
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2.2.3.2 Epidermal Growth Factor Receptor (EGFR) pathway 
Under homeostatic conditions, EGFR signaling is activated in ISC/EB by three redundantly 
active ligands released from different sources (Biteau and Jasper, 2011; Jiang et al., 2011; Xu 
et al., 2011). Visceral muscles produce the ligand Vein, Keren is released from ECs, and Spitz 
is expressed in ISCs and EBs. Clones mutant for EGFR components do not proliferate (Biteau 
and Jasper, 2011; Jiang et al., 2011; Xu et al., 2011). As for Wnt, EGFR inhibition does not 
alter the survival nor the differentiation of ISCs. In contrast, a gain of function of EGFR is 
sufficient to induce ISC overproliferation. Basal levels of EGFR signaling are maintained by 
different mechanisms avoiding tumor generation by excessive ISC proliferation: Jin et al have 
demonstrated that the MAP kinase cascade induced upon EGFR activation phosphorylates 
Capicua a major inhibitor of both cell cycle gene and Pointed, the transcription factor activated 
downstream of EGFR signaling pathway. Phosphorylated Capicua is then excluded from the 
nuclei, pnt and cell cycle genes repression is released and ISC proliferation is induced (Jin et 
al., 2015). Moreover, EGFR signaling levels are kept in check by chromatin modifiers called 
Kismet and Trr (Gervais et al., 2019). These two complexes cooperate to induce the expression 
of an EGFR regulatory gene called Cbl within ISCs. Trr and Kismet loss of function inhibits 
Cbl expression and leads to abnormal ISC accumulation, associated with a significant increase 
in EGFR activity.  
2.2.3.3 The JAK/STAT signaling pathway 
In Drosophila, the JAK/STAT signaling pathway is a major player of tissue homeostasis. It is 
required for the coordination of stem cell proliferation and differentiation in many tissues. In 
addition, it is required for testis niche maintenance and digestive tract development (Arbouzova 
and Zeidler, 2006). 
JAK/STAT signaling is initiated by binding of glycosylated Unpaired (Upd1) (Harrison et al., 
1998) and Upd-like proteins (Upd2, Upd3) (Agaisse et al., 2003; Gilbert et al., 2005; Hombria 
et al., 2005) to the receptor Domeless (Dome) (Brown et al., 2003; Chen et al., 2002). The signal 
is then transduced within the cells through the receptor associated JAK kinase Hopscotch (Hop) 
(Binari and Perrimon, 1994) and the transcription factor Stat92E (Hou et al., 2002; Yan et al., 
1996). When activated, Stat92E dimerizes and translocates to the nucleus to induce the 
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expression of target genes, including Socs36E a negative regulator of JAK/STAT and Stat92E 
itself (Arbouzova and Zeidler, 2006) (Figure 7).  
Upd ligands are released from multiple sources, but JAK/STAT activity is only detected in 
ISC/EBs (Beebe et al., 2010; Jiang et al., 2009; Liu et al., 2010). Osman et al. have reported 
that Upd1 is released from ISCs and acts in autocrine manner to induce ISC proliferation in 
baseline conditions (Osman et al., 2012). In ageing flies, ISC proliferate abnormally, this feature 
is partially mediated by both Upd2 and Upd3 ligands released from EBs and ECs. In addition, 
these two ligands are also overexpressed upon bacterial infection in order to induce rapid 
epithelial turnover (Osman et al., 2012). Upd ligands are also released from the inner circular 
muscles and the outer longitudinal muscles and activate JAK/STAT signaling within ISC/EB 
cells (Lin et al., 2010). Clones mutant for JAK/STAT components are less proliferative and 
lack mature cells, while elevated signaling levels accelerate the rate of ISC division. Hence, 
JAK/STAT pathway regulates ISC proliferation and differentiation in healthy and pathogenic 
conditions. 
2.2.3.4 The Hippo pathway: autonomous and non-autonomous restriction of ISC 
proliferation 
The Hippo pathway also plays a pivotal role in the regulation of ISC proliferation. Hippo 
pathway, which is regulated by mechanical forces applied on cells, ensure an adapted organ 
growth and an efficient tissue renewal by regulating both cell proliferation and apoptosis 
(Harvey et al., 2003; Pantalacci et al., 2003; Thompson and Cohen, 2006; Udan et al., 2003; 
Wu et al., 2003). 
The Hippo complex is composed of four kinases: Warts (wts) (Justice et al., 1995; Xu et al., 
1995), Hippo (hpo) (Harvey et al., 2003; Pantalacci et al., 2003; Udan et al., 2003; Wu et al., 
2003), mob as tumor suppressor (mats) (Lai et al., 2005) and Salvador (Sav) (Kango-Singh et 
al., 2002; Tapon et al., 2002). Hpo phosphorylates Sav and thus stabilizes their physical 
interaction (Aerne et al., 2015; Wu et al., 2003). Hpo than phosphorylates Mats that interacts 
with Wts and potentiates its kinase activity (Justice et al., 1995; Wei et al., 2007; Wu et al., 
2003). The kinase cascade inactivates a unique nuclear effector called Yorki (Yki) (Huang et 
al., 2005; Oh and Irvine, 2008; Ren et al., 2010b), a transcriptional coactivator that induces the 
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expression of antiapoptotic (DIAP1) and cell cycle genes (Cyclin E) (Dong et al., 2007; Huang 
et al., 2005).  
Within ISCs, Hippo inhibits Yki expression required for ISC proliferation (Huang et al., 2005; 
Karpowicz et al., 2010; Ren et al., 2010a; Shaw et al., 2010). Yki gain of function (or wts loss 
of function) induces abnormal ISC proliferation by surexpression of DIAP1 and Cycline E 
(Shaw et al., 2010). Moreover, Yki is required for ISC proliferation following pharmacological 
or immune stress (Ren et al., 2010a). Yki activity is dependent of its physical association to two 
proteins: Scalloped (Sd) and Brahma. The complexe Yki/Sd/Brahma binds to Yki target genes 
and promotes ISC proliferation (Jin et al., 2013). Interestingly, in steady state conditions Hippo 
activates caspase proteins that induce programmed cell death. These caspases inactivate 
Brahma by inducing its proteolytic cleavage (Jin et al., 2013) (Figure 8). 
In addition, Hippo signaling acts non-autonomously within EC cells in order to restrict ISC 
proliferation. In damaged ECs, Yki increases the expression of both Upd (Shaw et al., 2010; 
Staley and Irvine, 2010; Vodovar et al., 2005) and Keren (Ren et al., 2010a). Subsequently, 
both JAK/STAT and EGFR signaling are activated within ISCs, inducing their proliferation. 
Therefore, the Hippo signaling pathway in general -and Yki in particular- acts as a sensor of 
epithelia stress within ECs allowing them to signal to the ISC when damaged. 
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Figure 8 : Overview of the Hippo pathway in Drosophila 
Adapted from (Taha et al. ; 2018)  
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2.2.4 Regulation of ISC behavior in stress conditions  
The intestine is an organ in continuous contact with the surrounding environment. Thus, in 
addition to the normal regeneration of the tissue, the gut has also to cope with external stresses 
like physical (lesions), chemical (oxidative stress) or infectious aggressions. To re-establish the 
integrity of the tissue and ensure a functional physiological state of the organ, ISCs are also 
actively solicited. A careful control of their proliferative potential is then indispensable and 
ensured by the same signaling pathways that are active in basal conditions. In the following 
section, I will describe some experimental approaches used to induce the fly midgut 
regeneration. In the second part, I will describe different signals that are communicated to ISC 
in stress conditions in order to activate mitogenic signaling pathways mainly EGFR, Wnt and 
JAK/STAT. 
 
2.2.4.1 Experimental techniques used to study the midgut regeneration  
In order to study ISC response to epithelial damage several approaches involving feeding flies 
different tissue-damage inducing agents have been used: 
1. Oral infection of flies with different strains of pathogenic bacteria (Pseudomonas 
entomophila, Erwinia carotovora (Ecc15), Pseudomonas aeruginosa, Serratia 
marcescens, Escherichia coli...) (Apidianakis et al., 2009; Buchon et al., 2009a; 
Buchon et al., 2009b; Cronin et al., 2009; Vodovar et al., 2005). 
2. Chemicals feeding with compounds like Hydrogen peroxide and Paraquat (Choi et al., 
2008) that induce oxidative stress, dextran sodium sulfate (DSS) that disrupts the 
basement membrane, or Bleomycin, a cytotoxic antibiotic that causes damages to ECs 
(Amcheslavsky et al., 2009). 
3. The targeted expression of proapoptotic genes such as reaper (Rpr) within EC cells 
inducing their death (Jiang et al., 2011). 
2.2.4.2 Signaling pathways in midgut regeneration upon damages 
Differentiated ECs are the first target of bacterial infections and cytotoxic agents since these 
cells are the first to encounter the stressors. Indeed, pathogenic bacterial infection or Bleomycin 
treatment induce EC apoptosis and removal from the intestinal epithelium (Amcheslavsky et 
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al., 2009; Apidianakis et al., 2009; Buchon et al., 2010; Jiang et al., 2009). ISCs respond to EC 
loss by increasing their proliferative capacity in order to replenish the midgut. Interestingly, 
apoptosis inhibition within ECs abolishes ISC proliferation, whereas the apoptosis induction by 
the expression of Rpr in ECs is sufficient to induce ISC proliferation, even in the absence of 
infection (Jiang et al., 2011). Thus, EC apoptosis is a main signal for the activation of ISC 
proliferation upon gut damages.  
At the molecular level, damaged ECs secrete the Upd3 ligand that activates JAK/STAT 
signaling within ISCs, therefore inducing their proliferation (Buchon et al., 2009a; Cronin et 
al., 2009; Jiang and Edgar, 2009). Moreover, Upd3 released from damaged EC signals to the 
surrounding visceral muscles that transduce the JAK/STAT signaling and release Vein that also 
induces ISC proliferation (Buchon et al., 2010; Jiang et al., 2011). The other EGFR ligand 
Keren is also released from damaged EC and further potentiates ISC proliferation (Buchon et 
al., 2010; Jiang et al., 2011). Interestingly, EGFR signaling is also required for both damaged 
EC-detachment from the epithelium and their morphogenesis during regenerative episodes 
(Buchon et al., 2010). Indeed, EGFR inhibition within infected ECs blocks the disruption of 
cell-cell adhesion and their subsequent delamination from the epithelium, and abolishes ISC 
proliferation (Buchon et al., 2010). Recently, an additional function of EGFR within 
regenerating EC was also reported. In addition to ISC proliferation, endoreplication within EC 
provides a mechanism of infection-induced regeneration to compensate for lost cells. During 
regeneration, newly formed ECs inherit the activated EGFR signaling from EB, post-
transcriptionally activate the translational factor E2F gene and undergo multiple rounds of 
endoreplication that lead to EC hypertrophy and higher ploidy (Xiang et al., 2017).  
EBs also participate to the induction of ISC proliferation. Upon damage, EBs secrete the EGFR 
ligand Spitz and the JAK/STAT ligand Upd and activate these pathways within ISCs inducing 
their proliferation (Buchon et al., 2010; Jiang et al., 2011; Tian et al., 2015). Similarly, 
following infection or DSS treatment, Wg is secreted by EBs and activates Wnt signaling within 
ISCs via the activation of Myc expression (Cordero et al., 2012). It has been shown that the 
RAL GTPase proteins (RAL) are expressed in ISC/EB and are required for membrane receptor 
endocytosis within ISCs to properly induce Wnt signaling. RALA acts downstream of the Wg 
ligand and upstream of β-catenin and its overexpression is sufficient to induce Wnt activation 
42 
 
 
 
and ISC proliferation upon damages. Moreover, the same mechanism is conserved in murine 
intestine (Johansson et al., 2019). 
Investigating the communication between signaling pathways, epistasis genetic analysis 
demonstrated that the Upd capacity to induce ISC proliferation upon infection is abolished in 
an EGFR mutant background. Thus, EGFR acts downstream of JAK/STAT in order to induce 
ISC proliferation upon acute damage (Buchon et al., 2010; Jiang et al., 2011; Xu et al., 2011). 
In the same line, Xu et al. showed that EGFR, Wnt and JAK/STAT act redundantly in the 
regulation of ISC proliferation in steady state condition and that simultaneous inhibition of the 
three signaling pathways induces ISC loss (Figure 10). 
Despite the critical requirement for these signaling pathways in the regulation of ISC behavior, 
their activity is not exclusive to these cells. It is rather conserved in different type of organs 
among diverse species. Thus, it is important to look for intrinsic factors that specifically 
characterize adult stem cells. In the Drosophila adult midgut, escargot (esg) is expressed in 
ISC/EB and it is a hallmark of diploid cells including germline stem cells and cyst stem cells 
of the adult testis (Kiger et al., 2000; Voog et al., 2014) in addition to imaginal discs during 
development (Fuse et al., 1994). 
2.2.5 The importance of EMT-inducing factors in ISCs 
Clones lacking Esg or the zeb TF Zfh1 loose Dl-positive ISCs and they are solely composed of 
differentiated cells. It was shown that esg knockdown induces an upregulation of Pdm1 and 
Prospero, as well as other differentiation markers. Dam-ID profiling further showed that Esg 
represses the expression of differentiation genes by direct binding to their regulatory regions 
under basal conditions (Korzelius et al., 2014). In regenerating guts, when the production of 
new ECs is vital, Pdm1 represses the expression of esg in differentiating EBs thus ensuring a 
rapid turnover of lost cells (Korzelius et al., 2014; Tang et al., 2018). Within EBs, Esg is 
required at two different levels. First, it enables EBs to form long protrusions that establish 
contacts with differentiated cells. This mesenchymal-like phenotype allows EBs to sense 
environmental cues, pausing their differentiation until a signal is communicated from 
neighboring dying ECs (Antonello et al., 2015). Expression of miR-8, the fly homolog of the 
mammals miR200, represses the expression of esg and zfh1, the homologous gene of the EMT-
TF Zeb, and induces final differentiation of EB into EC. On the other hand, esg plays a central 
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role in the EC fate decision by directly inhibiting the expression of a negative regulator of Notch 
called Amun (Loza-Coll et al., 2014). 
Therefore, esg plays a pivotal role in both maintenance of stemness and the cell fate choice 
between EEs and ECs (Figure 9). 
 
 
Figure 9: esg TF regulates both stemness and ISC differentiation 
Within ISCs (green) and EBs (orange), Esg activates the transcription of stemness genes (Dl) and inhibits that of differentiation 
genes, Pdm1, Prospero (pros). High Esg levels in EBs leads to the formation of cellular protrusions that sense the external 
environment. The balance between Esg and miR8 triggers EC terminal differentiation. Within EBs, Esg also inhibits the 
expression of Amun, a negative repressor of Notch. Esg expression is inhibited by Pdm1 within ECs. 
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Figure 10 : ISC regulation by neighboring cells and tissues  
ISC receive signals from both epithelial (EC : Enterocytes, EE: Enteroendocrine, EB : Enteroblast) and non epithelial sources 
( VM : visceral muscles , basement membrane and enteric neurons). Some cells such as the EE regulate ISC activities indirectly 
via the VM. 
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2.3 Evolutionary conservation between mammals small intestine and 
Drosophila adult digestive tract  
Although there is a physiological divergence between vertebrates and insects, there is a great 
potential for modelling human intestinal diseases in Drosophila because of the high level of 
preservation between the two models with regard to the cellular lineage and the signaling 
pathways that regulate both ISC proliferation and differentiation. 
In the following section, I will compare the Drosophila adult midgut to its mammalian 
counterpart, the small intestine. I will describe the small intestine structural organization, the 
cellular lineage and plasticity as well as the signaling pathways implicated in the gut 
homeostasis. In the final part, I will discuss the effect of signaling pathways deregulation in 
both intestinal cancer initiation and progression.  
2.3.1 Comparison between structural and cellular organization 
In contrast to the simple linear epithelium that lines the Drosophila adult midgut, the 
mammalian small intestine is ordered in crypt of Lieberkühn, tubular epithelium invagination 
that harbors ISC and thus constitutes a proliferative zone and the intestinal villi that project into 
the intestinal lumen and represent the differentiated segment (Schmidt et al., 1988; Wright, 
2000). Despite these structural differences absorptive EC and secretory cells accomplish the 
mammalian small intestine major functions. The secretory cell lineage is further divided into 
EE cells that produce systemic hormone, and two additional cell types not found in Drosophila: 
Goblet cells that secrete mucin and facilitates the transition of compact stools into the colon, 
and Paneth cells, the only crypt-resident differentiated cells secret protective antimicrobials 
products and constitute an important niche for ISC (Barker et al., 2008) (Figure 11). As 
mentioned earlier, Drosophila EE cells are subdivided into four different classes (Beehler-
Evans and Micchelli, 2015). Further investigations are required to test whether these 
populations resemble Goblet or Paneth cells. 
In mammals, ISCs divide once per day and generate progenitors known as transient amplifying 
cells (TA), owing to their capacity to divide four-five times before terminally differentiating 
into Enterocytes (EC) or secretory cells while leaving the transient amplifying compartment 
toward the villi (Heath, 1996). In Drosophila, EB are post mitotic and thus give rise to EC 
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without further division while EE progenitors conserve a restricted mitotic capacity similarly 
to TA cells (Guo and Ohlstein, 2015). 
At the structural level, Evidences about region specific identity within mammalian small 
intestine are also emerging. The expression of genes encoding for digestive enzymes, ion 
transporters, and antimicrobial peptides among others is highly regionalized (Bradley et al., 
2011; Cash et al., 2006; Rindi et al., 2004). This regionalization is also governed by region-
specific TF such as GATA and CDX2 . Moreover, the region-specific expression profile is 
maintained for a long time in the absence of environmental stimuli. 
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Figure 11 : The mammalian intestinal epithelium 
The adult mammalian intestine is organized into crypts and villi. The crypt is the proliferative zone 
containing two types of ISC, LGR5+ stem cells and +4 cells interspersed between Paneth cells. 
ISC give rise to transient activating cells (TA) that proliferate and give rise to differentiated cells 
in the villus zone. Villi contains 4 types of differentiated cells: Enterocytes, Tuft cells, 
Enteroendocrine cells and Goblet cells. 
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2.3.2 Cellular plasticity  
Within the mammals small intestine there is two types of ISC: the +4 cells that occupy the 4th 
position above the crypt basis (Cairnie et al., 1965) and the Crypt base columnar cells (CBC) 
located between Paneth cells and named after their shape and their position (Cheng and 
Leblond, 1974). +4 cells are quiescent and characterized by the expression of transcriptional 
repressor Bmi1, required for the maintenance of their undifferentiated state (Tian et al., 2011) 
whereas CBC cells divide rapidly and are characterized by the expression of the Leucine-rich 
G protein-coupled receptor 5 gene (Lgr5) encoding for R-spondin receptor that potentiates the 
Wnt signaling pathway (Barker et al., 2007). Recently the Bmi1+ were named “reserve stem 
cells” due to their capacity to replace lost CBC cells (Tian et al., 2011). On the other hand, the 
organoids generated from a single CBC contain Bmi1+ cells. Moreover, some types of 
progenitor cells located at +4 positions are also able to dedifferentiate in order to produce CBC 
upon their ablation (Takeda et al., 2011). Thus, the intestinal epithelial homeostasis relies on 
the plasticity of active ISC: the CBC, reserve stem cells: Bmi1+ and committed progenitors. 
 In Drosophila, evidences about different ISC types were brought by the work of many 
laboratories. the work of Marianes and Spradling has demonstrated that the ISC of the posterior 
midgut are the most active whereas those of the anterior and the middle midgut are relatively 
quiescent. Moreover they have proved the presence of ISC with different morphology and 
division rate (Marianes and Spradling, 2013).  
Concerning the cellular plasticity in the Drosophila adult midgut, a recent study have 
demonstrated that in a situation of extreme stress (food deprivation for 2 days) ISC/EB cells are 
completely lost in posterior midgut and the gut is shortened (Lucchetta and Ohlstein, 2017). 
Surprisingly, after refeeding flies, the gut length is restored to wild type in one day and the 
number of ISC increases significantly. By performing lineage tracing analysis it was 
demonstrated that 4n polyploid pre-EC are able to dedifferentiate and give rise to diploid ISC 
by a process called amitosis. 
2.3.3 Conservation of signaling pathways 
In the following paragraph, I will briefly describe the regulation of mammalian ISC 
proliferation by both Wnt and Notch pathway and their differentiation by BMP. 
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2.3.3.1 The Wnt signaling pathway in homeostasis 
In the mammalian intestine, Wnt signaling is the main mitogenic pathway. It forms a decreasing 
gradient from the crypt toward the villus, with the highest activity located at the basis of the 
crypt (Batlle et al., 2002; Munoz et al., 2012). During homeostasis, Wnt is required for the 
maintenance of CBC, as well as for Paneth cell terminal differentiation. Wnt inactivation (van 
Es et al., 2012) inhibits CBC proliferation in both normal and pathogenic conditions and thus 
leads to crypt loss (Kuhnert et al., 2004; Pinto et al., 2003). Both Paneth cells and the 
surrounding stroma secrete Wnt ligands (Sato et al., 2009; Valenta et al., 2016). In Drosophila, 
both surrounding muscles and EB cells provide the Wnt ligand. Thus, the niche aspect of Wnt 
ligand as well as the function of Wnt signaling in ISC proliferation are both conserved in the 
Drosophila adult midgut. 
2.3.3.2 The Notch signaling pathway  
In contrast to its role in limiting ISC proliferation in Drosophila, Notch is a main mitogenic 
pathway in mammals. The inhibition of Notch signaling induces a complete loss of CBC and 
TA, associated with a large increase in the number of secretory cells (Milano et al., 2004; van 
Es et al., 2005). In contrast, overexpression of  NICD is sufficient to induce the expansion of 
the proliferative compartment and the loss of the secretory lineage (Fre et al., 2005).Hence, 
Notch signaling governs both ISC proliferation and EC cell fate choice in the mammal’s 
intestinal crypt.  
Interestingly, as mentioned earlier Notch signaling pathway is required for the production of 
EC in Drosophila adult midgut and the inhibition of Notch signaling in the midgut induces 
secretory cells accumulation (Ohlstein and Spradling, 2007). Thus, some aspects of Notch 
signaling are conserved between Drosophila and mammals intestine. 
2.3.3.3 The Bone Morphogenetic Protein (BMP) signaling pathway  
BMP proteins are growth factors, belonging to the TGF-β family (Feng and Derynck, 2005; 
Massague, 2012; Miyazono et al., 2005; Moustakas and Heldin, 2009). 
Profile analysis of BMP signaling components in mammals small intestine revealed that the 
BMP ligand expression is enriched in the mesenchymal region surrounding villi (Bitgood and 
McMahon, 1995; Haramis et al., 2004; Hardwick et al., 2004). The inhibition of BMP signaling 
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in mice intestine induces and ectopic formation of crypts in the villi region and ISC over 
proliferation, induced by Wnt signaling upregulation. Moreover, mice defective for Bmp 
receptor have altered intestinal morphology, in addition to a defective secretory lineage terminal 
differentiation (Auclair et al., 2007). Thus, in contrast to Notch signaling, BMP signaling limits 
ISC hyper proliferation and is required for secretory cell lineage differentiation. 
In Drosophila adult intestine, the function of BMP signaling is so controversial: An initial study 
by Tian et al in 2013 has demonstrated that BMP signaling is required for ISC self-renewal in 
both normal and stress conditions, by antagonizing Notch signaling pathway in basally locate 
ISC (Tian and Jiang, 2014). Later on, it was demonstrated that damaged EC cells secrete Bmp 
ligands that activates ISC pool expansion by favoring ISC symmetric division (Tian et al., 
2017). After recovery, BMP signaling is auto inhibited in EC cells in order to repress ligand 
secretion and to restore ISC proliferation to basal levels (Tian et al., 2017). During regeneration, 
BMP activation within ISC cells limits their proliferation, providing an effective equilibrium 
between signals and an efficient response to damages (Guo et al., 2013). The finding of both 
Guo et al and tian (after recovery) are in line with the function of BMP as growth inhibitory 
factor in mammalian intestine. An additional role of BMP in cell differentiation is also observed 
in the middle midgut where it is required for the specification of proton secreting cells called 
copper cells (Guo et al., 2013; Li et al., 2013) as well as in the midgut for the differentiation 
and growth of EC cells (Tian and Jiang, 2014; Zhou et al., 2015). 
2.3.4 The deregulation of ISC function: intestinal cancer initiation and progression 
Given the great conservation between mammals and Drosophila adult midgut organizations, 
functions and regulatory mechanisms, in addition to the 70% similarity in disease genes, the 
Drosophila intestine has also been used to model colorectal cancers. 
In both mammal’s small intestine and Drosophila midgut, the main event leading to cancer 
initiation is ISC hyper proliferation, induced either by over activation of mitogenic signaling 
pathways or by inhibition of differentiation pathways (Apidianakis et al., 2009; Ohlstein and 
Spradling, 2007; Sansom et al., 2004). In human, Wnt constitutive activation by APC loss of 
function is the leading cause of colorectal cancers (Sansom et al., 2004). In the Drosophila 
midgut, the Apc1 mutation mimics the tumor development observed in mammals (Cordero et 
al., 2009; Lee et al., 2009). In both cases, the proto-oncogene Myc (a downstream effector of 
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Wg signaling) is upregulated and required for tumor maintenance (Athineos and Sansom, 2010; 
Cordero et al., 2009; Finch et al., 2009; Lee et al., 2009; Sansom et al., 2007). Following 
initiation by APC LOF and Myc upregulation, tumor progression from adenoma to invasive 
carcinoma in both mammals and Drosophila requires the mutation of the proto-oncogene K-
RAS, encoding a small GTPase that transduces external signals to the nucleus and mutated in 
40 to 50% of colorectal cancers (Sansom et al., 2006; Wang et al., 2013) (Figure 12). 
In the fly adult midgut, tumor initiation is accelerated by pathogenic bacterial infections. 
Indeed, dying EC cells secrete mitogenic signaling molecules that potentiate ISC proliferation. 
As it is known for tumor cells, proliferating ISC also secrete autocrine growth factors (Figure 
14). 
As discussed is this paragraph, an excess ISC proliferation can lead to tumor development, 
whereas a week ISC activity can lead to the gut degeneration. Thus, it is tempting to speculate 
the intrinsic factors that act downstream of the complex regulatory pathways in basal 
physiological conditions in order to maintain the pool of ISCs and to regulate their proliferation 
rate. In the following part, I will focus on the recent findings on the TF called Shavenbaby, the 
equivalent of the mammalian OvoL in Drosophila. 
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Figure 12 : ISC implication in intestinal cancer 
ISC tumors are genetically induced within ISC by : Notch inhibition, EGFR activation, Wnt activation (APC loss/ 
Wg overexpression ) in addition to tumor suppressor genes inhibition. Additional stress signals (infection) induces 
EC death that induces ISC proliferation and tumor initiation. Dividing cells secrete autocrine signals that sustain 
tumor growth. Growing tumors invade the neighboring EC and induces their detachment. Detached EC activates 
the stress signal JNK and inhibits Hpo pathway and subsequently secretes paracrine signals (Upd2,Upd3). VM also 
secretes growth factors. Wnt activation induces Myc expression within ISC/EB. Myc activates Spitz that signals 
to EC where it activates EGFR signaling. EGFR signaling within EC induces Upd3 ligand release. Upd3 activates 
JAK/STAT signaling within ISC. Spitz and Stat together induces intestinal hyperproliferation. K-Ras oncogene is 
required for both tumor initiation and growth following APC LOF.  
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3 OvoL/Shavenbaby factors and stem cells 
My thesis director, Dani Osman, was a post-doctoral fellow in the lab of Bruno Lemaitre at 
Ecole Polytechnique Federale of Lausanne (EPFL), where he studied several aspects of 
Drosophila adult midgut organization, such as antero-posterior regionalization, and the 
regulation of ISC behavior by signaling pathways. He observed that the Shavenbaby TF (and 
some of its target genes) are expressed in the adult midgut. He further showed that Svb is 
required downstream of both EGFR and WNT signaling, in order to ensure proper ISC 
proliferation. Interestingly, Svb integrates the same signaling pathways in Drosophila embryo 
during terminal differentiation. Moreover, Svb germinal isoforms called Ovo are required to 
maintain female germline stem cells. Based on these data, we decided to explore in more detail 
the requirement for Svb in the Drosophila adult midgut homeostasis and ISC behavior. I began 
my thesis in the new lab of Dani in the Doctoral School of Sciences and technologies at Tripoli, 
Lebanon. There, I validated the expression of svb and some target genes in the adult midgut and 
learned how to handle the powerful genetic tools available in Drosophila. At the end of my first 
year, I moved to France to join the lab of Francois Payre, who has contributed to the 
identification of ovo/Shavebaby, as well as deciphering the molecular mechanisms involved in 
the morphogenesis of the Drosophila embryonic epidermis. 
In the following section, I will summarize current knowledge on svb/ovo, emphasizing its 
functions in Drosophila and I will discuss the functions of ovo/svb homolog in various species. 
I will focus in more detail on its mode of action and the signaling pathways that regulate its 
expression in embryos. I will also present findings of François’ lab concerning the mechanisms 
that provide a strict control to Svb transcriptional activity. 
3.1 The ovo/shavenbaby locus  
Shavenbaby (Svb) is a zinc finger transcription factor (Mevel-Ninio et al., 1991) encoded by 
the ovo/shavenbaby locus located on the X chromosome (Busson et al., 1983; Oliver et al., 
1994). The locus encodes three main protein isoforms, from alternative promoters. There are 
two germline-specific proteins OvoA and OvoB, and Shavenbaby is the protein expressed in 
somatic tissues (Mevel-Ninio et al., 1995).  
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Figure 13: The ovo/shavenbaby locus encodes three different protein isoforms 
Schematic representation of the ovo/svb locus, with encoded mRNAs and corresponding proteins. Coding sequences 
(CDS) are in blue and non-coding regions in white. The three isoforms contain four zinc fingers (gray circles) in addition 
to a transcription activation domain (green). Svb and OvoA contain an additional repression domain (pink) and Svb 
comprises a specific N terminal extension (light blue) encoded by the 1s exon (Delon et al. 2003). 
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All three isoforms share the same DNA binding and transcriptional activator domains. Whereas 
OvoB is a transcriptional activator, OvoA possess an additional repression domain and thus 
acts as a transcriptional repressor (Andrews et al., 2000; Mevel-Ninio et al., 1995). Of note, the 
first exon of ovoB mRNA is non-coding, and the translation starts only at a very downstream 
AUG located in exon 2a, despite an open reading frame covering the whole exonic sequence. 
Svb entirely overlaps OvoA and possesses an additional N terminal region, encoded by a 
somatic-specific exon called 1s (Delon et al., 2003) (Figure 13). 
3.2 Ovo functions in the germline 
The first ovo mutation was identified in Drosophila, in a screen of recessive X-linked mutations 
inducing female sterility (Mohler, 1977). Later on, somatic genetic screens have identified 
mutations at the same locus, called shavenbaby, since mutant embryos are devoid of epidermal 
trichomes (Wieschaus et al., 1984). Mutations affect either ovo function or svb function, or 
both, suggesting that both functions are encoded by a common locus (Oliver et al., 1987). The 
ovo/svb locus is therefore required during development for two distinct functions, one somatic 
(svb) in both sexes and the other in the female germline (ovo) (Mevel-Ninio et al., 1995). 
Ovo proteins are implicated in the differentiation, survival, and sex determination of the female 
germ line (Garfinkel et al., 1994; Mevel-Ninio et al., 1991; Mével-Ninio et al., 1995; Oliver et 
al., 1987). A large number of ovo mutations have been identified and induce progressive 
defects, from defective oocyte maturation, oogenesis interruption, tumor formation and a 
complete loss of germ cells. Ovo proteins regulates the expression of ovarian tumor (otu), a 
gene required for ovarian differentiation and also leading to tumors (Gans et al., 1975; King 
and Burnett, 1957; King and Storto, 1988; Oliver et al., 1993; Oliver and Pauli, 1998; Oliver et 
al., 1987; Pauli et al., 1993) as well as that of ovo itself, through direct binding to their proximal 
promoter region (Lu et al., 1998; Lu and Oliver, 2001). 
The two germinal isoforms, OvoA and OvoB are differentially expressed in the course of 
ovarian development. The ovoB promoter is active throughout oogenesis, whereas the ovoA 
promoter displays barely detectable activity until the very end of oogenesis (Andrews et al., 
2000). Dominant sterile mutations have been identified (OvoD) and show gradual phenotypes 
that are reminiscent of the progressive loss of ovo function (Busson et al., 1983; Campos-
Ortega, 1983; Kerridge and Dura, 1982; Oliver et al., 1987; Perrimon et al., 1986). Molecular 
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analysis of ovoD mutations revealed that they result from the creation of a new AUG codon 
upstream of the normal translation start site of the OvoB protein. OvoD mutations thus lead to 
the premature production of OvoA, which antagonizes OvoB for the control of germ line 
(Andrews et al., 1998; Mevel-Ninio et al., 1996). Thus, the fine regulation of ovoA and ovoB 
expression is critical for the formation and differentiation of the germline.  
At the beginning of embryogenesis, OvoB mRNA is uniformly distributed in the syncytial 
blastoderm (Mevel-Ninio et al., 1995) then it accumulates within polar cells, also known as 
primordial germ cells (PGC,), which give rise to germline cells (Hayashi et al., 2017). Within 
PGCs, OvoB activates the expression of genes required for germline specification, including 
vasa, nanos and piwi. The knockdown of OvoB or the expression of OvoA specifically within 
PGC leads to the formation of agametic ovaries and testes in adults. A similar function is also 
observed in mice, with OvoL2 being expressed in PGCs and required for their development 
(Hayashi et al., 2017). Moreover, OvoL1 is also expressed later in adult mice testes, within 
spermatocytes and spermatids and is required for proper germline maturation (Li et al., 2005). 
ovo1 mutants were previously shown to display hypogenitalism and have reduced ability to 
reproduce (Dai et al., 1998). 
Hence, ovo is an important regulator of the germ line in a broad range of animals. 
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3.3 Svb is required and sufficient for trichome formation  
Drosophila embryos are characterized by the alternance of epidermal cells with a smooth 
surface and cells that form apical extensions called trichomes (Figure 14). At the end of 
embryogenesis, epidermal cells secrete a complex exoskeleton called cuticle, which displays a 
stereotyped pattern of trichomes providing an exquisite readout of embryonic development, 
with specific trichomes organization along the anterior-posterior and dorsal-ventral axes (Payre, 
2004). svb mutants have been isolated from the genetic screen performed by Nusslein and 
Wieschaus (Nusslein-Volhard et al., 1984; Wieschaus et al., 1984), since they display an almost 
complete lack of trichomes (Figure 16). Consistently, svb is specifically expressed in trichome 
cells (Mevel-Ninio et al., 1995; Payre et al., 1999) and its ectopic expression, in smooth cells, 
is sufficient to force the formation of extra trichomes (Payre et al., 1999). 
3.4 Ovo/svb functions across animal species 
ovo/svb is specific to metazoans and well conserved throughout animals (Kumar et al., 2012). 
In mammals, there are three genes called OvoL-1, -2 and -3 initially described for their 
conserved role in epidermal differentiation and germline development (Dai et al., 1998; Hayashi 
et al., 2017). In addition to these two tissues, studies in various species have disclosed a wide 
range of additional functions for ovo/svb orthologs. 
For example, in Caenorhabditis elegans worms lin-48 is also required for the development of 
the hindgut, the male tail and the excretory duct cell (Johnson et al., 2001). OvoL2 is an 
important regulator of kidney formation and homeostasis in mice (Aue et al., 2015; Dai et al., 
1998). The murine renal collecting duct is lined by specialized epithelial cells, characterized by 
the expression of Grainyhead-Like homolog 2 (Grhl2). GrhL2 is a transcription factor that 
associates to the Histone 3 lysine 4 trimethylation (H3K4me3), a marker of transcriptionally 
active chromatin. OvoL2 is a direct target of Grhl2 in the renal collecting duct, and its re-
expression is sufficient to compensate for the lack of Grhl2, otherwise leading to collapsed 
lumen and affected epithelial barrier (Aue et al., 2015). 
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Figure 14 : Svb is required for trichome formation in Drosophila  
(A) Cuticle of freshly eclosed larvae where trichome belts underlines the third thoracic (t3) and all abdominal segment (a1-
a8). (B) Closeup view of the wildtype A4 ventral cuticle, with 6 rows of epidermal trichomes. 
(C) Closeup of the same region in a svb mutant, which lack most trichomes (Payre et al., 1999). 
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A growing body of evidence implicates OvoL factors in the control of progenitors (Kitazawa 
et al., 2016; Li and Yang, 2014) and stem cells (Kim et al., 2014), in many cases through 
counteracting pro-EMT factors. Pioneering work from the Dai’s lab has shown that OvoL1 and 
OvoL2 play key roles in the control of epidermal progenitors. Inactivation of OvoL1 and 2 
blocks the terminal differentiation and promotes the expansion of embryonic epidermal 
progenitor cells (Lee et al., 2014; Wells et al., 2009). Conversely, overexpression of Ovol2 
reduces the population of progenitors and leads to precocious differentiation (Lee et al., 2017). 
Notably, Ovol1/2 deficient cells loose their epithelial characteristic and undergo EMT-like 
transformation. Further studies, showed that OvoL1/2 repress the activity of EMT-inducing 
factors, including Zeb1 (Lee et al., 2014). A similar behavior has also been observed during 
mammary development, where OvoL2 is required for proper morphogenesis and regeneration 
(Watanabe et al., 2014). In mouse adult skin, OvoL2 function is required during both wound 
healing and hair regeneration. In this context, OvoL2 restricts the migration speed, optimizes 
the directionality of migrating cells and maintains their proliferative capacity, thus ensuring an 
efficient tissue repair (Haensel et al., 2019). 
Moreover, OvoL2 is expressed in human corneal epithelial cells where it is required for their 
maintenance (Kitazawa et al., 2016) and Ovol2 mutations are the most frequent cause of corneal 
dystrophy (Davidson et al., 2016). In the planarian flatworm, ovo is also required for eye 
regeneration from pluripotent stem cells (Cross et al., 2015; Lapan and Reddien, 2012). Several 
studies have disclosed functions of Ovo-like factors in angiogenesis, heart formation and 
placental development in mammals (Bai et al., 2018; Kusama et al., 2018; Renaud et al., 2015; 
Unezaki et al., 2007). It has been shown that OvoL factors regulate the fate of progenitor cells 
for trophoblast development, which normally involves differentiation into a syncytium that 
mediates exchanges between maternal and fetal blood (Renaud et al., 2015). OvoL 
downregulation is essential to trophoblast attachment to the endometrial epithelium, probably 
to increase the expression of EMT-associated transcription factors Zeb1 and Snail. It has also 
been shown that OvoL2 interacts with the nuclear factor ER71 to promote the formation of 
hematopoietic and endothelial cells from embryonic stem cells (Kim et al., 2014). Finally, both 
OvoL1 and OvoL2 were recently identified as regulators of induced pluripotent stem cells 
(iPSCs) reprogramming towards epithelial lineages (Kagawa et al., 2019; Watanabe et al., 
2019). 
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Unbiased profiling of human tumors have shown a broad implication of OvoL factors in the 
metastatic potential, and thus morbidity, of prevalent cancers. This includes colorectal (Ye et 
al., 2016), renal (Ricketts et al., 2012), breast (Hong et al., 2015; Roca et al., 2013; Watanabe 
et al., 2014), prostate (Roca et al., 2013; Roca et al., 2014), lung cancers (Wang et al., 2017), 
as well as nasopharyngeal carcinoma and osteosarcoma (Liu et al., 2018). Tumor cells with 
reduced OvoL levels, display increased expression of EMT-inducing factors such as miR-200 
and Zeb (Gregory et al., 2008) favoring the invasion of healthy tissues where they seed 
secondary tumors (Roca et al., 2013; Roca et al., 2014). Computational simulations have 
suggested that relative dosage of OvoL vs miR-200/Zeb drive either epithelial (E) or 
mesenchymal (M) fates, and, importantly, can give rise to an intermediate E/M state that 
displays both epithelial and mesenchymal characteristics (Hong et al., 2015; Jia et al., 2015). 
Recent data support that the most aggressive tumor cells with high metastatic capacity are those 
with a dual E/M potential. Both OvoL and GrhL2 have been identified as phenotypic stability 
factors that stabilize the hybrid state (Biswas et al., 2019).  
To conclude, OvoL/Svb transcription factors have been strongly conserved during evolution 
and are required for the regulation of various epithelial functions, including the regulation of 
somatic and germline precursor cells from Drosophila to mammals. 
 
3.5 The regulation of shavenbaby developmental expression 
svb expression in embryonic epidermal cells is controlled by multiple signaling pathways 
including Wnt, EGFR, Notch and Hedgehog (Payre, 2004) (Figure 15). In the ventral epidermis, 
svb integrates both EGFR and Wnt signaling to determine the subset of cells that will form 
trichomes. EGFR activates svb expression in trichome cells, whereas Wnt/Wingless (Wg) 
inhibits its expression to generate smooth cells (Payre et al., 1999). 
Combined efforts between our lab and that of David Stern have shown that the cis-regulatory 
landscape of svb spans over 100kb upstream the svb promoter and comprises at least seven 
enhancers (see (Stern and Frankel, 2013) for review) (Figure 16). Three large cis-regulatory 
regions driving svb epidermal expression were initially identified and named proximal, medial 
and distal elements (McGregor et al., 2007). Further work delineated smaller enhancers called 
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DG2, DG3, Z, A, E, and 7 driving expression in largely overlapping populations of trichome 
cells and, together, they recapitulate the complete pattern of svb expression in the embryonic 
epidermis (Frankel et al., 2010; Frankel et al., 2011). The E element was further dissected into 
two smaller enhancers, E3 and E6, driving expression in ventral and dorsal cells respectively 
(Frankel et al., 2010; Frankel et al., 2011). Alexandre Ahmad Al Sawadi, a former member of 
our lab, has next restricted the E3 292 bp region named E3-N (Crocker et al., 2014). In a same 
vein, he delineated the shortest version of the 7 (proximal) enhancer to a small region of 247 
bp. 
 
  
Figure 15: svb integrates multiple signaling pathways to define its spatial register  
(A) In ventral epidermal cells, Wg  activates engrailed (En) and Hh expression in two rows 
of cells (the posterior compartment), Rhomboid (Rho) activates EGFR and Serrate (Ser) 
the Notch pathway. (B) svb integrates these singling inputs through different enhancers. 
(C) The regulation of svb expression by Wg, Hh, Notch and EGFR establishes the 
epidermal pattern of svb that prefigures the differentiation of trichomes (adapted from 
Payre, 2004) 
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Figure 16 :: svb embryonic expression is governed by the collective activity of 7 enhancers  
(A) svb expression pattern of in a stage 14 Drosophila embryo detected by in situ hybridization 
(B) Localization of svb epidermal enhancers DG2, DG3, Z, A, E3 and E6, and 7, within the ovo/svb 
locus in Drosophila melanogaster and schematization of their respective activity in the dorsal 
(upper) and ventral (lower) part of the epidermis. Svb enhancers display overlapping expression 
between each other and, together, recapitulates the pattern of endogenous svb expression (adapted 
from Stern and Frankel., 2013).  
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This pretty exhaustive functional characterization of svb enhancers reveals the prevalence of 
apparently redundant enhancers driving similar pattern of expression. Similar cis-regulatory 
organization was also noticed for key developmental regulators (Hong et al., 2008), its 
functional role remained, however, to be investigated. svb has provided an exquisite model to 
address the function of such apparently redundant, or shadow, enhancers. Genomic engineering 
allowed the generation of a small deletion that removes three remote enhancers and the fine 
readout of trichome implantation revealed no defects on the trichome pattern in normal 
conditions (Frankel et al., 2010). However, when embryos develop under non-optimal 
conditions, such as lower or higher temperature, or with slightly comprised genetic 
backgrounds, the lack of these enhancers leads to partial trichome loss. Therefore, the existence 
of apparently redundant enhancers confers robustness to developmental program in the face of 
challenging internal (genetic) or environmental conditions (Frankel et al., 2010; Frankel et al., 
2012). 
 
Following the identification of svb enhancers, Ahmad has searched for transcription factors that 
may directly regulate svb expression. He used an RNAi approach to screen more than 250 TF 
expressed in the embryo at the time of epidermis differentiation (Menoret et al., 2013) and he 
tested the effect of their depletion on the activity of the smallest versions of E3 (E3-14) and 7 
(9CJ2) enhancers. This was complemented by “one-hybrid assay” that enables automated 
identification of TFs that bind a given regulatory regions when introduced in yeat. These two 
approaches have highlighted the role of multiple TFs in the regulation of svb expression by 
binding to the E3-14 or the 7 enhancers. The main TFs of interest are the following: Pointed 
(Pnt, EGF signaling pathway), Scalloped (Sd, Hippo pathway), SoxNeuro (SoxN) and Dichaete 
(Sox factors) and Pangolin/dTCF (Pan, Wg signaling pathway) and Pdm1/Nubbin. 
Therefore, svb embryonic expression is controlled by multiple signaling pathways that directly 
regulate the activity of svb enhancers. 
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3.6 Svb governs the expression of trichome effector genes  
In order to identify effector genes directly responsible for the remodeling of epidermal cells 
that underlies trichome formation, the lab has undertaken the identification of Svb target genes. 
Candidate approaches succeeded in the identification of a dozen of Svb direct targets and in the 
elucidation of their individual function for trichome formation (Chanut-Delalande et al., 2006; 
Fernandes et al., 2010). Genome-wide approaches combined mRNA profiling and in vivo ChIP-
seq of Svb bound regions in epidermal cells provided a broader picture (Menoret et al., 2013). 
Together, these data demonstrated that Svb directly activates the expression of approx. 150 
genes, encoding various regulators of epithelial cell organization (actin remodeling, 
extracellular matrix, junctional/membrane complexes) and cuticle composition (Menoret et al., 
2013). To better understand the mechanism by which Svb regulates the expression of its target 
genes, enhancer reporter assays were realized in the embryos. Svb downstream enhancers 
contained one or more Svb binding sites (ACaGTTAgag) and individual mutation of these sites 
compromised the activity of target gene enhancers. 
These data demonstrated that Svb directly regulates the expression of a whole set of effector 
genes that are collectively responsible for the formation of trichomes (Figure 17). 
 
3.7 Pri temporally regulates Svb transcriptional activity 
pri has been initially identified as a long non-coding RNA (lncRNA)(Tupy et al., 2005). One 
main result from unbiased profiling of cellular RNAs has been the unexpected prevalence of 
uncharacterized transcripts. Although they often share similarities with mRNAs (spliced, 
polyadenylated, etc..) these transcripts were called lncRNAs, since they do not present classical 
open reading frames, besides small ORF (smORFs) that were expected to occur just randomly. 
However, recent evidence, shows that smORF can encode bioactive peptides, from viruses to 
humans (Albuquerque et al., ; Couso, 2015; Couso and Patraquim, 2017; Hashimoto et al., 
2008; Kastenmayer et al., 2006; Payre and Desplan, 2016; Plaza et al., 2017; Zanet et al., 2015).  
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 Figure 17 : Svb regulates the expression of effector genes for trichome formation 
Svb activates the expression of a set of genes directly implicated in trichome formation by regulating: the actin 
cytoskeleton (singed, forked, wasp, shavenoid,....), the extracellular matrix production (miniature,...), the production 
of cuticle components and enzymes implicated in cuticle pigmentation/sclerotization (yellow,...) as well as other 
genes whose function has not yet been defined (Chanut-Delalande et al., 2006) 
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The pri gene produces a 1.5kb poly-adenylated RNA with four smORFs and compelling 
evidence have shown that they encode four functionally redundant peptides of 11 to 32 amino 
acids (Galindo et al., 2007; Kondo et al., 2007; Savard et al., 2006). Pri is dynamically expressed 
during Drosophila embryogenesis, including in the epidermis (Galindo et al., 2007; Kondo et 
al., 2007). Similar to svb depletion, pri loss of function leads to the absence of trichomes (Kondo 
et al., 2007). In collaboration with Yugi Kageyama's group, the lab thus tested possible 
relationships between these two genes. While pri loss of function does not affect the expression 
of svb (and vice versa), it suppresses the expression of svb target genes suggesting that Pri 
regulates the transcriptional activity of Svb rather than its expression (Kondo et al., 2010). 
Unexpectedly, the lab showed that Pri peptides induce the elimination of the N-terminal region 
of Svb protein, which contains exon 1s and a large part of the repressive domain. This post-
translational modification thus leads to the conversion of Svb from a long repressive form 
(SvbREP) to a short transcriptional activating form (SvbACT) (Kondo et al., 2010; Zanet et al., 
2016).  
To elucidate the molecular mode of action of Pri peptides, Emilie Benrabah performed a 
genome-wide functional RNAi screen in cultured cells, to identify the cellular factors required 
for Svb maturation. Emilie Benrabah and Jennifer Zanet demonstrated that the conversion of 
SvbREP into SvbACT results from a limited proteasome degradation (Zanet et al., 2015). Pri 
peptides bind to Ubr3, an E3 ubiquitin ligase, to allow its association with Svb via three 
conserved lysine residues in the Svb N-terminus. The recognition of Svb by Ubr3 allows its 
ubiquitination and targeting to the proteasome, which ensures degradation of the N-terminal 
part of Svb containing the repressive domain (Zanet et al., 2015). This degradation is specific 
to the somatic form Svb and the couple Pri/Ubr3 does not affect OvoA and OvoB which do not 
contain the N-terminal region bound by Ubr3 (Kondo et al., 2010) (Figure 20). 
By regulating Ubr3 binding specificity, Pri peptides induce partial proteasome degradation of 
Svb and thus its conversion from a long repressive form to a short transcriptional activator. 
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Figure 18 : Pri peptides induce proteasome-mediated processing of the Svb protein  
In theIn the absence of pri expression, Svb is translated as a long transcriptional repressor. Following the production and 
binding of Pri peptides on Ubr3, it undergoes a conformational change allowing it to interact with Svb via its N-terminal 
part. Ubr3 recruits the E2 ligase Ubcd6 which ubiquitinates Svb thus ensuring its targeting to the proteasome where its N-
terminal part is degraded. Svb is then released and acts as a transcriptional activator to trigger the expression of trichome 
effector target genes (Zanet et al., 2015). 
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3.8 The ecdysone hormone times epidermal differentiation by inducing pri 
expression 
The deciphering of Svb activation highlights a very sophisticated mechanism (Zanet et al., 
2015) and one may ask what it the rationale for this multistep activation process. An explanation 
has come from deciphering the regulation of pri expression, showing that a main role of Pri 
peptides is to provide a temporal regulation of Svb activity.  
In insects, the steroid hormone ecdysone controls major developmental transitions, namely 
larval molting and pupal metamorphosis (Yamanaka et al., 2013). The production of ecdysone 
is regulated by various internal and external cues, such as tissue growth (Colombani et al., 2005; 
Delanoue et al., 2010), nutrition (Andersen et al., 2013) or light (Yamanaka et al., 2013; 
Yamanaka et al.). In larvae, ecdysone is produced by the prothoracic gland from food 
cholesterol that, following its uptake, it undergoes a cascade of modifications by metabolic 
enzymes. Inactivation of any of these enzymes leads to similar defects, with very thin 
undifferentiated cuticle, a phenotype called "Halloween" (Niwa and Niwa, 2014). Once 
synthesized, ecdysone is secreted into the hemolymph and target tissues locally transformed it 
into 20-hydroxy-ecdysone (20E), the active form of ecdysone. 20E binds to a heterodimeric 
nuclear receptor EcR/Usp (ecdysone Receptor and Ultraspiracle) to activate the expression of 
a temporal cascade of many genes (Hill et al., 2013). 
To identify additional major regulators of trichome development, Hélène Chanut performed an 
unbiased genetic screen using overlapping small deficiencies that, together, cover the whole 
second chromosome (Chanut-Delalande et al., 2014; Dubois et al., 2016). The screen identified 
a novel uncharacterized gene, which displayed a striking trichome-less phenotype. This gene 
encodes Gst-E14 and further characterization demonstrated that this protein is required for 
proper cholesterol uptake and/or handling within the prothoracic gland (Chanut-Delalande et 
al., 2014; Enya et al., 2014) and, thereby, for ecdysone production. Consistently, all other 
mutants deprived of ecdysone showed a similar trichome-less phenotype, which was previously 
overlooked because of poor cuticle differentiation. In Gst-E14 or other Halloween mutants, svb 
is normally expressed, but the expression of trichome effector genes is abolished. Thus the 
absence of ecdysone prevents the expression of pri, leading to the accumulation of SvbREP that 
never matures and explains the absence of trichome effectors expression. Importantly, the 
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expression of pri in a mutant lacking ecdysone is sufficient to restore trichome formation, even 
though cuticle differentiation remains compromised (Chanut-Delalande et al., 2014). Finally, 
combining systematic characterization of pri enhancers and EcR ChIP-seq, the team 
demonstrated that pri is a direct, and major, target of ecdysone signaling (Chanut-Delalande et 
al., 2014). 
In conclusion, ecdysone provides a systemic control that temporally turns ON, via the activation 
of pri expression, the genetic program governed by Svb and allowing the formation of 
trichomes (Figure 18). 
 
 
The result section corresponds to two articles exploring for the first time Svb and Pri functions 
in adult stem cells. The first paper, for which the majority of experiments were done by Jérôme, 
focuses on adult Malpighian tubules. The second preprint describes the major results I obtained 
during my thesis, concerning the function of Svb/Pri in the Drosophila adult midgut. 
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Figure 19: Ecdysone regulates the temporality of trichome formation by activating the expression of polished-rice  
(A) Transient peaks of ecdysone controls the temporality of developmental transitions for hatching at each larval stage and the 
initiation of metamorphosis. 
(B) Ecdysone bound EcR activates the expression of polished-rice (pri). This triggers the production of Pri peptides which 
allow Ubr3/proteasome-dependent maturation of Svb. Svb, transcribed as a long representative (SvbREP), is converted into a 
transcriptional activator (SvbACT) to initiate the genetic program of trichome formation (from Zanet et al., 2016) 
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Results 
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Summary of paper 1 
At the beginning of my thesis, Jérôme Bohère a former PhD student in our laboratory was 
working on the characterization of Svb function within Renal Nephric Stem Cells (RNSC). This 
work and the one in the gut have emerged following initial observations made by Dani , who 
originally found the expression of Svb in both intestinal and renal adult stem cells. 
Jérôme has demonstrated that the mature SvbACT, resulting from Ubr3-Pri-proteasomal 
processing, is required for protecting RNSC from apoptosis. 
Svb physically interacts with Yorkie (Yki), the nuclear factor of the Hippo pathway well known 
to control the proliferation/apoptosis balance. The SvbACT/Yki complex directly binds to a 
regulatory region of Drosophila Inhibitor of Apoptosis, DIAP1 and induces its expression in 
stem cells. Jérôme’s work has therefore revealed a new function of Svb in the Hippo signaling 
pathway and a way of protecting somatic stem cells to cope with apoptosis. 
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ARTICLE
Shavenbaby and Yorkie mediate Hippo signaling to
protect adult stem cells from apoptosis
Jérôme Bohère1, Alexandra Mancheno-Ferris1, Sandy Al Hayek1,2,3, Jennifer Zanet1, Philippe Valenti1,
Kohsuke Akino4, Yuya Yamabe4, Sachi Inagaki5, Hélène Chanut-Delalande1, Serge Plaza1,6, Yuji Kageyama4,5,
Dani Osman2,3, Cédric Polesello 1 & François Payre 1
To compensate for accumulating damages and cell death, adult homeostasis (e.g., body fluids
and secretion) requires organ regeneration, operated by long-lived stem cells. How stem cells
can survive throughout the animal life remains poorly understood. Here we show that the
transcription factor Shavenbaby (Svb, OvoL in vertebrates) is expressed in renal/nephric
stem cells (RNSCs) of Drosophila and required for their maintenance during adulthood. As
recently shown in embryos, Svb function in adult RNSCs further needs a post-translational
processing mediated by the Polished rice (Pri) smORF peptides and impairing Svb function
leads to RNSC apoptosis. We show that Svb interacts both genetically and physically with
Yorkie (YAP/TAZ in vertebrates), a nuclear effector of the Hippo pathway, to activate the
expression of the inhibitor of apoptosis DIAP1. These data therefore identify Svb as a nuclear
effector in the Hippo pathway, critical for the survival of adult somatic stem cells.
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The family of OvoL/Ovo/Shavenbaby (Svb) transcriptionfactors has been strongly conserved across evolution and ischaracteristic of animal species. Initially discovered in flies
for a dual function in the development of the germline and of
epidermal derivatives (Ovo/Svb)1,2, mammalian orthologs
(OvoL1-3) have soon been identified3,4. OvoL/svb genes produce
several protein isoforms and the existence of three partially
redundant paralogs in mammals complicates their genetic ana-
lysis. There is a single gene in Drosophila, which expresses
germline- (ovo) and somatic-specific (svb) transcripts from dif-
ferent promoters. Previous work has well-established the role of
Svb in the development of embryonic epidermal tissues2, where it
triggers a tridimensional cell shape remodeling for the formation
of actin-rich apical extensions, called trichomes. Svb expression is
driven by a large array of cis-regulatory regions, which have
become a paradigm for elucidating the function5,6 and evolu-
tion7–9 of developmental enhancers. Svb enhancers directly
integrate multiple inputs from upstream regulatory pathways2,5,10
and often drive similar patterns5,6,11, together conferring
robustness to epidermal development in the face of varying
environmental conditions and/or genetic backgrounds5,6. During
embryogenesis, the Svb transcription factor directly activates a
battery of >150 target genes12–14 collectively responsible for actin
and extra-cellular-matrix reorganization that underlies trichome
formation. Recent studies have unraveled a tight control of the
Svb protein activity in response to Polished rice peptides (Pri, also
known as Tarsal-less), which belongs to a fast-growing family of
peptides encoded from small open reading frames (smORF)
hidden within apparently long noncoding RNAs15,16. Svb is first
translated as a long-sized protein that acts as a repressor (SvbREP)
17. Pri smORF peptides then induce a proteolytic processing of
SvbREP leading to the degradation of its N-terminal region and
releasing a shorter activator form, Svb[ACT 17,18. Further work has
demonstrated that pri expression is directly regulated by periodic
pulses of steroid hormones19, allowing a functional connection
between hard-wired genetic regulatory networks (svb expression)
and systemic hormonal control (pri expression) for a proper
spatio-temporal control of epidermal cell morphogenesis15.
Recent studies suggest that OvoL/Svb factors display broader
functions throughout epithelial tissues in both normal and var-
ious pathological situations. Molecular profiling of human tumors
has revealed that OvoL deregulation is a feature of many carci-
nomas, directly linked to the metastatic potential of morbid
cancers20–23, including kidney24. OvoL factors have been
proposed25,26 to counteract a conserved core of regulators com-
posed of Snail/Slug and Zeb1-2 transcription factors, as well as
the micro RNA mir200, well known to promote
epithelial–mesenchymal transition (EMT)27. The activity of OvoL
might help stabilizing a hybrid phenotype between epithelial and
mesenchymal states25, providing many advantages for both
tumors and normal stem cells28. Indeed, recent data show that,
like adult somatic stem cells, the most aggressive tumors often
display a hybrid E/M phenotype27, and the expression of specific
OvoL isoforms can annihilate the metastatic potential of mam-
mary tumors20,29. In addition, OvoL/Svb factors have been linked
to the control of various progenitors/stem cells, from basal
invertebrates30 to humans31–33. Therefore, whereas a large body
of evidence supports a key role for OvoL/Svb in the behavior of
somatic stem cells, a functional investigation of their mode of
action in vivo remains to be undertaken.
Here, we built on the knowledge and tools accumulated for the
study of Svb function in flies to investigate its putative con-
tribution to the behavior of somatic stem cells in the adult. We
show that in Malpighian tubules, which ensure renal function in
insects34,35, svb is specifically expressed in the adult renal/nephric
stem cells (RNSCs). We further find that the main function of Svb
in the kidney is to protect RNSCs from apoptosis by controlling
the expression of the inhibitor of apoptosis, DIAP1, in interaction
with Yorkie (Yki), a nuclear effector of the Hippo pathway.
Results
svb is expressed in RNSCs and controls their maintenance. To
assay whether svb might be expressed in the adult, we tested large
genomic reporter constructs that cover each of the seven
enhancers contributing to svb expression7,8. We found that one
enhancer, svbE 8, drove specific expression in tiny cells of the
Malpighian tubules (Supplementary Figure 1a, b).
Malpighian tubules are mainly composed of two types of
differentiated cells35. The principal cells—characterized by the
homeodomain Cut protein (Fig. 1a, b)—express the vacuolar-
ATPase (V-ATPase) that establishes an H+ electrochemical
potential promoting trans-epithelial secretion of Na+ and K[+ 34.
The second main population of Malpighian tubules are termed
stellate cells, featured by the expression of the Teashirt (Tsh)
transcription factor (Fig. 1a), and that regulate the transport of Cl
− and water34. While both principal and stellate cells display
large-sized polyploid nuclei, a third population of small diploid
cells, originally referred to as tiny cells with putative myoendo-
crine and/or neuroendocrine activity36,37, are located in the lower
tubules (Fig. 1a, b). Accumulated evidence now supports that
these tiny cells ensure the renewal of at least some populations of
kidney cells38,39 and correspond to adult RNSCs (see also
Supplementary Figure 4). It has been shown that RNSCs derive
from a subpopulation of intestinal stem cell precursors that
migrate in Malpighian tubules during post-embryonic develop-
ment40. RNSCs are characterized by the expression of Escargot
(Esg), a transcription factor of the Snail/SLUG family that is also
expressed in intestinal stem cells41 where it acts to prevent stem
cell differentiation42,43. Co-localization with an esg-LacZ reporter
confirmed that the svbE enhancer was active in RNSCs (Fig. 1c
and Supplementary Figure 1). To define the minimal region of svb
responsible for the expression in RNSCs, we assayed a collection
of overlapping constructs5. This identified two independent
elements, the svbE3N and svbE6 enhancers5,7, which despite having
distinct activities during embryogenesis7 both drive similar
expression in adult RNSCs (Supplementary Figure 1c).
Having established that two enhancers drive specific expression
of svb in the adult stem cells of the renal system, we next assayed
consequences of depleting svb function in RNSCs. We used a
well-controlled genetic system, hereafter referred to as esgts. esgts
ensures RNAi-mediated gene depletion, specifically in stem
cells44, as monitored by GFP expression (Fig. 2a, b and
Supplementary Figure 2a). In addition, the expression of esgts-
driven transgene(s) and/or RNAi is tightly regulated in a
temporal manner by a temperature shift, ensuring that stem cell
manipulation is turned ON only in adults (3 days after eclosion)
to rule out any earlier developmental defects (Fig. 2c). We also
developed an image analysis pipeline, allowing automated
quantification of the whole population of RNSCs (see Methods).
In control conditions, the number of esg-positive RNSCs remains
stable after adult hatching, with approx. 350 cells per tubules
(Fig. 2a–c). We only noticed a weak reduction of RNSCs after
1 month. In contrast, esgts-driven RNAi depletion of svb in adults
led to a progressive loss of RNSCs, which were completely absent
after 32 days of treatment (Fig. 2a–c). Although not affecting
RNSCs before (day 0, Supplementary Figure 2d)—or shortly after
(2 days, Fig. 2c)—inducing transgene expression, the effects of svb
depletion in the adults were already strong following 8 days of
treatment, with a two-fold reduction in the number of RNSCs
(Fig. 2a–c and Supplementary Figure 2). Similar results were
observed when using either a second RNAi construct
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(Supplementary Figure 2b), or an independent driver of RNSCs
(dome-MESO-gal4) to knockdown svb (Supplementary Figure 2e).
We identified another transcription factor, Hindsight (Hnt), as
being specific of RNSCs within Malpighian tubules (Supplemen-
tary Figure 2c); and the loss of RNSCs upon svb depletion was
confirmed by staining against Hnt (Supplementary Figure 2e).
Finally, the key role of svb in the maintenance of adult RNSCs
was further demonstrated by results from genetic mosaics
(MARCM45), showing that mutant cells bearing strong alleles
of svb were unable to maintain RNSCs (Fig. 2d and Supplemen-
tary Figure 2f, g).
Taken together, these data thus reveal that svb is specifically
expressed in RNSCs and critically required for the maintenance of
the adult stem cell compartment.
Svb processing is essential for its activity in RNSCs. In the
epidermis, Svb activity relies on a proteolytic processing that
causes a switch from a repressor to an activator form15 (see
Fig. 3a). This processing is gated by Pri smORF peptides, which
bind to and activate the Ubr3 ubiquitin E3-ligase that, in turn,
triggers a limited degradation of Svb operated by the protea-
some18. Thereby, pri mediates a systemic control of Svb
maturation since the expression of pri is directly regulated by the
ecdysone receptor (EcR)19.
To assess whether the function of Svb in Malpighian tubules
also required its proteolytic maturation, we investigated a putative
function of pri and ubr3 in RNSCs. We screened a collection of
pri reporter lines19,46 and identified two cis-regulatory regions
driving expression in RNSCs (Fig. 3b and Supplementary Figure
3a, b). Consistently with the expression of pri in RNSCs, pri
knockdown strongly impacted the population of RNSCs (Fig. 3c–e
and Supplementary Figure 3c). The effects of RNAi-mediated
depletion on RNSCs were even stronger for pri than for svb, as
previously observed in the epidermis17. The lack of Pri peptides
indeed leads to the accumulation of the Svb repressor14,17,19,
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which may explain a stronger downregulation of Svb target genes
when compared to svb mutants14. In the case of RNSCs, it is also
possible that pri-RNAi depletion is more efficient (smORF
peptides are likely very unstable when compared to typical
protein half-life), and/or that Pri peptides fulfil Svb-independent
functions as also reported during embryogenesis17. In addition, a
dominant negative form of the ecdysone receptor (EcRDN) that
abolishes pri expression during both embryonic and post-
embryonic development19 was sufficient to reduce the number
of stem cells when specifically expressed in adult RNSCs
(Fig. 3c–e). Furthermore, we found that ubr3 was also required
for RNSC maintenance, as deduced from results of RNAi-
mediated depletion (using three non-overlapping constructs) or
genetic nullification18 of ubr3 activity (Fig. 3c–e, Supplementary
Figure 3d). Finally, the expression of OvoA (see Fig. 3a) that
behaves as a constitutive repressor isoform of Svb17,47,48
mimicked the effects observed in svb loss of function conditions
(Fig. 3c, e). Reciprocally, the expression of OvoB (see Fig. 3a) that
acts as a constitutive activator isoform of Svb17,47,48 was sufficient
to rescue the lack of ubr3 function (Fig. 3c, e), demonstrating that
Svb function in RNSCs relies on its matured transcription
activator form.
These results provide compelling evidence that the whole
regulatory machinery discovered for its role in the development
of epidermal cells17–19 is also at work in adult RNSCs. We
therefore concluded that the post-translational maturation of the
Svb transcription factor is essential for the maintenance of
RNSCs.
Svb protects renal nephric stem cells from apoptosis. The loss
of RNSCs observed following the lack of svb function or
maturation could theoretically result from at least three different
causes: (i) lack of proliferation, (ii) precocious differentiation, or
(iii) increased cell death. We therefore assayed the putative
contribution of each of those aspects in the loss of stem cells
resulting from svb inactivation.
Consistent with the quiescent behavior of RNSCs, we observed
a low frequency of RNSC division in controls, as deduced from
staining with the mitotic marker phospho-Histone H3 (Supple-
mentary Figure 4a, b) and as previously noticed38. Additional cell
lineage analysis using the esg-Gal4 and dome-MESO-Gal4 drivers
confirmed that adult renal stem cells/progenitors give rise to a
progeny of large differentiated cells (Cut positive) in lower
tubules (Supplementary Figure 4c, d). Similar analyses using the
Alkaline-Phosphatase 4 driver (Aph4-Gal4) that is specific of
differentiated principal cells49 in lower tubules showed no
progenitor/progeny figures (Supplementary Figure 4c), support-
ing that only RNSCs are able to sustain cell renewal. Therefore,
even a complete block of stem cell division cannot account for the
disappearance of RNSCs observed in the absence of svb.
We next investigated a putative influence of svb on RNSC
differentiation, making use of the lineage-tracing system called
ReDDM that has been recently developed for intestinal stem
cells50. Based on differences in the stability of two fluorescent
proteins, ReDDM allows marking renal progenitors that
express both mCD8::GFP and H2B::RFP, while their progeny
only maintain the very stable H2B::RFP (see Fig. 4a). In control
conditions, we detected rare H2B::RFP progeny (Fig. 4a)
confirming a low rate of cell renewal in Malpighian tubules38,39
(Supplementary Figure 4b). Recent work has shown that the
expression of mir-8 (the fly homolog of mir-200 in vertebrates)
downregulates the expression of EMT-inducing factors Escar-
got and Zfh1 (the homolog of Zeb1), triggering a strong burst of
stem cell differentiation in the intestine50. Similarly, we found
that mir-8 expression in RNSCs forced esg+ cells to
differentiate and only rare RNSCs persisted after 8 days of
treatment (Fig. 4a, Supplementary Figure 5). Upon mir-8
expression, the progeny (H2B::RFP-positive, GFP-negative
cells) of RNSCs present in lower tubules also expressed
Alkaline Phosphatase 4 confirming that the depletion of RNSCs
upon mir-8 overexpression was caused by their premature
differentiation (Supplementary Figure 5). In contrast, no
significant modification of the progenitors/progeny ratio was
observed in svb-RNAi conditions when compared to controls,
showing that svb depletion did not trigger RNSC differentiation
(Fig. 4a, Supplementary Figure 5).
Finally, we tested whether svb-depleted RNSCs were lost
because they underwent apoptosis. As a first step, we assayed
consequences of blocking programmed cell death by expressing
the viral caspase inhibitor p3551. Although the expression of p35
had no detectable effect by itself on RNSCs, it rescued the number
of RNSCs when svb was depleted (Fig. 4b). Next, we stained for
cells undergoing apoptosis using the Terminal deoxynucleotidyl
transferase dUTP Nick End Labelling (TUNEL), an assay
allowing the detection of apoptotic DNA fragmentation. While
apoptotic figures were almost absent in control conditions,
expression of the pro-apoptotic gene reaper induced a strong
increase in the number of TUNEL-positive cells (Fig. 4c).
Similarly, knocking down svb in stem cells led to frequent
apoptotic figures in RNSCs (Fig. 4c) consistently with the
progressive decrease in RNSC number observed throughout
adult life (Fig. 2c).
Taken together, these data show that the loss of RNSCs
observed upon svb loss of function is primarily due to stem cell
death, indicating that a main role of Svb is to protect adult stem
cells from undergoing apoptosis.
Svb acts downstream of Hippo. Previous work has shown that
the Hippo pathway is a key regulator of the Drosophila gut
homeostasis, controlling proliferation and survival of stem cells
for tissue regeneration52,53. Since the Hippo pathway54,55 is a key
sensor of various stresses renowned to induce apoptosis56,57, we
then investigated its function and putative interplay with Svb in
the control of RNSC behavior.
The core Hippo complex is composed of two kinases, Hippo
(Hpo) and Warts (Wts) and two scaffolding proteins, Salvador
and Mob As Tumor Suppressor54,55. Activation of Hippo leads to
the phosphorylation of the co-transcription factor Yorkie (Yki),
preventing its positive action on the transcription of target genes
such as DIAP1 and bantam, favoring resistance to apoptosis and
proliferation, respectively54,55. Consistently, we found that
activation of the pathway via Hpo overexpression induced a
strong reduction in the number of RNSCs (Fig. 5a, b). Similarly,
knockdown of Yki resulted in dramatic RNSC loss (Supplemen-
tary Figure 3d and 6a). Conversely, increased Yki activity was
sufficient to induce a remarkable increase in the number of
RNSCs (Fig. 5), providing additional evidence of the proliferative
potential of RNSCs. These data showing the role of the Hippo
pathway in the regulation of RNSC survival/proliferation, we next
assessed how it interacted with Svb function. Co-expression of
OvoB—mimicking a constitutive activator form of Svb (see
Fig. 3a)—together with Hpo was sufficient to rescue the loss of
RNSCs (Fig. 5). These results therefore suggested that Svb was
acting downstream of Hpo. Indeed, the strong increase in the
number of renal stem cells observed following increased Yki
activity was entirely suppressed upon simultaneous expression
either of svb-RNAi, or of the constitutive repressor OvoA (Fig. 5).
Quantification indicated that esg+ cells overexpressing Yki were
even more sensitive to svb loss-of-function than otherwise normal
RNSCs (Fig. 5b). Of note, Yki over-proliferating cells showed
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aberrant cell morphology reminiscent of tumors derived from
intestine stem cells, which also display increased sensitivity to cell
death when compared to normal stem cells58, and that might
explain why RNSCS with high Yki levels cannot survive upon Svb
knockdown. Hence, the function of Yki in RNSCs requires Svb,
suggesting that Svb was interacting with this nuclear effector of
the Hippo pathway. Supporting this view, we found that RNSC
survival could not be rescued either by expression of OvoB in the
absence of Yki (Supplementary Figure 6a), or by the over-
expression of Yki in the absence of Svb (Fig. 5). In contrast, the
artificial re-expression of a key target gene of Yki, DIAP1, was
sufficient to compensate for svb-depletion, including in most
extreme conditions, i.e., following 32 days of treatment (Figs. 2
and 5a).
In sum, both Svb and Yki are required for RNSC homeostasis,
functionally interacting for the survival of adult stem cells. We
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thus concluded that Svb acts downstream of Hippo cytoplasmic
core components and, together with Yki, both nuclear factors are
required to protect RNSCs from apoptosis.
Svb as a nuclear effector of the Hippo pathway. Having estab-
lished that Svb and Yki functionally interact, we sought to deci-
pher the underlying molecular mechanisms and how these two
regulators contribute to the control of relevant effector gene
expression, e.g., DIAP1.
A first piece of evidence emerged from the comparison of
in vivo chromatin immuno-precipitation (ChIP-seq) datasets
between Svb14 and Yki59. We found that Svb and Yki share
>1.300 common genomic binding sites (Supplementary Figure 7a
and Supplementary Table 1) and statistical tests established the
significance of this overlap (Supplementary Figure 7b). Interest-
ingly, co-binding of Yki was rare for the direct target genes of
Svb identified in the epidermis12–14, as illustrated by shavenoid
or dusky-like that both lack Yki binding (Supplementary Figure
7c,d). In contrast, Svb was often bound to known Yki target
genes, such as bantam, piwi, fat, or nanos60 (Supplementary
Figure 7e, f). Importantly, ChIP-seq also revealed that Svb binds
in vivo to an enhancer of DIAP1 (Fig. 6a), previously identified
as a Yki direct binding site61,62 and that drives specific
expression in intestinal stem cells63. We therefore tested if Svb
might regulate DIAP1 expression in adult RNSCs. Although
weak in control conditions, we observed specific expression of
the DIAP1-LacZ reporter in RNSCs, which was strongly
enhanced upon Yki overexpression (Fig. 6b). This induction of
DIAP1 expression upon Yki overexpression was antagonized by
OvoA (Fig. 6b). Similar results were obtained with the isolated
DIAP1-4.3-GFP62 enhancer that contains binding sites for Yki
and Svb. Although OvoB did not show significant influence
(Supplementary Figure 6b), the expression of DIAP1-4.3-GFP
was again enhanced by Yki overexpression and abrogated upon
counteracting Svb activity (Fig. 6b). These results thus strengthen
the conclusion that Svb and Yki functionally interact in RNSCs
to prevent apoptosis, at least in part through promoting DIAP1
expression.
The transcriptional activity of Yki/YAP/TAZ is well known to
rely on the regulation of its subcellular localization between the
cytoplasmic versus nuclear compartments. Assaying a putative
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influence of Svb on Yki distribution, we did not however detect
any consequences of Svb activity (either SvbACT or SvbREP) on
in vivo Yki nuclear accumulation within RNSCs (Supplementary
Figure 6c). Yki is unable to bind DNA by itself and need to
associate to sequence-specific transcription factors55. Hence we
assayed whether Yki could associate with Svb to explain the
functional interactions observed in RNSCs between these two
nuclear factors. Biochemical assays showed that Svb bound to
Yki, as seen by reciprocal co-immunoprecipitation in protein
extracts prepared from cultured cells (Fig. 7a). Both the full length
repressor and matured Svb activator interacted with Yki (Fig. 7a).
It has been shown that Yki contains two WW protein domains,
mediating interaction with partners bearing PPxY motifs (such as
Wts61 or Mad64). Of note, we detected two PPxY motifs within
the Svb protein, at position 523 (PPFY) and 881 (PPSY), i.e.,
within the region common to Svb repressor and activator forms.
We found that the mutation of Yki WW motifs was sufficient to
abrogate the interaction with both forms of Svb (Fig. 7a).
Furthermore, point mutations of Svb PPxY motifs also impaired
interaction with Yki, as monitored using immunoprecipitation
assays (Fig. 7a). We next investigated the in vivo consequences of
impairing Svb/Yki interaction, investigating the functional
behavior of the Svb mutant lacking Yki interaction motifs (Svb-
PPxY). When expressed in the embryonic epidermis, Svb-PPxY
retained the ability to induce ectopic trichomes, consistent with a
function of Svb being independent of Yki activity for the terminal
differentiation of epidermal tissues (Supplementary Figure 8a). In
contrast, Svb-PPxY behaved as a potent dominant negative
mutant within adult stem cells. Previous work has shown that
SvbACT and SvbREP display distinct patterns of intra-nuclear
distribution, characterized by diffuse nucleoplasmic localization
or accumulation in dense foci, respectively17. Svb-PPxY::GFP
displayed a discrete accumulation in foci, reminiscent of that
observed for the repressor (Fig. 7b). Importantly, expression of
Svb-PPxY in RNSCs significantly reduced their number, as
observed upon Svb or Yki knockdown (Fig. 7c). These data
therefore indicate that Svb physically interacts with Yki (via PPxY
and WW motifs, respectively) and impairing specifically this
interaction alters adult stem cell behavior.
One important question was whether the interaction between
Svb and the Hippo pathway also took place in other tissues. The
function of Hippo has been initially described in larval imaginal
discs, which give rise to most adult tissues65 and Yki overexpression
promotes cell proliferation in both wing and eye discs61. We tested
Svb/Yki genetic interactions in the wing using collier-Gal4 that
drives expression in the medial (L3–L4) intervein region. Yki
expression resulted in the expansion of this region due to tissue
overgrowth (Fig. 8a). In contrast, OvoA leads to both a reduction of
the L3–L4 region and the absence of epidermal trichomes. As in
RNSCs, OvoA was epistatic to Yki, since the wing region expressing
both yki and ovoA was smaller than in controls and lacked
trichomes (Fig. 8a). As expected for a mutant unable to interact
with Yki, we found that expression of Svb-PPxY did not affect wing
cell proliferation. Additional evidence of interaction between the
Hippo pathway and Svb/Pri came from genetic assays demonstrat-
ing the importance of relative levels of their activity. While lowering
wts activity causes a wing overgrowth phenotype (Fig. 8b), we
noticed that reducing pri activity suppressed this phenotype
(Fig. 8b, c). Furthermore, wts mutation can lead to dramatic
defects in wing development when introduced in a given genetic
background, and decreasing pri dosage was sufficient to almost
completely restore normal wings (Supplementary Figure 8b).
In the eye, overexpression of Yki using the GMR-Gal4 driver
promoted extra cell proliferation resulting in an increased eye
size. Similar results were obtained following pri overexpression,
and co-expressing pri and yki resulted in a synergistic eye growth
(Supplementary Figure 9a). Northern blotting of RNAs extracted
from adult heads revealed that DIAP1 mRNA levels were
increased following pri overexpression (Supplementary Figure 9b),
while there was no effect on yki or cycE mRNA.
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Two different genomic insertions allowing the expression of Svb-PPxY::GFP (#6C and #9C) decrease the number of renal stem cells (p= 0.0059 and
0.0023). Values are presented as average ± standard error of the mean (SEM) and boxes with whiskers (10–90 percentile), p-values from Mann–Whitney
test (**p < 0.01). Scale bar is 3 µm
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We interpret these results to imply that Svb functionally
interacts with Yorkie, both in adult stem cells and in specific
developing tissues, to regulate a subset of transcriptional targets
of the Hippo pathway, including the activation of DIAP1
expression.
Discussion
Our results show that Shavenbaby is expressed and required for
the maintenance of adult renal stem cells in flies, supporting the
conclusion that the OvoL/Svb family of transcription factors plays
a key and evolutionarily-conserved role in the behavior of pro-
genitors/stem cells.
The role of Svb in adult stem cell maintenance in flies requires
both a fine control of its expression and of its transcriptional
activity. Svb expression in RNSCs involves at least two separable
enhancers, driving similar expression patterns. Svb was one of the
first cases to reveal the functional importance of apparently
redundant (or shadow) enhancers in the phenotypic robustness of
regulatory networks5,6 across tissues and development stages11.
Our data suggest that a similar cis-regulatory architecture is also
underlying the control of adult stem cells.
RNSCs maintenance further requires a proper post-
translational maturation of the Svb protein, in response to Pri
smORF peptides. During both embryonic17 and post-embryonic
development18,19, the main role of Pri peptides is to provide a
temporal control of Svb activity, conveying systemic steroid sig-
naling19. It is therefore possible that Pri smORF peptides also
connect genetic networks to hormonal control for the regulation
of adult stem cells. Recent work has shown that various smORF
peptides contribute to the regulation of developmental pathways,
muscle formation and physiology, etc…15,66,67, and our findings
extend their influence to the control of adult stem cells. It has
been proposed that the emerging field of smORF peptides may
open innovative therapeutic strategies16,68, for example peptido-
mimetic drugs, which might also be of interest for regenerative
medicine.
Our results establish that a main function of Svb in adult stem
cells is mediated by a functional interplay with the Hippo path-
way, well established for its roles in the control of adult stem
cells52–54. Our results indicate that Svb behaves as a nuclear
effector of Hippo, relying on a direct interaction with Yorkie in
order to protect stem cells from apoptosis, at least in part through
the regulation of DIAP1 expression. Analysis of genome-wide
binding events further suggests that the Svb/Yki interaction is
involved in the control of a broader set of Hippo-regulated genes,
including during development. Since both Pri and Ubr3 are also
essential for the survival of adult stem cells, it is interesting to
note that Ubr3 protects the DIAP1 protein from degradation69,
and direct binding of Ubr3 on the activated form of DIAP1 is
elicited in the presence of Pri peptides18. Therefore, in addition to
the control of DIAP1 expression (via Svb), Ubr3 and Pri could
also stabilize the DIAP1 protein to protect stem cells from
apoptosis. Although initially restricted to TEAD transcription
factors, the number of Yorkie (YAP/TAZ) nuclear partners is
rapidly growing55. Interestingly, recent work has shown a direct
interaction of YAP/TAZ with the pro-EMT factors Snail/Slug, in
the control of stem cell renewal and differentiation70. As pre-
viously reported for intestinal stem cells42,43,50, we show that pro-
EMT regulators are also required for preventing premature dif-
ferentiation of renal stem cells. While pro-EMT and OvoL factors
are often viewed as antagonistic factors20,25, in vivo studies in
Drosophila stem cells show that they both contribute to their
maintenance, Svb/Yki preventing their apoptosis and EMT fac-
tors their differentiation. Since many studies have implicated the
Hippo pathway, pro-EMT and OvoL/Svb factors in various
tumors, new insights into their functional interactions in adult
stem cells may provide additional knowledge directly relevant to
understand their connections in human cancers.
Methods
Drosophila work. Flies were cultured (unless otherwise noted) at 25 °C, using
standard cornmeal food (per liter: 17 g inactivated yeast powder, 80 g corn flour, 9
g agar, 45 g white sugar, and 17 ml of Moldex). Similar results were also observed
using a richer medium (same composition except 45 g of yeast powder). Female
adult flies were used in all analyses throughout the study and placed on fly food
supplemented with fresh yeast, which was changed every 2 days. Conditional
expression in RNSCs was achieved by maintaining tub-Gal80ts expressing flies at
18 °C, until adulthood. Eclosed females aged for 3-days were shifted to 29 °C for
induction of gene expression and were kept at 29 °C for the indicated period of
time (in most cases 8 days). Virgin females bearing svbR9, svbPL107, or ubr3B
mutations18,47 over FM0 balancers were mated with males of the following gen-
otype: y, w, hs-FLP, tub-Gal80, FRT19A; UAS::mcd8-GFP; tub-Gal4/TM6B, Tb.
Females of the correct phenotype (not B and not Tb) were heat shocked for 1 h at
37 °C. For G-TRACE experiments, females w; UAS-RedStinger, UAS-FLP, Ubi-p63E
(FRT.STOP)Stinger/CyO were crossed with esg-Gal4, dome-MESO-Gal4 or c507-
Gal4 males and raised at 18 °C until adulthood. Females were kept at 25 °C and
dissected after 20 days. Flies were transferred on fresh food every 2 days and
dissected at the indicated time. Detailed information about the genotype of each
Drosophila stock is given in Supplementary Information.
Histology. Tissues were dissected in 1× PBS, fixed in 4% formaldehyde in PBS for
15 min at room temperature, washed for 5 min in PBS containing 0.1% Triton X-
100 (PBT) and fixed again during 20 min. Following a 5 min wash in PBT, tissues
were blocked for 30 min in PBT containing 1% BSA. Primary antibodies were
incubated overnight at 4 °C. Anti-ß-Galactosidase (Cappel Cat#08559761) anti-
body was used at 1:1000, anti-Cut (DSHB Cat#2B10), anti-GFP (Acris Antibodies
Cat#TP401) at 1:200, anti-phospho-Histone H3 (Upstate Cat#TAKMA312B), anti-
Disc-large (DSHB Cat#4F3 anti-discs large) at 1:500, anti-Arm (DHSB Cat# N2
7A1) at 1:100, anti-Hnt (DHSB Cat# 1G9) at 1:30. AlexaFluor-488 or -555 sec-
ondary antibodies (ThermoFischer Scientific Cat#Z25302 and Cat#Z25205) were
incubated for 2 h at room temperature at 1:500. After three washes, tissues were
mounted in Vectashield (Vector Laboratories). For X-gal staining, adult tissues
were dissected in 1× PBS, fixed in 1% glutaraldehyde in PBS for 15 min at room
temperature and washed in PBS. The staining solution was warmed up at 37 °C for
10 min plus another 10 min after addition of 8% X-Gal (5-bromo-4-chloro-3-
indoyl-ß-D-Galactopyranoside). The X-Gal solution used to reveal the ß-
Galactosidase activity was: 10 mM NaH2PO4·H2O/NA2HPO4·2H2O (pH= 7.2),
150 mM NaCl, 1 mM MgCl2·6H2O, 3.1 mM K4 (FeII(CN)6), 3.1 mM K3 (FeIII
(CN)6), 0.3% Triton X-100. Bright-field pictures were acquired using a Nikon
Eclipse 90i microscope.
TUNEL assays. TUNEL staining was performed following a protocol kindly
provided by A. Bergmann. Tissues were dissected in 1× PBS, fixed in 4% for-
maldehyde in PBS for 30 min at room temperature, washed for 3 times 15 min in
PBS containing 0.3% Triton X-100 (PBT) and blocked 15 min in PBT+ 5%
Normal Goat Serum (PBNT). Anti-GFP antibody was incubated overnight at 4 °C.
The following day, tissues were washed with WB (50 mM Tris/HCl pH= 6.8, 150
mM NaCl, 0.5% NP40, 1 mg/ml BSA) and incubated overnight with the secondary
antibody. Tubules were then washed 3 times in WB and incubated 30 min at 65 °C
with 99 µl of 100 mM Na-Citrate+ 1 µl of 10% Triton X-100. Following quick
washes with WB, tubules were incubated in 45 µl of labelling solution (in situ cell
death detection TMR Red kit, Roche), for 30 min at 37 °C. 5 µl of the enzyme
solution was added for 2 h at 37 °C. Tubules were finally washed in PBT and
mounted in Vectashield.
Microscopy, image, and statistical analysis. Images of whole Malpighian tubules
were acquired on a LSM710 confocal scanning microscope (×20 objective), using
automated multi-position scan. After stitching, tiled images of individual pairs of
tubules were analyzed with IMARIS 8.0 to quantify the number of GFP-positive
cells. Data of at least three independent experiments (approx. 20 tubules) were
combined. All statistical analyses were carried out using Prism 5 (GraphPad).
Comparisons between normally distributed groups were carried out using
Student’s t-test, unpaired, two-tailed and incorporating Welch’s correction to
account for unequal variances. One-way ANOVA with Bonferroni correction was
used when multiple comparisons were applied. In all figures, ns indicates p ≥ 0.05, *
indicates 0.05 > p ≥ 0.01, ** indicates 0.01 > p ≥ 0.001, and *** indicates p < 0.001.
Close-up pictures were acquired using Leica SPE and Leica SP8 confocal laser
scanning microscopes (×40 and ×63 objectives). Laser intensity and background
filtering was set according to the control samples and remained the same for all
subsequent samples. The intensity of pictures has been enhanced equally for all
images within the same experiment using adjustments in Photoshop CS5. All
images were processed using Adobe Photoshop and Illustrator CS5.
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Western blotting and immunoprecipitation. Drosophila S2 cells (Drosophila
Genomics Resource Center, stock number: 6) were grown in Schneider medium
supplemented with 10% fetal calf serum and 1% penicillin/streptomycin (Invitro-
gen) at 25 °C. We used either S2 cells or stable cell lines co-expressing the copper-
inducible constructs pMT-Svb::GFP and pMT-pri17. S2 cells were cultured in six-
well plates (1.75 × 106 cells/3 ml) and transfected in 100 µl of Opti-MEM (Invi-
trogen) with 3 µl of FugeneHD (Promega) and the indicated constructs. CuSO4
(final concentration of 1 mM) was used to induce the expression of pMT plasmids.
The following plasmids were used: pAc-Yki::HA and its related mutated version
pAc-Yki-WW::HA, pAc-Svb::GFP, and pAc-Svb-PPxY::GFP. S2 cells were lysed on
ice in 250 µl of ice-cold lysis buffer (150 mM NaCl, 50 mM Tris/HCl pH= 8.0),
0.5% NP40, 1 mM EGTA, and protease inhibitors (Roche). After clearing by
centrifugation at 18,000g for 10 min, immuno-precipitations from transfected
lysates were done in lysis buffer, using anti-GFP antibody (GFP-trap, Chromotek),
or anti-HA antibody (Covance) and Fast-Flow Protein G-Sepharose (Sigma
#P3296). Immuno-precipitated samples were separated by SDS-PAGE and trans-
ferred to PVDF membranes, then blotted by using the following antibodies: anti-
GFP (Acris Antibodies, Cat#TP401, 1:10,000), anti-HA (Covance, Cat#BLE901513,
1:2000), and anti-Yki (1:4000, kind gift of K. Irvine). Secondary antibodies were
anti-mouse or anti-rabbit IgG-HRP conjugates (Jackson Laboratory, Cat#515-035-
003, 1:10,000), detected using the ECL Clarity (Bio-Rad). Uncropped scans of blots
are supplied in Supplementary Information.
Northern blot analysis. Two days-old adults were frozen with liquid nitrogen and
heads were sorted with sieves, followed by RNA purification with Isogen (Nippon
Gene). 1 μg of RNA per lane was separated by formaldehyde-agarose gel electro-
phoresis and then transferred to a nylon membrane (Roche). Hybridization and
wash procedures were carried out at 52 and 65 °C, respectively. The filters were
reacted with an alkaline phosphatase-conjugated anti-DIG antibody (Roche) and
chemiluminescent reactions with CPD-Star (Roche) were detected by LAS
4000mini (GE Healthcare).
Data availability
The ChIP-seq datasets analyzed during the current study are available in the
EMBL-EBI repository: https://www.ebi.ac.uk/biosamples/samples/
SAMEA2439952, https://www.ebi.ac.uk/biosamples/samples/SAMN01041482,
https://www.ebi.ac.uk/biosamples/samples/SAMN02231205, https://www.ebi.ac.
uk/biosamples/samples/SAMN02231213, https://www.ebi.ac.uk/biosamples/
samples/SAMN02231206. The data that support the findings of this study are given
in Supplementary Table 1. Detailed scripts and computer code used for ChIP-seq
analysis are available from the corresponding author on request.
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Supplementary  Figure  1:  svb  enhancers  driving  expression  in  RNSCs  
(a)  Schematic   representation   of   the   svb   locus,   with   validated   enhancers   indicated   as   boxes;;   those  
driving  expression  in  RNSCs  are  in  blue.  (b)  The  svbE10  enhancer  (svbE10-­GFP)  is  active  in  RNSCs,  as  
shown   by   co-­expression   with   esg-­LacZ   (red).   (c)   The   shorter   elements   svbE3N   and   svbE6   are   each  
sufficient  to  drive  expression  in  RNSCs  as  revealed  by  X-­Gal  staining  and  comparison  with  esg-­lacZ.  
Scale  bar  is  50  µm.  
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Supplementary  Figure  2:  svb  is  required  for  RNSC  maintenance  
(a)  esgts-­driven  expression  of  svb-­RNAi  in  the  adult  (8  days  of  treatment)  depletes  the  renal  stem  cell  
compartment,  as  shown  by  staining  against  GFP  (green),  Armadillo  (Arm,  purple  or  red)  and  DNA  (blue).  
(b)  effect  of  a  second  RNAi  targeting  non-­overlapping  regions  of   the  svb  mRNA  on  RNSCs  (8  days,  
p=0.0042).  (c)  The  transcription  factor  Hindsight  (Hnt,  red)  is  expressed  in  esg-­positive  RNSCs  (green).  
(d)  Staining  for  Hnt  (red)  3  days  after  hatching  (referred  to  as  day  0  in  Fig.  1)  confirms  the  presence  of  
adult   RNSCs   before   inducing   esgts   svb-­RNAi   expression.   (e)   dome-­MESO-­Gal4   drives   specific  
expression  (mCherry,  red)  in  RNSCs,  as  shown  by  colocalization  with  Hnt  (green).  dome-­MESO-­driven  
expression  of  svb-­RNAi  leads  to  a  reduction  in  the  number  of  Hnt-­positive  RNSCs.  Nuclei  are  in  blue.  
(f)  Mosaic  clones  (MARCM)  of  control  and  svbPL107  mutant  cells,   labelled  with  GFP  (green),  25  days  
after  clone  induction.  The  cell  contour  is  revealed  by  staining  against  Dlg  (red).  (g)  closeup  of  MARCM  
clones,  labelled  by  GFP  (green)  and  stained  for  Cut  (purple).  In  both  control  and  svbR9  mutant,  clonal  
cells  with  a  small  diploid  nucleus  display  moderate  levels  of  Cut,  a  characteristic  feature  of  RNSCs  44.  
Values  are  presented  as  average  +/-­  standard  error  of  the  mean  (SEM)  and  boxes  with  whiskers  (10-­
90  percentile).  P-­values  are  from  a  Mann–Whitney  test  (**,  P<0,01).  Scale  bar  is  30  µm  in  all  panels,  
except  g  (3  µm).  
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Supplementary  Figure  3:  Pri  expression  and  function  in  RNSCs  
(a)  Drawing  of  the  pri  locus,  with  the  priA  and  priJ  enhancers  (blue)  that  are  both  active  in  adult  RNSCs.  
(b)  Fork  region  of  Malpighian  tubules  of  the  indicated  genotype;;  X-­Gal  staining  reveals  the  activity  of  
priA  and  J  enhancers   in  subsets  of  RNSCs   in  comparison   to   the  esg-­LacZ   reporter.   (c)  esgts-­driven  
expression  of  GFP  alone  (ctrl),  or  together  with  svb-­RNAi  and  pri-­RNAi.  In  all  pictures  GFP  is  in  green  
and  anti-­Cut  in  purple.  Scale  bar  is  30  µm.  (d)  Consequences  of  esgts-­driven  expression  of  GFP  alone  
(ctrl)   or   together  with  various  RNAi   constructs  on   the  number  of  RNSCs,   after   8  days  of   treatment.  
Values  are  presented  as  average  +/-­  standard  error  of  the  mean  (SEM)  and  boxes  with  whiskers  (10-­
90  percentile).  P-­values  from  Mann–Whitney  test  are  mCherry-­RNAi  (0.1134),  yki-­RNAiHMS  (<0.0001),  
ubr3-­RNAi106993  (0,0101),  ubr3-­RNAi45166  (0.0022);;  (ns,  P≥  0.05;;  *P<0.05,  **,  P<0,01;;  ***,  P  <  0.001).  
Scale  bar  is  100  µm.  
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Supplementary  Figure  4:  Proliferation  and  lineage  of  RNSCs  
(a)  Fork  region  of  the  Malpighian  tubules,  with  RNSCs  marked  by  esg-­Gal4>GFP  (green)  and  mitotic  
cells  by  immuno-­staining  against  phospho-­Histone  H3  (Ser10)  (PH3,  red).  Nuclei  were  stained  by  Topro-­
3  (blue).  Scale  bar   is  30  µm.  The  bottom  panels  show  a  closeup  of   two  RNSCs  undergoing  mitosis.  
Scale  bar   is  10  µm.   (b)  Disrupting  renal  homeostasis   in   the  adult   through  expression  of   tsh-­RNAi   in  
stellate  cells  (c724-­Gal4  driver)  reduces  their  number  and  favour  mitotic   figures,  as  followed  by  PH3  
staining.   Flies   were   kept   at   18°C   before   hatching   and   dissected   after   4   days   at   29°C.   Values   are  
presented  as  average  +/-­  standard  error  of  the  mean  (SEM)  and  boxes  with  whiskers  (10-­90  percentile).  
).   P-­values   from   Mann–Whitney   test   are   <0.0001   (***).   (c)   G-­TRACE   lineage-­tracing   experiments  
performed  with  esg-­Gal4   and  dome-­MESO-­Gal4,   two   drivers   specific   of  RNSCs,   or  Aph4-­Gal4   that  
drives   specific   expression   in   neighbouring   principal   cells   located   in   lower   tubules.   In   G-­TRACE  
experiments,  the  nuclear  DsRed  protein  (Red-­Stinger,  red)  that  is  expressed  under  the  control  of  UAS  
sequences  accumulates  in  cells  in  which  the  Gal4  driver  is  active.  The  nuclear  GFP  protein  (Stinger,  
green)  -­controlled  by  a  flp/FRT  cassette-­  is  expressed  both  in  progenitors  (Gal4-­positive  cells)  and  in  
their  progeny  (Gal4-­negative  cells).  Many  G-­TRACE  progeny  cells  are  visible  in  the  lower  tubule  region  
(white  arrows)  for  both  RNSC  drivers,  while  we  never  observed  progeny  from  Aph-­Gal4.  Scale  bar  is  50  
µm  (d)  Closeup  of  esg  G-­TRACE  experiments,  focusing  on  the  region  of  lower  tubules.  Progeny  cells  
(GFP  positive,  RFP  negative)  are  highlighted  by  white  arrowheads.  On  the  right  panel,   tubules  were  
processed   for  anti-­Cut  staining   (blue),   revealing   that  RNSC  progeny  differentiate   into   large  polyploid  
cells  principal  cells,  characterized  by  high  levels  of  Cut.  Flies  were  raised  at  18°C  until  hatching  and  
kept  21  days  at  25°C  before  dissection.  Scale  bar  is  10  µm.  
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Supplementary  Figure  5:  consequences  of  svb-­RNAi  or  mir8  overexpression  on  RNSCs  
(a)   esg-­ReDDM   lineage-­tracing   in   control   conditions,   following  mir8   over-­expression   or   svb   RNAi-­
depletion.  RNSCs  display  a  green  cytoplasm  (GFP)  and  a  red  nucleus  (H2B::RFP),  while  their  progeny  
only  maintain  the  stable  H2B-­RFP  signal.  Pictures  are  the  separate  channels  of  those  shown  in  Fig.  3a.  
(b)  esg-­ReDDM   lineage-­tracing  with  or  without  mir8  over-­expression.  Cells  prematurely  differentiated  
upon  mir8  overexpression  also  express   the  Aph4-­LacZ   reporter   (blue),  a  specific  marker  of  principal  
cells  in  lower  tubules.  Scale  bar  is  30  µm  
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Supplementary  Figure  6:  effect  of  Svb  on  Yki  function  and  subcellular  distribution  
(a)  esgts  was  used  to  drive  the  expression  of  GFP  and  the  indicated  transgenes,  for  8  days.  Expression  
of  OvoB  has  not  significant  effect,  in  contrast  to  yki-­RNAi  that  induces  a  drastic  drop  in  RNSC  number.  
This  phenotype  was  not  rescued  by  the  co-­expression  of  OvoB.  Scale  bar  is  30  µm.  (b)  esgts  was  used  
to  drive  the  expression  of  yki,  or  SvbACT  (ovoB)  in  RNSCs.  The  expression  of  DIAP1  was  followed  by  
the  activity  of  the  4.3-­GFP  enhancer.  Flies  were  dissected  8  days  after  induction.  Scale  bar  is  10  µm.  
(c)  Svb  has  not  detectable  effect  on  Yki  subcellular  location.  esgts  was  used  to  drive  the  expression  of  
yki::GFP  in  addition  to  svb-­RNAi,  or  SvbREP  (ovoA),  or  SvbACT  (ovoB),  in  RNSCs.  GFP  is  in  yellow  and  
nuclei  (Lamin)  in  cyan.  Flies  were  dissected  8  days  after  induction.  Scale  bar  is  3  µm  
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Supplementary  Figure  7:  comparison  of  Yki  and  Svb  binding  to  the  Drosophila  genome  
(a)  Venn  diagram  representing  the  genome-­wide  intersection  between  Yki  and  Svb  ChIP-­seq  peaks,  in  
pink  and  green,  respectively.  (b)  Comparison  of  the  observed  intersection  (Evobs)  between  Yki  and  Svb  
ChIP-­seq   peaks   versus   a   series   of   100   randomly   permutated   (Evperm)   samples,   indicating   the  
significance   of   the   observed   intersection   (p<0,01).   (c-­f)   Location   of   Svb   and   Yki   binding   sites   on  
shavenoid,  dusky-­like,  bantam  and  piwi  loci.  MACS  peaks  of  Svb  and  Yki  ChIP-­seq  are  in  green  and  
magenta,  respectively.  
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Supplementary  Figure  8:  Function  of  Svb/Pri  in  embryonic  and  adult  tissues  
(a)  cuticles  of  embryos  expressing  different  forms  of  the  Svb  transcription  factor  under  the  control  of  the  
ptc-­Gal4  driver.  (b)  Adult  wings  were  also  used  to  test  genetic  interactions  between  pri  and  wts  in  the  
context  of  sdETX4  males.  
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Supplementary  Figure  9:  pri  induces  overgrowth  and  activates  DIAP1  expression  
(a)  Adult  head  cases  dissected   form   flies  expressing   the   indicated   transgenes   in   the  eye,  under   the  
control  of  GMR-­Gal4.  (b)  Northern  blots  of  adult  head  mRNAs  revealing  the  expression  of  yorkie,  Cyclin  
E  and  DIAP1  in  wild-­type  (wt),  GMR-­Gal4  (GMR>)  and  GMR-­Gal4,  UAS-­pri  (GMR>pri)  flies.  The  black  
arrow  highlights  a  strong  upregulation  in  DIAP1  transcripts  upon  pri  overexpression.  
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Uncropped  scans  of  Western  and  Northern  blots  
  
Figure  7a  
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Supplementary  Figure  9  
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Supplementary  Methods  
  
Fly  stocks 
The following Drosophila melanogaster stocks were used in this study: tsh-LacZ 
(BL#11370), esg-lacZ (BL#10359) Aph4-LacZ (BL#12285), esg-Gal4, UAS-GFP; tubulin-
Gal80ts/ SM6-TM6B1 (B. Edgar), y, w, hsFLP, tubulin-Gal80 FR19A; UAS-mcd8::GFP/Cyo; 
tubulin-Gal4/TM6B,Tb (N. Tapon), esg-Gal4,UAS-mcd8::GFP/Cyo; UAS-H2B::RFP, 
tubulin-Gal80ts/TM22 (M. Dominguez), col-Gal4, UAS-mcd8::GFP/Cyo and dome-MESO-
Gal4 (M. Crozatier), GMR-Gal4/Cyo (BL#9146), tal-Gal4/TM3, Sb (J.P. Couso), c507-Gal4 
(referred to as Aph4-Gal4, J. Dow), c724-Gal4 (J. Dow), G-TRACE (BL# 28280), svbE-GFP, 
svbE10-lacZ, svbE3N-lacZ, svbE6-lacZ (D. Stern), svbE3N-GFP (this publication), svbR9, 
FRT19A/FMO , svbPL107, FRT19A/FMO3, ubr3B,FRT19A/FMO4 (H. Bellen), y, w, FRT82B, 
wtsX1/TM3, Sb (N. Tapon), w, FRT82B, priS18.1/TM6B (J.P. Couso), Diap1-lacZ (BL#12093), 
UAS-Cherry-RNAi (BL# 35785), UAS-svb-RNAi (VDRC # 41584, TRIP GL00335), UAS-
ubr3-RNAi (VRDC #22901,#106993, #45166), UAS-yki-RNAi (VDRC #KK104523, TRIP 
#HMS00041), UAS-tsh-RNAi (BL#	  28022), UAS-pri-RNAi (J.P. Couso), UAS-OvoA 3, UAS-
OvoB3, UAS-OvoA::GFP, UAS-OvoB::GFP 5, UAS-Svb-PPxY::GFP (this publication), UAS-
EcRDN (BL#9449), UAS-mir8 (S.M. Cohen), UAS-p35 (B. Monier), UAS-hpo/CyO (N. 
Tapon), UAS-yki/TM3, Sb (D.J. Pan), UAS-yki::GFP (BL#28815), UAS-DIAP1 (N. Tapon), 
UAS-pri/CyO (J.P. Couso), UAS-rpr (BL# 5823). 
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Full  genotypes    
 
Figure 1a: y, w/w; esg-Gal4, UAS-GFP/ tsh-LacZ 
Figure 1b: y, w/w; esg-Gal4, UAS-GFP 
Figure 1c: y, w/w; esg-LacZ/+; svbE3N-GFP/+ 
 
Figure 2a-c control: y, w/w; esg-Gal4, UAS-GFP/+; tubulinGal80ts/+ 
Figure 2a-c svb-RNAi: y, w/w; esg-Gal4, UAS-GFP/+; tubulin-Gal80ts/ UAS-svb-RNAi  
Figure 2d control: y, w, hsFLP, tubulin-Gal80, FR19A/ FRT19A; UAS-mCD8::GFP/+; 
tubulin-Gal4/ ry506 
Figure 2d svbR9: y, w, hsFLP, tubulin-Gal80, FR19A/ y, w, svbR9, FRT19A; UAS-
mCD8::GFP/+; tubulin-Gal4/+ 
 
Figure 3b: tal-Gal4/ UAS-HB2::RFP 
Figure 3c control: y, w/w; esg-Gal4, UAS-GFP/+; tubulin-Gal80ts/ + 
Figure 3c svb-RNAi: y, w/w; esg-Gal4, UAS-GFP/+; tubulin-Gal80ts/ UAS-svb-RNAi 
Figure 3c ovoA: y, w/w; esg-Gal4, UAS-GFP/+; tubulin-Gal80ts/ UAS-ovoA 
Figure 3c ovoB: y, w/w; esg-Gal4, UAS-GFP/+; tubulin-Gal80ts/ UAS-ovoB 
Figure 3c pri-RNAi: y, w/w; esg-Gal4, UAS-GFP/+; tubulin-Gal80ts/ UAS-pri-RNAi 
Figure 3c EcRDN: y, w/w; esg-Gal4, UAS-GFP/+; tubulin-Gal80ts/ UAS-EcRDNB2w650A 
Figure 3c ubr3-RNAi: y, w/w; esg-Gal4, UAS-GFP/ UAS-ubr3-RNAi; tubulin-Gal80ts/ +  
Figure 3c ubr3-RNAi + ovoB: y, w/w; esg-Gal4, UAS-GFP/ ubr3-RNAi; tubulin-Gal80ts/ UAS-
ovoB/+  
Figure 3d control: y, w, hsFLP, tubulin-Gal80, FR19A/ FRT19A; UAS-mCD8::GFP/+; 
tubulin-Gal4/ ry506 
Figure 3d ubr3null: y, w, hsFLP, tubulin-Gal80, FR19A/ y,w, ubr3B, FRT19A; UAS-
mCD8::GFP/+; tubulin-Gal4/+ 
 
Figure 4a control: y, w/w; esg-Gal4, UAS-mCD8::GFP/+; UAS-H2B::RFP, tubulin-Gal80ts/+ 
Figure 4a mir8: y, w/w, UAS-mir8; esg-Gal4, UAS-mCD8::GFP/+; UAS-H2B::RFP, tubulin-
Gal80ts/+ 
Figure 4a svb-RNAi: y, w/w; esg-Gal4, UAS-mCD8::GFP/+; UAS-H2B::RFP, tubulin-
Gal80ts/ UAS-svb-RNAi 
Figure 4b control: y, w/w; esg-Gal4, UAS-GFP/+; tubulin-Gal80ts/ + 
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Figure 4b p35: y, w/; esg-Gal4, UAS-GFP/ UAS-p35; tubulin-Gal80ts/+ 
Figure 4b svb-RNAi: y, w/w; esg-Gal4, UAS-GFP/+; tubulin-Gal80ts/ UAS-svb-RNAi 
Figure 4b p35+ svb-RNAi: y, w/; esg-Gal4, UAS-GFP/ UAS-p35; tubulin-Gal80ts/ UAS-svb-
RNAi 
Figure 4c control: y, w/w; esg-Gal4, UAS-GFP/+; tubulin-Gal80ts/ + 
Figure 4c >>Rpr: y, w/w UAS-rpr; esg-Gal4, UAS-GFP/+; tubulin-Gal80ts/ + 
Figure 4c svb-RNAi: y, w/w; esg-Gal4, UAS-GFP/+; tubulin-Gal80ts/ UAS-svb-RNAi 
 
Figure 5 control: y, w/w; esg-Gal4, UAS-GFP/+; tubulin-Gal80ts/ + 
Figure 5 hpo: y, w/w; esg-Gal4, UAS-GFP/ UAS-hpo; tubulin-Gal80ts/+ 
Figure 5 yki: y, w/w; esg-Gal4, UAS-GFP/+; tubulin-Gal80ts/ UAS-yki 
Figure 5 DIAP1: y, w/w; esg-Gal4, UAS-GFP/ +; tubulin-Gal80ts/ UAS-DIAP1 
Figure 5 svb-RNAi: y, w/w; esg-Gal4, UAS-GFP/ +; tubulin-Gal80ts/ UAS-svb-RNAi 
Figure 5 hpo+ ovoB: y, w/w; esg-Gal4, UAS-GFP/ UAS-hpo; tubulin-Gal80ts/ UAS-ovoB 
Figure 5 yki+ svb-RNAi: y, w/w; esg-Gal4, UAS-GFP/ +; tubulin-Gal80ts/ UAS-ovoB, UAS-
yki.  
Figure 5 yki+ ovoA: y, w/w; esg-Gal4, UAS-GFP/ +; tubulin-Gal80ts/ UAS-yki, UAS-ovoA.  
Figure 5 DIAP1+ svb-RNAi: y, w/w; esg-Gal4, UAS-GFP/ +; tubulin-Gal80ts/ UAS-DIAP1, 
UAS-svb-RNAi  
 
Figure 6b control: y, w/w; esg-Gal4, tubulin-Gal80ts; DIAP1-LacZ/+ 
Figure 6b yki: y, w/w; esg-Gal4, tubulin-Gal80ts; DIAP1-LacZ/ UAS-yki 
Figure 6b ovoA: y, w/w; esg-Gal4, tubulin-Gal80ts; DIAP1-LacZ/ UAS-ovoA 
Figure 6b yki + ovoA: y, w/w; esg-Gal4, tubulin-Gal80ts; DIAP1-LacZ/ UAS-yki, UAS-ovoA 
Figure 6b control: y, w/w; esg-Gal4, tubulin-Gal80ts/ +; DIAP14.3-GFP/+ 
Figure 6b yki: y, w/w; esg-Gal4, tubulin-Gal80ts/+; DIAP14.3-GFP / UAS-yki 
Figure 6b ovoA: y, w/w; esg-Gal4, tubulin-Gal80ts/ +; DIAP14.3-GFP / UAS-ovoA 
Figure 6b yki + ovoA: y, w/w; esg-Gal4, tubulin-Gal80ts/+; DIAP14.3-GFP / UAS-yki, UAS-
ovoA 
 
Figure 7b ovoB::GFP: y, w/w; esg-Gal4, tubulin-Gal80ts/ UAS-ovoB::GFP 
Figure 7b ovoA::GFP: y, w/w; esg-Gal4, tubulin-Gal80ts/ UAS-ovoA::GFP 
Figure 7b svbPPxY::GFP: y, w/w; esg-Gal4, tubulin-Gal80ts/ UAS-svb-PPxY-6C::GFP 
Figure 7b svbPPxY::GFP: y, w/w; esg-Gal4, tubulin-Gal80ts/+; UAS-svb-PPxY-9C::GFP/+ 
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Figure 8a control: y,w/w; col-Gal4, UAS-mCD8::GFP/+ 
Figure 8a yki: y,w/w; col-Gal4, UAS-mCD8::GFP/+; UAS-yki /+ 
Figure 8a ovoA: y,w/w; col-Gal4, UAS-mCD8::GFP/+; UAS-ovoA/+ 
Figure 8a yki + ovoA: y,w/w; col-Gal4, UAS-mCD8::GFP/+; UAS-yki, UAS-ovoA/+ 
Figure 8a svbPPxY: y,w/w; col-Gal4, UAS-mCD8::GFP/+; UAS-svb-PPxY::GFP /+ 
Figure 8b ctrl: y,w/w; FRT82B/+ 
Figure 8b pri/+: y,w/w; FRT82B, priS18.1/+ 
Figure 8b wts/+: y,w/y,w; FRT82B, wtsX1 /+ 
Figure 8b pri/+, wts/+: y,w/w; FRT82B, priS18.1, wtsX1 /+ 
 
Figure Sup1b: y, w/w; esg-LacZ/svbE10-GFP 
Figure Sup1c: y, w/w; esg-LacZ/+ 
Figure Sup1c: w; svbE3N-LacZ/+ 
Figure Sup1c: w; svbE6-LacZ/+ 
 
Figure Sup2a control: y, w/w; esg-Gal4, UAS-GFP/+; tubulin-Gal80ts/+ 
Figure Sup2a svb-RNAi: y, w/w; esg-Gal4, UAS-GFP/+; tubulin-Gal80ts/ UAS-svb-RNAi 
(VDRC#41584) 
Figure Sup2b svb-RNAi: y, w/w; esg-Gal4, UAS-GFP/+; tubulin-Gal80ts/ UAS-svb-RNAi 
(TRIP#GL00335) 
Figure Sup2c: y, w/w; esg-Gal4, UAS-GFP/+; tubulin-Gal80ts/+ 
Figure Sup2d control: y, w/w; esg-Gal4, UAS-GFP/+; tubulin-Gal80ts/+ 
Figure Sup2d svb-RNAi: y, w/w; esg-Gal4, UAS-GFP/+; tubulin-Gal80ts/ UAS-svb-RNAi 
Figure Sup2e control: y,w/w; dome-MESO-Gal4, UAS-mCherry/+ 
Figure Sup2e svb-RNAi: y,w/w; dome-MESO-Gal4, UAS-mCherry/+; UAS-svb-RNAi/+ 
Figure Sup2f control: y,w, hsFLP, tubulin-Gal80,FR19A/ FRT19A; UAS-mCD8::GFP/+; 
tubulin-Gal4/ ry506 
Figure Sup2f
 svbPL107: y,w, hsFLP, tubulin-Gal80, FR19A/ y,w, svbPL107, FRT19A; UAS-
mCD8::GFP/+; tubulin-Gal4/+ 
Figure Sup2g control: y,w, hsFLP, tubulin-Gal80,FR19A/ FRT19A; UAS-mCD8::GFP/+; 
tubulin-Gal4/ ry506 
Figure Sup2g
 svbR9: y,w, hsFLP, tubulin-Gal80 FR19A/ y,w, svbR9, FRT19A; UAS-
mCD8::GFP/+; tubulin-Gal4/+ 
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Figure Sup3b esg-LacZ: y,w/w; esg-LacZ/+ 
Figure Sup3b priA-LacZ: y,w; priA-LacZ/+ 
Figure Sup3b priJ-LacZ: y,w/+; priJ-LacZ/+ 
Figure Sup3c control: y,w/w; esg-Gal4, UAS-GFP/+; tubulin-Gal80ts/ + 
Figure Sup3c svb-RNAi: y,w/w; esg-Gal4, UAS-GFP/+; tubulin-Gal80ts/ UAS-svb-RNAi 
Figure Sup3c pri-RNAi: y,w/w; esg-Gal4, UAS-GFP/+; tubulin-Gal80ts/ UAS-pri-RNAi 
Figure Sup3d control: y,w/w; esg-Gal4, UAS-GFP/+; tubulin-Gal80ts/+ 
Figure Sup3d cherry-IR: y,w/yv; esg-Gal4, UAS-GFP/+; tubulin-Gal80ts/ UAS-Cherry-RNAi 
Figure Sup3d yki-IR HMS: y,w/y,w; esg-Gal4, UAS-GFP/ +; tubulin-Gal80ts/ UAS-yki-
RNAiHMS00041 
Figure Sup3d ubr3-IR 106993: y,w/w; esg-Gal4, UAS-GFP/ UAS-ubr3-RNAiVDRC#106993; 
tubulin-Gal80ts/ + 
Figure Sup3d ubr3-IR 45166: y,w/w; esg-Gal4, UAS-GFP/ UAS-ubr3-RNAi VDRC#45166; 
tubulin-Gal80ts/ + 
 
Figure Sup4a: y,w/y,w; esg-Gal4, UAS-GFP/  
Figure Sup4b ctrl: w; c724-Gal4/+  
Figure Sup4b Tsh RNAi: w/w; c724-Gal4/+; UAS-Tsh-RNAiJFO 2856  
Figure Sup4c dome-Gal4: w; UAS-Red-Stinger, UAS-Flp, ubi63(FRT-Stop)Stinger/ dome-
MESO-Gal4 
Figure Sup4c esg-Gal4: w; UAS-RedStinger, UAS-Flp, ubi63(FRT-Stop)Stinger/ esg-Gal4 
Figure Sup4c Aph4-Gal4: w; UAS-RedStinger, UAS-Flp, ubi63(FRT-Stop)Stinger/+ ; c507-
Gal4 
Figure Sup4d esg-Gal4: w; UAS-RedStinger, UAS-Flp, ubi63(FRT-Stop)Stinger/ esg-Gal4 
 
Figure Sup5a control: y, w/w; esg-Gal4, UAS-mCD8::GFP/+; UAS-H2B::RFP, tubulin-
Gal80ts/ + 
Figure Sup5a >mir8: y, w/w, UAS-mir8; esg-Gal4, UAS-mCD8::GFP/+; UAS-H2B::RFP, 
tubulin-Gal80ts/ + 
Figure Sup5a svb-RNAi: y, w/w; esg-Gal4, UAS-mCD8::GFP/+; UAS-H2B::RFP, tubulin-
Gal80ts/ UAS-svb-RNAi 
Figure Sup5b control: y,w/w; esg-Gal4, UAS-mCD8::GFP/+; UAS-H2B::RFP, tubulin-
Gal80ts/ Aph4-LacZ07028, ry 
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Figure Sup5b >mir-8: y,w/w, UAS-mir8; esg-Gal4, UAS-mCD8::GFP/+; UAS-H2B::RFP, 
tubulin-Gal80ts/Aph4-LacZ07028, ry 
 
Figure Sup6a control: y,w/w; esg-Gal4, UAS-GFP/+; tubulin-Gal80ts/+ 
Figure Sup6a ovoB: y,w/w; esg-Gal4, UAS-GFP/ +; tubulin-Gal80ts/UAS-ovoB 
Figure Sup6a yki-RNAi: y,w/w; esg-Gal4, UAS-GFP/ / UAS-yki-RNAi; tubulin-Gal80ts/+ 
Figure Sup6a yki-RNAi + ovoB: y,w/w; esg-Gal4, UAS-GFP/ UAS-yki-RNAi; tubulin-Gal80ts/ 
UAS-ovoB 
Figure Sup6b control: y,w/w; esg-Gal4, tubulin-Gal80ts/+; DIAP14.3-GFP/+ 
Figure Sup6b ovoB: y,w/w; esg-Gal4, tubulin-Gal80ts/+; DIAP14.3-GFP/ UAS-ovoB 
Figure Sup6c control: y,w/w; esg-Gal4, tubulin-Gal80ts/ UAS-Yki::GFP 
Figure Sup6c svb RNAi: y,w/w; esg-Gal4, tubulin-Gal80ts/ UAS-Yki::GFP; UAS-svb-RNAi /+ 
Figure Sup6c ovoA: y,w/w; esg-Gal4, tubulin-Gal80ts/ UAS-Yki::GFP; UAS-ovoA /+ 
Figure Sup6c ovoB: y,w/w; esg-Gal4, tubulin-Gal80ts/ UAS-Yki::GFP; UAS-ovoB /+ 
 
Figure Sup8a ctrl: y,w/w; ptc-Gal4/+ 
Figure Sup8a ovoA: y,w/w; ptc-Gal4/+; UAS-ovoA::GFP 
Figure Sup8a ovoB: y,w/w; ptc-Gal4/+; UAS-ovoB::GFP 
Figure Sup8a ctrl: y,w/w; ptc-Gal4/+; UAS-svb-PPXY::GFP 
Figure Sup8b ctrl: sdETx4/Y; FRT82B /+ 
Figure Sup8b wts/+: sdETx4/Y; FRT82B, wtsX1 /+ 
Figure Sup8b pri/+, wts/+: sdETx4/Y; FRT82B, priS18.1, wtsX1 /+ 
 
Figure Sup9a ctrl: y,w/w; GMR-Gal4/+ 
Figure Sup9a pri: y,w/w; GMR-Gal4/UAS-pri 
Figure Sup9a yki: y,w/w; GMR-Gal4/+; UAS-yki 
Figure Sup9a pri+ yki: y,w/w; GMR-Gal4/UAS-pri; UAS-yki/+ 
Figure Sup9b wt: Oregon-R 
Figure Sup9b GMR: y,w/w; GMR-Gal4/+ 
Figure Sup9b GMR>pri: y,w/w; GMR-Gal4/UAS-pri 
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ChIP-­seq  analysis  
Raw data (.fq files) of ChIPseq obtained for Yki 
6
 (GSM945893 GSM945894) and Svb
7
 
(GSM1184656, GSM1184657, GSM1184658) were processed in parallel, using the same 
pipeline. Briefly, reads were aligned to the Drosophila genome release Dm6 with BWA8. 
SAM files were converted into BAM files using SAMtools
9-11
 and further processed for peak 
calling. The quality of sequencing was checked using FastQC, and we used SAMTOOLS 
flagstat to calculate the percentage of mapped reads to estimate the quality of alignment from 
the percentage of mapped reads (as indicated below).  
Number  of  reads   FastQC   BAM  files   Mapping  
Svb_input   18,523,111	   13,322,332	   71,92	  %	  
Svb_Rep#1   16,956,734	   12,715,257	   74,99	  %	  
Svb_Rep#2   61,296,665	   46,185,543	   75,35	  %	  
Yki_input   41,901,421	   25,549,865	   60,98	  %	  
Yki_#1   29,985,092	   22,041,362	   73,51	  %	  
 
Peaks were called using MACS2
12
, using a p value of 0.1. The package ChIPpeakAnno
13
 
(available under RBioconductor) was used to identify co-binding regions of Svb and Yki, and 
to perform permutation-statistical tests
13
. An UCSC genome browser is available at: 
http://genome-­‐euro.ucsc.edu/cgi-­‐bin/hgTracks?hgS_doOtherUser=submit&hgS_otherUserName=amanchenoferris&hgS_otherUserSessionName=bohere_etal	  
 
DNA  constructs  and  mutagenesis  
The DNA region encoding point mutations to inactivate the two PPxY motifs of Svb (>PPxA) 
has been optimized to be chemically synthetized (Integrated DNA Technologies). Resulting 
DNA was amplified by PCR and cloned into the pAc-Svb::GFP construct
4
, linearized with 
PmlI and HindIII restriction sites, using the In-Fusion HD Cloning kit (Clontech  laboratories, 
Inc) to obtain the pAc-Svb-PPxY::GFP vector. The EcoRI fragment with both PPxA mutated 
sites from pAc-Svb-PPxY::GFP has been inserted into the pUASp-Svb::GFP
5
 linearized with 
EcoRI. All construct sequences have been verified by sequencing. 
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NORTHERN  blotting  
Using adult total RNAs as a starting material, DNA fragments containing coding sequence of 
yki, CycE and DIAP1 were reverse transcribed and PCR amplified. An SP6 promoter 
sequence (CAAGC TATTT AGGTG ACACT ATAG) was attached to each reverse primer 
for in vitro transcription. DIG-labelled probes were prepared with SP6 RNA polymerase, 
according to the supplier’s manual (Roche). 
 
Oligonucleotides  
Oligonucleotides  PPxY  mutagenesis  
5-TCAGCTCAGCATGCCACGCGTG-3   Integrated  DNA  
Technologies  
3’Ex2-­Fw  
5-CGGCAAGCCCAAGCTTTGGATGAGTGGC-3   Integrated  DNA  
Technologies  
3’Ex2-­Rev  
Oligonucleotides  Northern  blotting  
5-­CTGCCCAACTCCTTCTTCAC-­3   Integrated  DNA  
Technologies  
Yki  Forward  
5-­AACTGAATGGGGCTGATGAC-­3   Integrated  DNA  
Technologies  
Yki  Reverse  
5-­GATGACGTTGAGGAGGAGGA-­3     Integrated  DNA  
Technologies  
CycE  Forward  
5-­TGCGTCTTCTGCACCTTATG-­3   Integrated  DNA  
Technologies  
CycE  Reverse  
5-­CCGAGGAACCTGAAACAGAA-­3     Integrated  DNA  
Technologies  
DIAP1Forward  
5-­GCACAACTTTTCCTCGGGTA-­3     Integrated  DNA  
Technologies  
DIAP1Reverse  
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Summary of paper 2 
Here we show that the OvoL/Shavenbaby (Svb) transcription factor is required for adult gut 
homeostasis in flies. We find that Svb is specifically expressed and processed into the activator 
isoform in adult gut progenitors, i.e. intestinal stem cells and enteroblats (ISC/EB). Svb-ACT 
is required to protect stem cells from apoptosis, and sufficient to promote their proliferation. 
Indeed, genetic assays reveal that two main mitogenic pathways, EGFR and Wnt, activate svb 
expression in ISCs. We identified an enhancer driving svb expression in gut progenitors and 
demonstrate that its activity relies on the direct binding of nuclear effectors of the EGFR and 
Wnt pathways. In addition, we delineated a second svb enhancer driving expression in 
differentiated enterocytes (ECs). Strikingly, we find that this is the Svb-REP isoform that is 
expressed and required within ECs. Svb-REP induces the differentiation of EBs to ECs and is 
required to maintain proper differentiation and survival of ECs.  
Finally, we show that Svb-ACT is required for the growth of ISC-derived tumors and that Svb-
REP is sufficient to override deregulated signaling pathways, blocking tumorous behavior and 
leading to enterocyte differentiation.  
Taken together, our data in flies therefore demonstrate that controlled expression and 
maturation of the OvoL/Svb transcription factor plays a key role in the balance between stem 
cell maintenance/proliferation and enterocyte differentiation in the adult gut.  
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SUMMARY 
Conserved developmental signaling pathways, including Wnt and EGFR, are key 
regulators of adult stem cell homeostasis and underlying mechanisms are often 
deregulated in cancers. Recent studies of epithelial tumors have also implicated OvoL 
transcription factors, which produce antagonistic isoforms. Here, we show that Svb, the 
unique OvoL factor in Drosophila, integrates multiple regulatory inputs to control adult 
intestinal stem cells. In early stages of the lineage, Svb relays Wnt and EGFR signaling 
to ensure stem cell survival and renewal. This requires posttranslational processing of 
Svb into a transcriptional activator, triggered by Polished-rice micro-peptides in response 
to steroid signaling, and high Svb activator levels induce stem cell over-proliferation. In 
contrast, unprocessed Svb repressor drives differentiation in enterocytes, overriding 
mitogenic signals to suppress tumors. Thus, a switch in Svb transcriptional activity 
controls the balance between stem cell proliferation and differentiation, suggesting a 
broad role of OvoL/Svb in normal and cancer stem cells. 
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INTRODUCTION 
Living organisms are constantly exposed to aging and environmental challenges that 
disturb cell functions and ultimately lead to cell death. To maintain homeostasis, most 
adult organs are regenerated by self-renewing stem cells, which differentiate to replace 
dead cells and replenish damaged tissues. The highly regenerative digestive system is 
kept intact during adulthood by the activity of resident intestinal stem cells. Intestinal stem 
cells in flies have emerged as a powerful system to understand the signaling networks 
underlying stem cell biology and their implication in cancers (see (Herrera and Bach, 
2019; Li and Jasper, 2016; Perochon et al., 2018) for recent reviews). 
The adult fly midgut consists of a highly compartmentalized epithelium (Buchon et 
al., 2013; Marianes and Spradling, 2013), which shares anatomical and physiological 
similarities with its mammalian counterpart (Casali and Batlle, 2009). Drosophila intestinal 
stem cells (ISCs) are small diploid cells scattered along the basal surface of the epithelium 
(Micchelli and Perrimon, 2006; Ohlstein and Spradling, 2006). In steady state conditions, 
ISC divide asymmetrically to generate a new stem cell and a progenitor cell called 
enteroblast (EB) (Ohlstein and Spradling, 2007); ISCs and EBs express Escargot (Esg), 
a transcription factor of the Snail/Slug family (Korzelius et al., 2014; Loza-Coll et al., 
2014). EBs are post-mitotic cells that progressively acquire characteristics of either 
polyploid absorptive enterocytes (ECs) or hormone-secreting entero-endocrine cells 
(EEs) (Ohlstein and Spradling, 2007). It has been proposed that EEs arise from a 
separate pool of progenitors, called pre-enteroendocrines, which express markers of both 
ISCs and EEs (Biteau and Jasper, 2014; Zeng and Hou, 2015). 
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The evolutionarily conserved Notch pathway establishes the asymmetry between 
ISC and EB (Bardin et al., 2010; Micchelli and Perrimon, 2006; Ohlstein and Spradling, 
2007; Perdigoto et al., 2011). ISCs express Delta, a ligand that activates the Notch 
receptor in daughter EBs, as seen by upregulation of Su(H) expression. The EC fate 
requires high levels of Notch, whereas lower Notch signaling lead to EEs that maintain 
Prospero expression. The JAK/STAT pathway also contributes to the differentiation of 
committed progenitor cells into ECs and EEs (Beebe et al., 2010; Jiang et al., 2009). Gut 
homeostasis relies on a tight regulation of ISC division through cooperative activity of 
additional signaling pathways (reviewed in (Buchon and Osman, 2015)). For instance, the 
epidermal growth factor receptor (EGFR), Wnt and JAK-STAT pathways contribute to ISC 
preservation and proliferation (Biteau and Jasper, 2011; Jiang and Edgar, 2009; Jiang et 
al., 2011). Despite the wealth of knowledge accumulated on the role of signaling 
pathways in regulating ISC maintenance, division and differentiation, the intrinsic 
mechanisms by which ISCs integrate these cues remain poorly understood. 
 During embryogenesis, the activity of Wnt and EGFR pathways in the epidermis is 
mediated by a common target gene, ovo/shavenbaby (svb), which controls differentiation 
of epidermal trichome cells (Payre et al., 1999). Svb is a transcription factor, which 
undergoes post-translational processing from a repressor (SvbREP) to an activator 
(SvbACT) via limited proteasome degradation (Zanet et al., 2015). Svb maturation is 
triggered by Polished rice (Pri) peptides (Kondo et al., 2010), which are founding 
members of a fast growing family of peptides translated from small open reading frames 
(smORF peptides, see (Plaza et al., 2017; Saghatelian and Couso, 2015) for review). pri 
expression is directly activated by ecdysone (Chanut-Delalande et al., 2014), the main 
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steroid hormone in insects, which regulates –among others- reproduction, nutritional state 
and stress resistance in adults (Uryu et al., 2015). In addition to epidermal derivatives, 
the ovo/svb gene is also critical for germ cell maintenance and differentiation (Mevel-Ninio 
et al., 1995). It produces two germline-specific isoforms, called OvoA and OvoB, which 
are insensitive to Pri smORF peptides (Kondo et al., 2010) and act as “constitutive” 
repressor and activator (Andrews et al., 2000), respectively. 
Initially isolated in flies, Ovo/Svb was soon after identified in mammals (there are 
three paralogs called OvoL1-3) and shown to act in the epidermis and germline (Dai et 
al., 1998). Tumor profiling has recently identified OvoL factors as regulators of the 
metastatic potential of many human cancers, including the most prevalent ones such as 
breast (Roca et al., 2013), prostate (Fu et al., 2016), lung (Wang et al., 2017), as well as 
colorectal (Ye et al., 2016) cancers. Other studies have disclosed key roles of OvoL in 
the repair of mammalian epithelial tissues, e.g. for epidermal and mammary regeneration 
(Haensel et al., 2019; Watanabe et al., 2014). Moreover, OvoL factors are required for 
the differentiation of neural progenitors and the maintenance of human corneal epithelial 
cells (Kitazawa et al., 2016); deregulation of OvoL2 is a common cause of inherited 
corneal dystrophies (Davidson et al., 2016). In the planarian flatworm, OvoL/Svb is also 
expressed in eye progenitors and required for eye regeneration from multipotent stem 
cells (Lapan and Reddien, 2012), suggesting a conserved role of OvoL/Svb in 
progenitors/stem cells across animals. Indeed, we recently found that Svb is required in 
flies for the survival of adult renal nephric stem cells (RNSCs). We showed that Svb 
activates the expression of the Drosophila anti apoptotic protein (DIAP1) by interaction 
with Yorkie (a.k.a. YAP/TAZ), the nuclear effector of the Hippo pathway (Bohere et al., 
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2018). RNSCs derive from progenitors also producing intestinal stem cells (Xu et al., 
2018), suggesting a broader function of Svb in stem cells. 
 Here, we demonstrate that Shavenbaby is an important regulator of the intestinal 
stem cell lineage, essential to adult midgut homeostasis. svb is expressed in both 
ISC/EBs progenitors and differentiated ECs, and its inactivation induces apoptotic cell 
death. Svb acts downstream of EGFR and Wnt mitogenic signaling in progenitor cells, 
where it is processed into SvbACT through the Pri/proteasome axis. In contrast, SvbREP 
promotes differentiation toward ECs, where it is required to maintain functional 
organization of mature cells. Two separate enhancers drive svb expression in the stem 
cell lineage, and we performed large scale screening to identify the nuclear factors 
required for their activity in ISCs versus ECs. Our data indicate that svb expression in 
stem cells integrate direct inputs from Wnt and EGFR pathways, while svb expression in 
ECs is controlled by the OCT/POU factor Pdm1, renowned for its key role in enterocyte 
differentiation. Our results show how the Svb/Pri axis integrates multiple signaling 
pathways and transcription factors to coordinate ISC survival, renewal and differentiation. 
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RESULTS 
Svb is required to maintain Drosophila adult midgut progenitors 
svb expression is driven by a large array of enhancers, which collectively define at single 
cell resolution the pattern of epidermal differentiation in the embryo (Frankel et al., 2011; 
McGregor et al., 2007; Preger-Ben Noon et al., 2016; Sucena et al., 2003). To monitor 
svb expression in the adult midgut, we tested the activity of main svb enhancers. We 
found that the E svb enhancer (5 kb) drives specific expression in esg-positive cells, 
therefore identifying them as stem cells and enteroblasts (Figures 1A,B and S1A). Further 
dissection restricted the regions responsible for svb expression in progenitor cells to two 
separate enhancers called E3N (292 bp) and E6 (1kb). 
As a first step to investigate the function of Svb in intestinal stem cells, we used 
targeted RNAi-mediated depletion, at the adult stage. The conditional thermosensitive 
driver esgts (Micchelli and Perrimon, 2006) allowed svb knockdown in adult esg+ cells, 
resulting in a strong decrease in the number of progenitor cells (Figure 1C,C’). Using 
Delta-lacZ and Su(H)-GBE-lacZ to discriminate ISCs vs EBs, respectively, we observed 
strong reduction of both stem cells and enteroblasts upon svb knockdown (Figure 1C-E’). 
The requirement of svb in ISCs and EBS was confirmed svb depletion specifically in ISCs 
by using the ISCts driver (Wang et al., 2014) (Figure 1D,D’), or in EBs by using Su(H)ts 
(Zeng et al., 2010) (Figure S1B). Hence, svb depletion causes the loss of both ISCs and 
EBs, without detectable effects on enteroendocrine cells (Figure S1C). 
This conclusion was further tested by lineage-tracing using the acttsF/O system, which 
led to random inactivation of svb in dividing intestinal cells and their progeny (marked by 
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GFP). svb depletion leads to a strong decrease in both the number and size of GFP+ 
clones, when compared to controls (Figure 1F). This was also confirmed by the 
generation of genetically mutant cells for svb, using the MARCM technique (Lee and Luo, 
2001). In contrast to controls, we obtained very few clones of intestinal cells bearing the 
null svbR9 mutant allele (Delon et al., 2003). In addition, svb mutant clones were unable 
to grow and often restricted to single cells (Figure 1G). 
These results suggested that intestinal progenitors lacking svb undergo apoptosis, 
as recently shown for renal stem cells (Bohere et al., 2018). To test this hypothesis, we 
stained for the apoptotic marker cleaved-Dcp1 in guts bearing clones of progenitor cells 
lacking svb, using esgtsF/O (Jiang et al., 2009) to drive svb-RNAi. While only rare Dcp1-
positive cells were seen in controls, we observed many apoptosis figures in GFP+ cells 
upon svb depletion (Figure 1H). In addition, the apoptosis inhibitor DIAP1 partially 
rescued the loss of ISC/EBs when expressed together with svb-RNAi (Figure 1I). Finally, 
ReDDM lineage tracing (Antonello et al., 2015) indicated that stem cell loss upon svb 
depletion did not result from premature differentiation (Figure S1D). 
Taken together, these data show that Svb function is required to protect intestinal stem 
cells and enteroblasts from apoptosis. 
 
The Pri/Ubr3/proteasome axis controls Svb function in midgut progenitors 
Svb is translated as a large (1354 aa) repressor (SvbREP) that is processed into a shorter 
(909 aa) transcriptional activator (SvbACT) (Kondo et al., 2010). This switch is gated by Pri 
peptides that bind to and activate the E3 ubiquitin ligase Ubr3, triggering Ubr3 binding to 
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Svb (Zanet et al., 2015). Ubr3 then induces Svb processing via limited proteasome 
degradation of its N-term repression domain (see Figure 2C). Originally described in the 
epidermis (Chanut-Delalande et al., 2014; Kondo et al., 2010), there is growing evidence 
that Pri-dependent processing underlies Svb function in other somatic tissues (Pueyo and 
Couso, 2011; Ray et al., 2019), including adult stem cells (Bohere et al., 2018). 
To investigate whether Pri-mediated maturation of Svb was involved in ISC/EBs, 
we first examined pri expression in the adult midgut. Profiling of reporter lines (Chanut-
Delalande et al., 2014) showed that three pri enhancers (priA, priJ and priH) drive specific 
expression in ISC/EBs (Figure 2A,B). pri expression was also confirmed by the activity of 
a gene trap (Galindo et al., 2007) in ISC/EBs (Figure 2B). We next assayed the 
consequences of pri knockdown and observed an acute loss of progenitor cells when pri-
RNAi was driven by esgts (Figure 2D), or of stem cells when using the ISCts driver (Figure 
S2A). In the epidermis, ecdysone signaling times pri expression throughout embryonic 
and post-embryonic development (Chanut-Delalande et al., 2014). We reasoned that if 
this hormonal control of pri expression was occurring in the adult midgut, cell-autonomous 
disruption of the ecdysone pathway should affect the behavior of ISCs. Consistently with 
this prediction, downregulation of ecdysone signaling via a dominant negative receptor 
(EcR-DN, Figures 2E and S2D), or EcR-RNAi (Figure S2B,C), reduced the number of 
intestinal progenitor cells. Furthermore, pri expression was sufficient to rescue the loss of 
progenitors upon EcR inactivation (Figures 2E and S2D). These data thus support that 
pri is an important target of ecdysone required for the homeostasis of intestinal stem cells. 
The role of Pri peptides in triggering Ubr3-mediated processing of Svb in ISC/EBs 
was demonstrated by additional lines of evidence. First, knockdown of Ubr3 in intestinal 
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progenitor cells, or specifically in stem cells (Ubr3-RNAi driven by esgts or ISCts), resulted 
in a strong reduction of their numbers (Figures 2F and S2E). Second, we generated 
clones of Ubr3-null mutant cells, which were very rare and unable to expand (Figure 2G). 
Third, the loss of Ubr3 could be compensated by expression of the constitutive activator 
OvoB (Andrews et al., 2000; Kondo et al., 2010), indicating that a main function of Ubr3 
in ISCs is to operate Svb maturation into the activator form (Figures 2F and S2E). 
Taken together, these results establish that Svb undergoes Pri/Ubr3-dependent 
processing in intestinal stem cells to maintain the population of midgut progenitors. 
 
The Svb activator form triggers ISC proliferation 
Having shown that SvbACT is required for the survival of ISC/EBs, we next investigated if 
it could be sufficient to influence adult stem cell homeostasis. Hence, we expressed the 
OvoB constitutive activator using esgts and monitored the behavior of ISCs marked with 
Delta-lacZ. OvoB induced a strong increase in the number of ISCs (esg+, Dl-lacZ+), 
reaching up to four-fold the normal population (Figure 3A). This was due to ISC 
proliferation, as seen by increased levels of the mitotic marker phosphorylated-histone3 
(PH3, Figure 3A’). Furthermore, while pri has weak if any effects when expressed alone 
in stem cells, it provoked ISC over-proliferation when expressed together with SvbREP to 
induce the production of SvbACT (Figure 3B,B’). Similar results were obtained when pri 
and SvbREP were simultaneously expressed in esg+ cells, leading to increased numbers 
of progenitors and thus mimicking the phenotype of OvoB (Figure S3). 
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These data thus show that the SvbACT induced by Pri smORF peptides is sufficient 
to drive the proliferation of adult stem cells. 
 
Svb acts downstream of Wnt and EGFR mitogenic pathways in the adult midgut 
svb acts as a functional integrator of signaling pathways, including Wnt, EGFR, Hedgehog 
and Notch, mediating their roles in the embryonic epidermis (Payre, 2004). Since these 
pathways are well-established to control ISC behavior (Buchon and Osman, 2015), we 
investigated whether Svb could also mediate their activity in intestinal stem cells. 
As previously reported (Lin et al., 2008), inhibition of Wnt signaling by a dominant 
negative form of the nuclear effector TCF/Pangolin (TCF-DN) led to a marked decrease 
in the number of ISC/EBs (Figure 4A,A’). Co-expression of OvoB was not only sufficient 
to rescue the progenitor population, but could still induce ISC proliferation even when Wnt 
activity was compromised (Figure 4A,A’). Conversely, over-activation of Wnt signaling by 
expressing the Wingless ligand, or a constitutively active form of the nuclear effector ß-
Catenin (ArmS10), promotes ISC division (Lin et al., 2008). Wnt-induced stem cell 
proliferation was further potentiated upon expression of OvoB and abrogated when svb 
function was inhibited (Figure 4A). Similarly, EGFR activation (esgtsF/O>RasV12) that 
induces progenitor proliferation was counteracted upon svb depletion (Figure 4B). 
Knocking-down EGFR signaling (esgts>EGFR-DN) led to a loss of esg+ cells, and OvoB 
was also sufficient to bypass the depletion of stem cells (Figure 4B,B’). These results 
show that Svb is epistatic to, in other words likely acts downstream, Wnt and EGFR 
pathways to control adult stem cell maintenance and division. 
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Therefore, svb expression integrates inputs from Wnt and EGFR in both adult stem 
cells and embryonic epidermal cells (Payre et al., 1999); the underlying mechanisms yet 
remained to be elucidated. To identify in an unbiased manner transcription factors that 
control svb expression, we undertook functional screening in vivo, in the late embryonic 
epidermis, where Svb does not impinge on cell survival/ proliferation, as opposed to adult 
stem cells. We knocked down every TF showing detectable expression (Menoret et al., 
2013) at the time of epidermal differentiation (227 candidates, see Table S1) and assayed 
whether it affected the activity of svb enhancers (Figure S4A). This identified a few factors 
the depletion of which altered E3N expression, including TCF, the nuclear effector of Wnt, 
and Pointed (Pnt), an ets effector of the EGFR pathway. Analysis of the E3N sequence 
predicted putative binding sites for TCF and Pointed (Figure S4B-C) and we generated 
lacZ reporters with mutations within TCF (E3N-TCF-mt) or Pointed (E3N-Pnt-mt) sites. In 
the embryo, E3N-Pnt-mt displayed a reduced activity when compared to wild type E3N, 
whereas the inactivation of TCF sites induced a weaker but ectopic pattern (Figure S4D). 
To assay whether this altered pattern affected svb function, we generated transgenic lines 
driving svb under the control of E3N or E3N-TCF-mt and assayed their rescuing activity 
when introduced in svb mutants. While E3N-svb displayed clear rescue of trichomes 
consistent with previous report (Crocker et al., 2015), the mutation of TCF sites abrogated 
its rescuing activity (Figure S4E). Accordingly, both E3N-TCF-mt and -Pnt-mt reporters 
displayed strongly decreased expression when assayed in adult stem cells (Figure 4C). 
These data therefore show that the E3N svb enhancer integrates direct regulatory inputs 
from Wnt and EGFR pathways, to control the behavior of intestinal stem cells. 
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The Svb repressor promotes enterocyte differentiation 
In addition to stem cells, we observed expression of Svb within enterocytes as deduced 
from complementary pieces of evidence. In situ hybridization to svb mRNA stained small 
doublet cells located close to the basement membrane, i.e. ISC/EBs, but also revealed 
svb expression in ECs, which are located more apically and display characteristic large 
polyploid nuclei (Figure 5A). The production of Svb in both ISCs and ECs was also 
supported by the expression of a svb::GFP mini-gene rescue construct (Menoret et al., 
2013), while no expression was detected in EEs (Figure 5B,B’) consistent with the 
absence of svb function in EEs (Figure S1). Expression of the svb::GFP mini-gene is 
driven by only two enhancers: E (active in progenitors, see Figure 1) and 7, suggesting 
that the latter was responsible for svb expression in ECs. Indeed, even the shortest 
version of the svb-7 enhancer, termed 9CJ2 (232bp), drove expression in differentiated 
cells with large nuclei (Figure 5C). Using our screening assay to identify upstream 
regulatory factors, we found that 9CJ2 activity was reduced upon knocking down 
Pdm1/Nubbin (Figure S5), which controls EC differentiation (Micchelli and Perrimon, 
2006; Ohlstein and Spradling, 2006, 2007). We identified two putative Pdm1 binding sites 
within 9CJ2 (Figure S5B,C) and inactivated those by point mutations (9CJ2-Pdm-mt). 
Knockout of Pdm1 sites prevented 9CJ2 expression, both in the embryonic epidermis and 
in adult intestinal stem cells (Figures 5C and S5D). We thus conclude that svb is 
expressed in ECs under the control of the 7 enhancer, likely directly regulated by Pdm1. 
 The switch in Svb transcriptional activity triggered by pri is associated with a 
marked change in Svb intra-nuclear distribution: whereas SvbACT diffuses within the 
nucleoplasm, SvbREP accumulates in dense foci (Kondo et al., 2010; Zanet et al., 2015). 
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Svb appeared diffuse in esg+ cells (that express pri), while displaying foci in ECs, which 
don’t (Figure 5B’). Unlike ISCs that rely on SvbACT, SvbREP might thus be involved in the 
differentiation of enterocytes. To test this hypothesis, we expressed the full size Svb 
protein (SvbREP) in intestinal progenitor cells (esgts). The number of ISC/EBs was reduced 
and remaining esg+ cells displayed aberrant morphology, with enlarged nuclei 
reminiscent of polyploid ECs (Figure 5E). Moreover, SvbREP precluded the growth of 
esgtsF/O clones, limited to single cells with large nuclei (Figure 5D). These cells were 
negative for Dcp1 apoptotic staining and, accordingly, SvbREP phenotypes were not 
rescued by DIAP1 expression (Figure 5E,E’). These data thus suggested that SvbREP 
induces ISC/EB differentiation instead of cell death, a hypothesis we next tested using 
ReDDM lineage tracing. Indeed, the loss of progenitors seen upon SvbREP expression in 
esg+ cells was accompanied by a strong increase in differentiated cells with large nuclei 
(Figure 5F), showing that SvbREP induces differentiation towards the EC fate. 
 To investigate the role of Svb in differentiated enterocytes, we next knocked it 
down using the EC-specific driver MyoIAts (Jiang et al., 2009). svb depletion in ECs 
altered midgut organization, with a thinner epithelium and enlarged lumen (Figure 6A). 
We also noticed elevated Dcp1 levels (Figure S6A) and ultra-structural analyses 
confirmed that svb knockdown induced cell death, as seen by pyknotic nuclei and 
impaired cell contacts (Figure 6C). We then assayed which Svb form was required in ECs, 
through expressing either SvbREP or OvoB with MyoIAts. Intestines expressing SvbREP in 
ECs did not show any detectable homeostatic or structural changes (Figure S6B). In 
contrast, OvoB induced striking defects of the midgut, with abnormal multilayered 
intestinal wall and a reduced lumen (Figure 6A). Furthermore, OvoB caused the loss of 
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Myo1A expression, indicating deeply compromised differentiation (Figure 6B), as also 
manifested by brush border defects seen in electron microcopy (Figure 6C). 
Since the deregulation of Svb caused drastic phenotypes upon two weeks of 
treatment, the role of Svb in ECs was investigated upon shorter manipulation times (6 
days) to capture early defects. In these mild conditions, OvoB still impaired epithelium 
organization, with multilayered cells showing reduced apical actin accumulation (Figure 
6A,D). OvoB-induced extra-intestinal cells also displayed altered apico/basal polarity 
revealed by misdistribution of Scribble, which marks the lateral domain (Chen et al., 
2018), as well as of Tsp2a and Coracle that are components of septate junctions (Figures 
6D and S6). The conclusion that Svb function in ECs relies on the unprocessed SvbREP 
predicted specific consequences, which we assayed directly. First, unlike intestinal stem 
cells, Svb function in ECs should be insensitive to Ubr3; accordingly, we detected no 
defects upon MyoIAts-driven Ubr3 knockdown (Figure S6B). Second, the endogenous Svb 
protein should be converted into SvbACT upon expressing pri in ECs, and Pri was sufficient 
to induce prominent defects reminiscent of the OvoB phenotype (Figure 6D). 
We interpret these results to imply that the repressor form of Svb is required to 
maintain the proper differentiation of mature ECs in the adult midgut. 
 
Svb allows the growth of genetically-induced ISC tumors 
A main determinant of intestinal stem cell differentiation is the activation of Notch, 
suggesting that SvbREP may synergize with Notch to direct EC differentiation. As 
previously reported (Ohlstein and Spradling, 2007), inhibition of Notch induces tumor-like 
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expansion of ISCs (Figure 7A). Concomitant svb knockdown reduced the expansion of 
Notch-induced tumors. Strikingly, SvbREP was sufficient to suppress Notch tumors and 
force their differentiation (Figure 7A). Conversely, Notch activation by expressing the 
Notch intracellular domain (NICD) in esg+ cells caused an acute decrease in progenitors, 
likely differentiating in ECs (Figure S7A). The co-expression of OvoB with NICD restored 
progenitor populations, whereas SvbREP enhanced the NICD phenotype (Figure S7A). We 
also found antagonistic effects of SvbACT vs SvbREP on the phenotype of a dominant 
negative form of Delta, the Notch ligand in ISCs (Figure S7B). We next tested whether 
Svb could as well suppress tumors induced by additional signaling pathways. Indeed, 
SvbREP suppressed ICS-derived tumors resulting from the inactivation of JAK/STAT, or 
the activation of Wnt, in esg+ cells (Figures 7B and S7C,D). In addition, the depletion of 
svb in those tumors was sufficient to block their expansion in the midgut (Figure 7B). 
Hence, svb is required for the growth of ISC-derived tumors and SvbREP acts as a tumor 
suppressor, overriding different signaling pathways to promote differentiation. 
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DISCUSSION 
Our data show that the OvoL/Shavenbaby transcription factor is a key regulator of adult 
intestinal stem cells and their progeny. In stem cells, Svb acts as an activator sufficient to 
promote stem cell division, and mediating the proliferative activity of EGFR and Wnt 
pathways. Svb is also expressed in enterocytes, where the repressor form of Svb 
promotes differentiation. The balance between SvbACT and SvbREP is gated by Pri smORF 
peptides, which allow proteasome-mediated conversion of Svb transcriptional activity, in 
response to ecdysone signaling. Our results further suggest that the transcriptional switch 
of OvoL/Svb factors is a conserved mechanism for the control of stemness. 
svb integrates multiple regulatory cues for the homeostasis of adult stem cells 
Numerous studies have demonstrated the role of Wnt and EGFR signaling in adult stem 
cells and cancers (Normanno et al., 2006; Zhan et al., 2017), but little remains known on 
their specific molecular targets. We find that ovo/svb is a common target of Wnt and 
EGFR pathways mediating their activity in intestinal stem cells, as previously shown in 
the embryonic epidermis (Payre et al., 1999). Our data further indicate that the nuclear 
mediators of Wnt (TCF) and EGFR (Pointed) directly regulate a svb stem cell enhancer 
(E) (Figure 7C). Although the register of Wnt activity in the midgut remains a matter of 
debate (Perochon et al., 2018), the main EGFR mitogenic pathway is ON in ISCs and 
OFF in ECs (Jiang and Edgar, 2009; Jin et al., 2015), explaining restriction of svb E 
enhancer activity in stem cells. In addition, Pdm1, a key TF for the EC fate that is 
repressed in ISCs (Korzelius et al., 2014; Micchelli and Perrimon, 2006; Ohlstein and 
Spradling, 2006, 2007), activates a distinct enhancer (7) to drive svb expression in 
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enterocytes (Figure 7C). Of note, these two svb enhancers display similar expression in 
the embryo (Frankel et al., 2010; McGregor et al., 2007), supporting the notion that they 
harbor pleiotropic functions across the life-cycle (Preger-Ben Noon et al., 2018). Hence, 
the regulatory logic of svb expression is rewired in the adult intestinal lineage, involving 
separate enhancers and regulators between stem cells and enterocytes. 
SvbACT is required for the maintenance and proliferation of stem cells 
Svb function relies on post-translational control of its transcriptional activity. Svb 
processing into an activator is indispensable for the maintenance of stem cells, which 
otherwise undergo apoptosis. Adult stem cells are particularly resistant to apoptotic cell 
death, as shown for both intestinal and renal stem cells (Ma et al., 2016). In the latter, we 
recently reported that Svb physically interacts with Yorkie (YAP/TAZ in mammals), the 
nuclear effector of Hippo signaling (Staley and Irvine, 2012), to directly activate DIAP1 
expression (Bohere et al., 2018). Although renal stem cells are mostly quiescent (Bohere 
et al., 2018; Xu et al., 2018), intestinal stem cells self-renew under homeostatic conditions 
and proliferate in response to various challenges. Consistently, SvbACT is required and 
sufficient to promote intestinal stem cell proliferation, high SvbACT in ISCs leading to 
hyperplastic over-growth (Figure 7C). 
SvbREP triggers the differentiation of enterocytes 
Our results also show the expression and function of Shavenbaby in enterocytes, but not 
in enteroendocrine cells, consistent with an early separation between EC and EE lineages 
(Biteau and Jasper, 2014; Guo and Ohlstein, 2015; Zeng and Hou, 2015). In contrast to 
stem cells, Svb acts as a repressor within ECs where it is required for their maintenance 
and differentiation. Ectopic processing into SvbACT in ECs disrupts epithelial organization, 
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leading to multilayered cells that loose key features of mature ECs, including MyoI1A 
expression, brush border microvilli, as well as proper apical/basal polarity and junctions. 
Junctional complexes are established during EC maturation and they are essential for 
differentiation. For instance, Tsp2A (a component of septate junctions) is required for 
turning OFF Hippo and JAK/STAT in ECs, showing the link between EC maturation and 
the restriction of ICS proliferation (Xu et al., 2019). Indeed, SvbREP is a potent tumor 
suppressor, abrogating the growth of Notch, JAK/STAT, Wnt or EGFR-induced tumors 
and forcing differentiation towards the EC fate (Figure 7C). Therefore, SvbACT and SvbREP 
exert antagonistic functions within the adult intestinal lineage, SvbACT promoting stem cell 
proliferation and progenitor survival, while SvbREP later acts to induce and maintain 
enterocyte differentiation. 
Ecdysone function in intestinal stem cells 
The switch between SvbREP and SvbACT is triggered by Pri peptides throughout the fly life-
cycle (Bohere et al., 2018; Chanut-Delalande et al., 2014; Kondo et al., 2010; Zanet et 
al., 2015). pri is expressed in ISC/EBs but absent from ECs, and Pri peptides are required, 
together with their target Ubr3 ubiquitin ligase (Zanet et al., 2015), for stem cell 
maintenance. A key role of Pri is to mediate ecdysone signaling for developmental timing 
(Chanut-Delalande et al., 2014). We find that disrupting ecdysone signaling affects the 
behavior of intestinal stem cells, decreasing proliferation and promoting differentiation, 
i.e., as seen upon inhibition of Svb processing. The expression of pri, or of a constitutive 
Svb activator, can compensate compromised ecdysone signaling, showing that the 
regulation of Svb activity is a key target of hormonal control in intestinal stem cells. The 
role of ecdysone in midgut homeostasis remains to be fully elucidated (Miguel-Aliaga et 
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al., 2018), but it is tempting to speculate that ecdysone may contribute to adapt stem cell 
behavior in the face of various environmental conditions throughout the adult life. 
OvoL/Svb transcriptional switch for stem cell control across animals 
Mounting evidence suggests a wide role of the regulation of OvoL/Svb transcriptional 
activity in progenitor/stem cells. Svb is expressed and required in the posterior growth 
zone, a group of embryonic precursors that endow the sequential formation of posterior 
segments in most insects, and this ancestral Svb function relies on Pri and Ubr3 activities 
(Ray et al., 2019). OvoL factors are also known for their conserved role in germ cell 
precursors (Hayashi et al., 2017). In flies, the germline-specific OvoB activator and OvoA 
repressor are produced from two alternative promoters. OvoB is required for the 
maintenance of germ cells, while OvoA acts for their proper differentiation (Andrews et 
al., 2000; Hayashi et al., 2017). Precocious expression of OvoA leads to germ line loss 
(Andrews et al., 1998) and other ovo mutations cause ovarian tumors (Oliver et al., 1993). 
Although relying on different mechanisms between soma (post-translational processing) 
and germline (alternative promoters), the REP-to-ACT switch appears central to the 
function of Ovo/Svb factors in Drosophila. 
 Human OvoL factors are associated with many cancers, in particular those of 
epithelial origin, which often involve deregulated Wnt and EGFR signaling (Normanno et 
al., 2006; Zhan et al., 2017). Our studies in flies reveal opposing effects of SvbACT vs 
SvbREP, which promotes or suppresses stem cell-derived tumors, respectively. 
Interestingly, OvoL2 isoforms display strikingly different effects within tumor xenografts in 
mice, in which only the repressor suppresses tumor development (Watanabe et al., 2014). 
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OvoL/Svb have been proposed to act as general epithelial stabilization factors, 
counteracting epithelial to mesenchyme transition (EMT) (Lee et al., 2017; Watanabe et 
al., 2014). They have recently been identified as key factors for reprogramming 
mesenchymal fibroblasts towards induced pluripotent stem cells (iPSCs) (Kagawa et al., 
2019) and epithelial lineages (Watanabe et al., 2019). EMT is induced by a core of 
transcription factors, including Snail and Zeb1-2 in mammals (reviewed in (Nieto et al., 
2016)) and their fly homologs called Escargot and ZFh1-2 prevent ISC differentiation 
(Antonello et al., 2015; Korzelius et al., 2014; Loza-Coll et al., 2014). According to the 
model of an antagonism between EMT factors and OvoL/Svb, SvbREP promotes intestinal 
stem cell differentiation. However, our results draw a more complex picture, where SvbACT 
should also act together with Esg, ZFh1-2 for the maintenance of ISCs. EMT is not an all-
or-none process and instead progresses through a series of reversible intermediate 
states between the epithelial (E) and mesenchyme (M) phenotypes (Nieto et al., 2016). 
Such hybrid E/M phenotypes are hallmarks of normal and cancer stem cells, and relative 
doses of EMT factors and OvoL/Svb isoforms may provide a tunable window of stemness 
(Jolly et al., 2015). 
Taken together, these data show the importance of OvoL/Shavenbaby factors in the 
control of adult stem cell behavior, in both normal and tumorous conditions. We propose 
that OvoL/Shavenbaby factors are ancestral regulators of epithelial organization across 
animals, explaining their key roles in development, differentiation and adult homeostasis. 
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Figure 1: svb is expressed in ISC/EBs and is required for their maintenance 
(A) Schematic representation of the svb locus, with position of main enhancers (A, E, 7). 
(B) Expression of the E3N svb enhancer (GFP, green) in ISC/EBs, as shown by co-staining with esg-lacZ (β-Gal, red). 
(C,C’) Expression of Dl-lacZ (purple) in control and esgts>svb-RNAi. Close ups show separate channels for GFP (green) and Dl-
lacZ. (C); quantification esg+ progenitors (C’).  
(D,D’) Effect of svb-RNAi driven by ISCts (D); quantification of YFP+ cells (D’). 
(E,E’) esgts>svb-RNAi in enteroblasts marked by Su(H)-lacZ (red) and esgts>mCherry; (green) (E); quantification of Su(H)+ EBs (E’). 
(F) ActtsF/O clones (marked by GFP, green) of control and svb-RNAi cells. 
(G) Control and svbR9 null mutant MARCM clones, labeled by GFP (green). 
(H) Staining for the apoptotic marker DCP1 (red) in control and svb-RNAi esgtsF/O clones (GFP positive cells, green). 
(I) Quantification of GFP+ cells per posterior midgut in control esgts and >DIAP1, svb-RNAi, svb-RNAi+DIAP1. 
In this and all other figures, non-parametric two-tailed Mann-Whitney tests were used to compare two conditions, and Kruskal-Wallis 
tests for three or more conditions. P values are ns: p>0.05, ***: p<0.001, ****: p < 0.0001. DAPI is blue, scale bars, 20µm, except in 
B, C and E close ups (10µm). See also Figure S1. 
Al Hayek et al.,    p:  30 
 
Figure 2: Pri/proteasome processing of Svb is required for ISC/EB maintenance  
(A) Drawing of the pri locus, with position of Gal4 gene trap insertion. 
(B) Expression of priA, priJ or priH enhancers, as seen by lacZ reporters, and pri-Gal4>GFP transgene (green). 
(C) Schematic representation of Svb maturation by proteasome processing. OvoA and OvoB germinal isoforms are also shown. 
(D) Effect of RNAi-mediated pri depletion driven by esgts and quantification of GFP+ cells per posterior midgut. 
(E) Effect of esgts driven expression of EcR-DN, Pri, EcR-DN+Pri, or EcR-DN+OvoB and quantification. 
(F) esgts expression of Ubr3-RNAi alone, or in combination with OvoB. 
(G) Control and Ubr3 null MARCM clones visualized by GFP (green). 
P values are ns:>0.5, *: <0.05, ***: < 0.001, ****: <0.0001. Blue is DAPI, scale bars, 20µm. See also Figure S2. 
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Figure 3: The Svb activator induces ISC proliferation 
(A) Expression of esgts>GFP (green) and Dl-lacZ (purple) in control, or upon OvoB expression, and quantification of Dl-lacZ+ cells 
(ISCs) and GFP+ cells (ISC/EBs). 
(A’) Quantification of the mitotic marker PH3 in control egsts, OvoB and svb-RNAi. 
(B) Expression of YFP (yellow) in control ISCts, >OvoB, or SvbREP+Pri  
(B’) Quantification of (B). 
In A’ and B’ charts, the Y axis is drawn as log(10). Blue is DAPI. Scale bars, 20µm. P values are ns: p>0.5, *: p<0.05, **: p<0.01, ***: 
p < 0.001, ****: p<0.0001. See also Figure S3. 
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Figure 4: Svb acts downstream of mitogenic signaling pathways Wnt and EGFR in adult midgut 
(A) Control esgts and >TCF-DN, TCF-DN+OvoB, ArmS10, ArmS10+svb-RNAi  
(A’) Quantification of (A). 
(B) Control and esgts>EGFR-DN, EGFR-DN+OvoB; Bottom panels show egstsF/O>GFP (control) and expressing RasV12 alone, or in 
combination with svb-RNAi 
(B’) Quantification of (B). 
(C) Expression of wild type E3N-lacZ, or mutated versions for binding sites of either TCF (TCF-mt) or Pointed (Pnt-mt). 
DAPI is blue, scale bars, 20µm. P values are ****: p<0.0001. See also Figure S4. 
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Figure 5: The Svb repressor is expressed in enterocytes and promotes differentiation 
(A) Expression of svb mRNA in the adult posterior midgut as revealed by in situ hybridization. The inlet shows an enlarged view. 
(B) Expression of a svb mini-gene (Menoret et al., 2013) composed of svb-cDNA tagged by GFP (green) and driven by the E and 7 
svb enhancers. Red is esg>mCherry and white is Prospero. 
(C) Expression of wild type svb enhancer (9CJ2) and a mutated version disrupting Pdm1 binding sites (9CJ2-Pdm-mt). 
(D) esgts-F/O clones expressing SvbREP (GFP+, green) and stained for DCP1 (red. 
(E) Control and esgts>SvbREP or SvbREP+DIAP1. 
(E’) Quantification of (E). 
(F) ReDDM tracing in control and SvbREP flies and quantification of progenitors (GFP-positive, RFP-positive) versus differentiated cells 
(GFP-negative, RFP-positive). 
Blue is DAPI, scale bars, 20µm. P values are ns: p>0.5, ***: p < 0.001, ****: p<0.0001. See also Figure S5. 
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Figure 6: The Svb repressor is required to maintain enterocyte differentiation 
(A) Control and MyoIAts>svb-RNAi or OvoB. Cyan dye stains the lumen. 
(B) Control and MyoIAts>svb-RNAi or OvoB. ECs are visualized by GFP (green). 
(C) Electron micrographs of control (MyoIAts>GFP), >svb-RNAi and >OvoB. svb depletion or expression of OvoB leads to strong 
defects in enterocyte ultrastructure, including alteration of the brush border microvilli (highlighted in green), see also close-ups in 
inlets. Nuclei are pseudo-colored in purple, and visceral muscles located above the basement membrane are in pink. Arrowheads 
point to impaired cell contacts, the arrow points to a pyknotic nucleus. 
(D) Cross sections of control midguts (MyoIAts>mCherry-RNAi), or MyoIAts>svb-RNAi, OvoB or Pri. White is F-actin, green GFP and 
red is Scribble or Tsp2a. Blue is DAPI. Scale bars are 20µm (A, B, D) and 5µm in C. See also Figure S6. 
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Figure 7: SvbREP suppresses tumors in the gut epithelium 
(A) esgts-driven expression of Notch-RNAi alone, combined to svb-RNAi or to SvbREP; and quantification of progenitor cells (GFP+, 
green). 
(B) esgts expression of STAT-RNAi alone, combined to svb-RNAi or to SvbREP; and quantification of progenitors. 
In all panels, anti-Prospero is red and DAPI blue; scale bars, 20µm. P values are ns: p>0.5, **: p < 0.01, ****: p<0.0001. See also 
Figure S7. 
(C) Summary of the role of SvbACT and SvbREP in the control of intestinal stem cell maintenance, proliferation and differentiation. 
 Supplementary Figure 1 (related to Figure 1) 
(A) Expression of the E6 svb enhancer, as reported by X-gal staining (cyan) of a E6-LacZ reporter line. 
(B) svb knockdown in enteroblasts, driven by Su(H)Ts. Su(H)-GBE-GFP cells are in green and anti-Prospero in red. 
(C) Knocking-down svb function in enteroendocrine cells driven by VoilaTs does not affect their number. GFP positive cells are in 
green and anti-Prospero in red. 
(D) Schematic representation of the ReDDM lineage tracing system (Antonello et al., 2015), in which esgts drives expression of 
both mCD8::GFP and H2B::RFP. esg+ cells are labelled by GFP (green) and RFP (red), while differentiated progeny only 
maintains the very stable H2B::RFP. svb knockdown results in a strong decrease on esg+ cells (GFP+) upon two weeks of 
treatment, while it does not affect the ratio between progenitors (GFP+) and differentiated progeny (RFP+/GFP-). 
In all panels, blue is DAPI. P values from Mann-Whitney tests are: ns>0,05, ****<0,0001. 
  
 Supplementary Figure 2 (related to Figure 2) 
(A) Knockdown of pri by ISCts-Gal4 leads to the loss of YFP+ stem cell (yellow). 
(B) Depletion of the Ecdysone receptor (EcR) using two RNAi lines driven by esgts-Gal4 reduces the pool of intestinal progenitors 
(green). An RNAi line targeting mCherry was used as a negative control.  
(C) EcR knockdown driven by ISCts-Gal4 causes the loss of YFP+ stem cells (yellow). 
(D) Stem cell loss upon EcR-DN expression driven by ISCts-Gal4 is compensated by re-expression of pri. For easier visualization, 
the graph is shown using a log (10) y scale. 
(E) Depletion of Ubr3 driven by ISCts-Gal4 reduces the number of YFP+ stem cells (yellow) and can be compensated by 
concomitant expression of the constitute activator OvoB. For easier visualization, the graph is shown using a log (10) y scale. 
All panels display phenotypes following 10 days of treatment, with DAPI in blue and Anti-Prospero staining in red. P values from 
Mann-Whitney (A) or Kruskal-Wallis (B-E) tests are: ns>0.05; *<0.05; **<0.01; ***<0.001; ****<0.0001. 
 
 
  
 
Supplementary Figure 3 (related to Figure 3) 
Expression of OvoB, or Svb plus Pri, driven by esgts-Gal4 induces over-proliferation of GFP+ (green) progenitors and quantification 
of GFP+ cells. Blue is DAPI. P values from Kruskal-Wallis tests are: ns>0.05; ****<0.0001. 
 
 
 
 Supplementary Figure 4 (related to Figure 4) 
(A) The E3N svb enhancer is expressed in ventral epidermal trichome cells, with strong expression in the anterior-most (at left) 
row of trichomes within each segment. Lac-Z staining is in yellow, the Miniature protein (purple) highlights growing trichomes. 
Schematic view of functional screening for 227 TFs using ptc-GAL4 to drive corresponding RNAi. Knockdown of five candidate 
TFs alter the expression pattern of the E3N svb enhancer. 
(B) Drawing of the E3N svb enhancer, with position of binding sites for Ubx (Crocker et al., 2015), Pointed (Pnt) and TCF. 
(C) Evolutionary conservation of DNA sequence encompassing Pnt (red) and TCF (green) binding sites within the E3N enhancer. 
Nucleotides in red represent point mutations that have been introduced to disrupt either Pnt or TCF binding sites. 
(D) Consequences of knocking out Pnt or TCF binding sites on the expression of the E3N svb enhancer. Pictures show ventral 
view of stage 15 embryos. 
(E) Trichome rescue assays showing the influence of TCF binding site knockout. Picture show cuticle preparations of wild type, 
and svb mutant embryos, focusing on ventral of the posterior abdominal segments. Svb mutants display strong reduction in the 
number of trichomes, remaining trichomes are highly abnormal. Consistent with its expression pattern, the E3N enhancer driving 
svb cDNA (E3N-wt::svb) is able of rescuing trichomes in a svb mutant background, as seen in the anterior-most trichome row 
(bracketed). Knocking out TCF binding sites (E3N-TCF-mt::svb) strongly decreases trichome rescuing ability of the E3N enhancer. 
P values from Kruskal-Wallis tests are: ns>0.9; ****<0.0001. 
 
 Supplementary Figure 5 (related to Figure 5) 
(A) The 9CJ2 svb enhancer (purple) is expressed in most ventral epidermal trichome cells and in two stripes of trichome cells in 
the dorsal region of each abdominal segment. The Dusky-like protein (green) highlights growing trichomes. 
(B) Drawing of the 9CJ2 svb enhancer, with position of binding sites for Ubx (Crocker et al., 2015) and Nubbin/Pdm-1 (Pdm). 
(C) Evolutionary conservation of DNA sequence encompassing each of the two Pdm (orange) binding sites within the 9CJ2 svb 
enhancer. Nucleotides in red represent mutations that have been introduced to disrupt Pdm binding sites. 
(D) Consequences of knocking down Pdm binding sites on the expression of the 9CJ2 svb enhancer. Pictures show lateral (left 
panels), ventral (middle panels) and dorsal (right) views of stage 15 embryos. 
 
 
 
 
 Supplementary Figure 6 (related to Figure 6) 
(A) Myo1Ats expressing GFP (control) or in combination with svb-RNAi, or SvbREP. GFP is in green and cleaved DCP1 in red. 
(B) Myo1Ats expressing GFP alone (control) or in combination with Ubr3-RNAi or SvbREP. 
(C) Cross sections of midguts driving mCherry-RNAi (control) or SvbREP in ECs under MyoIAts control. White is Actin. Red is 
Coracle or Scribbled. Yellow is Tsp2a.  
In all panels, blue is DAPI, scale bars, 20µm. 
  
  
 
Supplementary Figure 7 (related to Figure 7) 
(A) esgts-Gal4 driven expression of Notch Intra Cellular Domain (NICD, which mimics activation of the Notch pathway) alone, or 
in combination with OvoB of SvbREP or svb-RNAi. 
(B) Expression of a dominant negative form of the Delta ligand (Dl-DN) alone, or in combination with OvoB, SvbREP, or svb-RNAi, 
driven by esgts-Gal4. 
(C, D) SvbREP counteracts progenitor over-proliferation upon activation of the Wnt pathway and imposes differentiation. esgts- 
driven expression of Wg or ArmS10, with or without concomitant expression of OvoB, SvbREP; pri-RNAi or svb-RNAi. 
In all panels GFP+ cells are in green, anti-Prospero staining is in red and DAPI in blue. Scale bar is 20µm. 
  
 
CONTACT FOR REAGENT AND RESOURCE SHARING 
Further information and requests for resources and reagents should be directed to and will be fulfilled by 
the Lead Contact, François Payre (francois.payre@univ-tlse3.fr) 
 
 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
 
Animal Breeding and Maintenance 
Drosophila melanogaster flies were kept at 25°C and grown on a standard cornmeal food medium (per liter: 
17 g inactivated yeast powder, 80 g corn flour, 9 g agar, 45 g white sugar, and 17 ml of Moldex). Crosses 
involving targeted expression under the control of Gal4/Gal80ts were maintained at 18°C until 3 to 4 days 
post hatching, and adult females were sifted to 29°C for 10-14 days for an optimal activity of the UAS/GAL4 
system. Flies were transferred to fresh food vials daily. For F/O and MARCM clonal analyses, 3-4 days 
adult female flies of the indicated genotypes were heat shocked 1 hour at 37ºC and then shifted to 25ºC for 
10 days. The full genotype of each Drosophila sample is detailed below. 
 
Full Genotypes as They Appear in Each Figure Panel 
Figure 1  
B) esg-LacZ/+;; svb-E3N-GFP/+ 
C) control: esg-Gal4, UAS-GFP.nls, tubP-Gal80ts/+; Delta-LacZ/+ 
C) svb-IR: esg-Gal4, UAS-GFP.nls, tubP-Gal80ts/+; Delta-LacZ/UAS-svbRNAi 
D) control: esg-Gal4, UAS-YFP/+; Su(H)-GBE-Gal80, tubP-Gal80ts/+ 
D) svb-IR: esg-Gal4, UAS-YFP/+; Su(H)-GBE-Gal80, tubP-Gal80ts/UAS-svbRNAi  
E) control: Su(H)-GBE-LacZ/+; esg-Gal4, tubP-Gal80ts/+; UAS-mCherry/+ 
E) svb-IR: Su(H)-GBE-LacZ/+; esg-Gal4, tubP-Gal80ts/+; UAS-mCherry/UAS-svbRNAi 
F) control: hs-FLP/+; actin<y+<Gal4/+; UAS–GFP/+ 
F) svb-IR: hs-FLP/+; actin<y+<Gal4/+; UAS–GFP/ UAS-svbRNAi 
G) control: y, w, hs-FLP, tubP-Gal80, FR19A; UAS-mCD8::GFP/+; tubulin-Gal4/ry506 
G) svbnull : y, w, hs-FLP, tubP-Gal80, FR19A/ y, w, svbR9, FRT19A; UAS-mCD8::GFP/+; tubulin-Gal4/+ 
H) control: esg-Gal4, UAS‐GFP, tub-Gal80ts/+; UAS‐FLP, act>CD2>Gal4/+ 
H) svb-IR: esg-Gal4, UAS‐GFP, tub‐Gal80ts/+; UAS‐FLP, act>CD2>Gal4/UAS-svbRNAi 
 
Figure 2 
D-F) control: esg-Gal4, UAS-mDC8-GFP, tubP-Gal80ts/+ 
D) pri-IR: esg-Gal4, UAS-mDC8-GFP, tubP-Gal80ts/+; UAS-priRNAi 
E) EcR-DN: esg-Gal4, UAS-mDC8-GFP, tubP-Gal80ts/ UAS-EcRDNB2w650A 
E) Pri: esg-Gal4, UAS-mDC8-GFP, tubP-Gal80ts/+; UAS-pri /+ 
E) EcR-DN+Pri: esg-Gal4, UAS-mDC8-GFP, tubP-Gal80ts/UAS-EcRDNB2w650A; UAS-pri/+ 
F) Ubr3-IR: esg-Gal4, UAS-mDC8-GFP, tubP-Gal80ts/UAS-Ubr3RNAi 
F) Ubr3-IR+OvoB: esg-Gal4, UAS-mDC8-GFP, tubP-Gal80ts/UAS-Ubr3-RNAi; UAS-ovoB/+ 
G) control: y, w, hs-FLP, tubP-Gal80, FR19A/ FRT19A; UAS-mCD8::GFP/+; tubulin-Gal4/ry506 
G) ubr3null: y, w, hs-FLP, tubP-Gal80, FR19A/ y, w, ubr3B, FRT19A; UAS-mCD8::GFP/+; tubulin-Gal4/+ 
 Figure 3 
A) control: esg-Gal4, UAS-GFP.nls, tubP-Gal80ts/+; Delta-LacZ/+ 
A) OvoB: esg-Gal4, UAS-GFP.nls, tubP-Gal80ts/+; Delta-LacZ/UAS-ovoB 
B) control: esg-Gal4, UAS-YFP/+; Su(H)-GBE-Gal80, tubP-Gal80ts/+ 
B) OvoB:  esg-Gal4, UAS-YFP/+; Su(H)-GBE-Gal80, tubP-Gal80ts/UAS-ovoB  
B) Svb+Pri: esg-Gal4, UAS-YFP/UAS-pri; Su(H)-GBE-Gal80, tubP-Gal80ts/UAS-Svb 
 
Figure 4 
A) control: esg-Gal4, UAS-mDC8::GFP, tubP-Gal80ts/+ 
A) TCF-DN: esg-Gal4, UAS-mDC8::GFP, tubP-Gal80ts/UAS-TCF-DN 
A) TCF-DN+OvoB: esg-Gal4, UAS-mDC8::GFP, tubP-Gal80ts/UAS-TCF-DN; UAS-OvoB /+ 
A) Arms10: UAS-Arms10/+; esg-Gal4, UAS-mDC8::GFP, tubP-Gal80ts/+ 
A) Arms10+svb-IR: UAS-Arms10/+; esg-Gal4, UAS-mDC8::GFP, tubP-Gal80ts/+; UAS-svbRNAi/+ 
A) Arms10+OvoB: UAS-Arms10/+; esg-Gal4, UAS-mDC8::GFP, tubP-Gal80ts/+; UAS-OvoB/+ 
B) upper panel: control: esg-Gal4, UAS-mDC8::GFP, tubP-Gal80ts/+ 
B) EGFR-DN: esg-Gal4, UAS-mDC8::GFP, tubP-Gal80ts/UAS-EGFR-DN; UAS-EGFR-DN/+ 
B) EGFR-DN+OvoB: esg-Gal4, UAS-mDC8::GFP, tubP-Gal80ts/UAS-EGFR-DN; UAS-ovoB/ UAS-EGFR-
DN 
B) control: esg‐Gal4, UAS‐GFP, tubP-Gal80ts/+; UAS‐FLP, act>CD2>Gal4/+ 
B) RasV12: esg‐Gal4, UAS‐GFP, tubP-Gal80ts/UAS-Ras-V12; UAS‐FLP, act>CD2>Gal4/+ 
B) RasV12+svb-IR: esg‐Gal4, UAS‐GFP, tubP-Gal80ts/UAS-RasV12; UAS‐FLP, act>CD2>Gal4/UAS-
svbRNAi/+ 
 
Figure 5 
D) SvbREP: esg‐Gal4, UAS‐GFP, tubP-Gal80ts/+; UAS‐FLP, act>CD2>Gal4/UAS-SvbREP 
E) control: esg-Gal4, UAS-GFP, tubP-Gal80ts/+  
E) SvbREP: esg-Gal4, UAS-GFP, tubP-Gal80ts/+; UAS-SvbREP 
E) SvbREP+DIAP1: esg-Gal4, UAS-mCD8::GFP, tubP-Gal80ts/UAS-DIAP1; UAS-SvbREP 
F) control: esg-Gal4, UAS-mCD8::GFP/+; UAS-H2B::RFP, tubP-Gal80ts/ + 
F) SvbREP: esg-Gal4, UAS-mCD8::GFP/+; UAS-H2B::RFP, tubP-Gal80ts/ UAS-SvbREP 
 
Figure 6 
A-C) control: Myo-Gal4, UAS-GFP, tubP-Gal80ts/+ 
A-C) svb-IR: Myo-Gal4, UAS-GFP, tubP-Gal80ts/+; UAS-SvbRNAi/+ 
A-C) OvoB: Myo-Gal4, UAS-GFP, tubP-Gal80ts/+; UAS-OvoB/+ 
D) control: Myo-Gal4, UAS-GFP, tubP-Gal80ts/+; UAS-mCherryRNAi/+ 
D) svb-IR: Myo-Gal4, UAS-GFP, tubP-Gal80ts/+; UAS-SvbRNAi/+ 
D) OvoB: Myo-Gal4, UAS-GFP, tubP-Gal80ts/+; UAS-OvoB/+ 
D) Pri: Myo-Gal4, UAS-GFP, tubP-Gal80ts/+; UAS-Pri/+ 
 
Figure 7 
A-B) control: esg-Gal4, UAS-mCD8::GFP, tubP-Gal80ts/+ 
A) Notch-IR: esg-Gal4, UAS-mCD8::GFP, tubP-Gal80ts; UAS-NotchRNAi 
A) Notch-IR+SvbREP: esg-Gal4, UAS-mCD8::GFP, tubP-Gal80ts; UAS-NotchRNAi/UAS-SvbREP 
B) STAT-IR: esg-Gal4, UAS-mCD8::GFP, tubP-Gal80ts/UAS-STAT92ERNAi 
 B) STAT-IR+SvbREP: esg-Gal4, UAS-mCD8::GFP, tubP-Gal80ts/UAS-STAT92ERNAi; UAS-SvbREP /+ 
 
Figure S1 
B) control: Su(H)GBE-Gal4, UAS-GFP/+; tubP-Gal80ts/+ 
B) svb-IR: Su(H)GBE-Gal4, UAS-GFP/+; tubP-Gal80ts/UAS-svbRNAi 
C) control: tubP-Gal80ts/+; Voila-GAL4, UAS-GFP.nls/+ 
C) svb-IR: tubP-Gal80ts/+; Voila-GAL4, UAS-GFP.nls/UAS-svbRNAi 
D) control: esg-Gal4, UAS-mCD8::GFP/+; UAS-H2B::RFP, tubP-Gal80ts/+ 
D) svb-IR: esg-Gal4, UAS-mCD8::GFP/+; UAS-H2B::RFP, tubP-Gal80ts/UAS-svbRNAi 
 
Figure S2 
A-C-D-E) control: esg-Gal4, UAS-YFP/+; Su(H)-GBE-Gal80, tubP-Gal80ts/+ 
A) pri-IR: esg-Gal4, UAS-YFP/+; Su(H)-GBE-Gal80, tubP-Gal80ts/UAS-priRNAi 
B) control: esg-Gal4, UAS-mCD8::GFP, tubP-Gal80ts/+  
B) EcR-IR#1: esg-Gal4, UAS-mCD8::GFP, tubP-Gal80ts/UAS-EcRRNAi,BL#58286 
B) EcR-IR#2: esg-Gal4, UAS-mCD8::GFP, tubP-Gal80ts/+; UAS-EcRRNAi, BL#29374 /+ 
C) EcR-IR#1: esg-Gal4, UAS-YFP/UAS-EcRRNAi,BL#58286; Su(H)-GBE-Gal80; tubP-Gal80ts/+  
C) EcR-IR#2: esg-Gal4, UAS-YFP/+; Su(H)-GBE-Gal80; tubP-Gal80ts/ UAS-EcRRNAi, BL#29374 
D) Pri: esg-Gal4, UAS-YFP/+; Su(H)-GBE-Gal80; tubP-Gal80ts/UAS-pri 
D) EcR-DN: esg-Gal4, UAS-YFP /UAS-EcRDNB2w650A; Su(H)-GBE-Gal80; tubP-Gal80ts/+  
D) EcR-DN+Pri: esg-Gal4, UAS-YFP /UAS-EcRDNB2w650A; Su(H)-GBE-Gal80; tubP-Gal80ts/UAS-pri  
2E) Ubr3-IR: esg-Gal4 , UAS-YFP /UAS-Ubr3RNAi; Su(H)-GBE-Gal80; tubP-Gal80ts/+  
2E) Ubr3-IR+OvoB: esg-Gal4, UAS-YFP / UAS-Ubr3RNAi; Su(H)-GBE-Gal80; tubP-Gal80ts/UAS-ovoB  
 
Figure S3 
control: esg-Gal4, UAS-mCD8::GFP, tubP-Gal80ts/+ 
OvoB: esg-Gal4, UAS-mCD8::GFP, tubP-Gal80ts/+; UAS-OvoB/+ 
SvbREP + Pri: esg-Gal4, UAS-mCD8::GFP, tubP-Gal80ts/UAS-pri ; UAS-SvbREP/+ 
 
Figure S4 
A) w; ; E3N-lacZ 
D) wt: w;; E3N-lacZ-wt 
D) Pnt-mt: w;; E3N-lacZ-Pnt-mt 
D) TCF-mt: w;; E3N-lacZ-TCF-mt 
E) wildtype: w 
E) svbbk: y1, w*, btd1, svb1/Y; 
E) E3Nwt::svb + svbbk: y1, w*, btd1, svb1/Y;; E3N-pRSQ-svb/+ 
E) E3NTCFmt::svb+svbbk: y1, w*, btd1, svb1/Y;; E3NTCFmt-pRSQ-svb/+  
 
Figure S5 
A) w; ; 9CJ2-lacZ 
D) wt: w; ; 9CJ2-lacZ 
D) Pdm-mt: w; ; 9CJ2-Pdm-mt-lacZ 
 
 Figure S6 
A) control: Myo-Gal4, UAS-GFP, tubP-Gal80ts/+ 
A) Ubr3-IR: Myo-Gal4, UAS-GFP, tubP-Gal80ts/UAS-Ubr3RNAi 
A,C) SvbREP: Myo-Gal4, UAS-GFP, tubP-Gal80ts/+; UAS-SvbREP/+ 
A,C) Pri: Myo-Gal4, UAS-GFP, tubP-Gal80ts/+; UAS-pri/+ 
B) Svb-IR: Myo-Gal4, UAS-GFP, tubP-Gal80ts/+; UAS-svbRNAi/+ 
B) OvoB: Myo-Gal4, UAS-GFP, tubP-Gal80ts/+; UAS-ovoB/+ 
 
Figure S7 
A-D) control: esg-Gal4, UAS-mCD8::GFP, tubP-Gal80ts/+ 
A) NICD: esg-Gal4, UAS-mCD8::GFP, tubP-Gal80ts/+; UAS-NICD/+ 
A) NICD+OvoB: esg-Gal4, UAS-mCD8::GFP, tubP-Gal80ts; UAS-NICD/UAS-OvoB 
A) NICD+SvbREP: esg-Gal4, UAS-mCD8::GFP, tubP-Gal80ts; UAS-NICD/UAS-SvbREP 
B) Dl-DN: esg-Gal4, UASmCD8::GFP, tubP-Gal80ts/UAS-Dl-DN 
B) Dl-DN+OvoB: esg-Gal4, UAS-mCD8::GFP, tubP-Gal80ts/UAS-Dl-DN; UAS-OvoB/+ 
B) Dl-DN+SvbREP: esg-Gal4, UAS-mCD8::GFP, tubP-Gal80ts/UAS-Dl-DN; UAS-SvbREP/+ 
B) Dl-DN+svb-IR: esg-Gal4, UAS-mCD8::GFP, tubP-Gal80ts/UAS-Dl-DN; UAS-svbRNAi/+ 
C) Wg: esg-Gal4, UAS-mCD8::GFP, tubP-Gal80ts/UAS-Wg 
C) Wg+OvoB: esg-Gal4, UAS-mCD8::GFP, tubP-Gal80ts /UAS-Wg; UAS-ovoB/+ 
C) Wg+SvbREP: esg-Gal4, UAS-mCD8::GFP, tubP-Gal80ts UAS-Wg; UAS-SvbREP /+ 
C) Wg+Svb-IR: esg-Gal4, UAS-mCD8::GFP, tubP-Gal80ts/UAS-Wg; UAS-svbRNAi/+ 
D) Arms10: UAS-Arms10/+; esg-Gal4, UAS-mDC8-GFP, tubP-Gal80ts/+ 
D) Arms10+pri-IR: UAS-Arms10/+esg-Gal4, UAS-mDC8-GFP, tubP-Gal80ts/+; UAS-priRNAi/+ 
D) Arms10+SvbREP: UAS-Arms10/+; esg-Gal4, UAS-mDC8-GFP, tubP-Gal80ts/+; UAS-SvbREP/+ 
D) Arms10+svb-IR: UAS-Arms10/+; esg-Gal4, UAS-mDC8-GFP, tubP-Gal80ts/+; UAS-svbRNAi/+ 
 
 
METHODS DETAILS  
In vivo screening of transcription factors  
We selected transcription and nuclear factors showing expression in stage-15 embryos (Menoret et al., 
2013) or enrichment in dorsal trichome cells (Preger-Ben Noon et al., 2016), resulting in a list of 227 
candidate factors. 273 representative UAS-RNAi lines were obtained from Bloomington and VDRC stock 
centers, taken from the TRIP or VDRC collection, respectively. Males from each UAS::RNAi carrying line 
(Table S1) were crossed with virgin females of stock w; ptc-Gal4; E3N-lacZ or w; ptc-Gal4; 9CJ2-lacZ and 
eggs were collected for 12 hr at 28°C. Embryos were dechorionated, fixed and stained using standard 
protocols (Fernandes et al., 2010), with mouse anti-ß-galactosidase (ß-gal; 1:500, Promega) and 
biotinylated goat anti-rabbit (1:1,000) antibodies, revealed using VECTASTAIN ABC Peroxidase Kit (Vector 
Laboratories). After washing, stained embryos were mounted in Glycerol/PBS (80/20%) and imaged using 
a Nikon Eclipse 90i microscope using NIS-elements software (Nikon). Each experiment (typical 200 
embryos per genotype) were performed at least three times and also included a UAS-w-RNAi as positive 
control and w embryos served as negative controls. Reporter patterns upon RNAi treatment were classified 
into “no change”, “reduced” or “ectopic” expression, the two latter were kept for additional characterization 
(Table S1). For rescuing assays, males carrying pRSQsvb constructs were crossed with females of stock 
y1, w* btd1, svb1/FM7-kr>GFP, allowing unambiguous phenotypical identification of svb-mutant embryos. 
First instar larva cuticles were prepared in Hoyer’s/lactic acid 1:1, imaged with phase-contrast microscopy, 
and trichomes were counted in the ventral region of A4 segments. 
 DNA constructs and transgenic lines 
DNA fragments from svb enhancers were cloned into placZAttB for reporter constructs and into pRSQsvb 
for rescue constructs (Crocker et al., 2015; Frankel et al., 2011; Menoret et al., 2013). All plasmids were 
integrated using the PhiC31 system into the same attP landing site (zh-86F) by Bestgene (Chino Hills, CA, 
USA) or in the Payre lab. Putative binding sites for transcription factors were identified using JASPAR 
(http://jaspar.genereg.net) and their evolutionary conservation was assayed using multiple sequence 
alignments (Clustal Omega and MUSCLE, https://www.ebi.ac.uk) with orthologous regions from several 
Drosophila species (http://flybase.org). Site specific mutations were introduced using DNA synthesis by 
Genscript (https://www.genscript.com) and modified enhancers were sub-cloned in reporter and rescue 
constructs using ligation-free cloning (In-Fusion, Takara) with the same oligonucleotides than respective 
wild type versions. All constructs were verified by sequencing and DNA sequences of wild type and mutated 
enhancers are given (Table S2). 
 
Immunofluorescence  
Stage-15 embryos were processed using standard protocols, using with mouse anti-ß-galactosidase (ß-
gal; 1:500, Promega), rabbit anti-Dyl at 1:400 (Fernandes et al., 2010), rabbit anti-Min 1:200 (Chanut-
Delalande et al., 2006) antibodies, AlexaFluor-488 or -555 secondary antibodies at 1:500 (Molecular 
Probes). Embryos were mounted in Vectashield mounting media (Vector Laboratories) and imaged using 
X20 and X40 objectives on a Leica Spe confocal laser scanning microscope with Leica Application Suite 
software, or a Zeiss 710 confocal microscope using the ZEN software (Zeiss). 
Adult midguts were dissected in 1% PBS and fixed for up to 1h at room temperature in a fresh 4% 
paraformaldehyde solution (Electron microscopy Science) prepared in PBS 1%. Following three washes of 
15 min each in 0.1% Triton-PBS (0.1% PBS-T), samples were blocked in 1% BSA-Triton-PBS for 30 min 
at room temperature, prior to overnight incubation with primary antibody at 4°C. The following primary 
antibodies were used: mouse anti-GFP, rabbit anti-GFP at 1:500 both, rabbit anti-ß-Galactosidase (MP 
Biomedicals) antibody at 1:1,000, rat anti-RFP (5F8) at 1:800, cleaved Drosophila Dcp-1 (Asp216) rabbit 
antibody at 1:100 (Cell signaling), mouse anti-Prospero (DHSB) at 1:100, rabbit anti-Phospho-Histone 3 
(Millipore) at 1:1,000, mouse anti-Coracle at 1:100 (DHSB), rabbit polyclonal Anti-Tsp2A and rabbit 
polyclonal anti-Scribble (gifts from D. St Johnston) at 1:1,000 both. F-Actin was stained with Phalloidin 
conjugated to Rhodamine (Invitrogen, at 1:500). The next day, samples were washed 3 times in 0.1% PBS-
T for 15 min each. Samples were next incubated with AlexaFluor-488 or -555 secondary antibodies at 1:500 
(Molecular Probes) for 2 hours at room temperature. After three washes, tissues were mounted in 
Vectashield mounting media containing DAPI (Vector Laboratories) for nuclear staining. Images of the 
whole posterior midgut were acquired on Leica SPE and Leica SP8 confocal microscopes (X40 objective). 
3 to 5 images were acquired for each posterior midgut to cover the 4a to 5 regions (Lemaitre and Miguel-
Aliaga, 2013). 
In situ hybridization 
RNA probes were synthetized from svb cDNA (Delon et al., 2003) using a DIG RNA Labeling Kit (Roche). 
Guts were dissected in a 1XPBS and fixed in freshly-prepared 4% formaldehyde 5Mm EGTA fix solution in 
PBS. After two washes in PBS, guts were dehydrated in successive baths of methanol (5 times), ethanol 
(5 times), followed by 1 hour in 1:1 xylene/ethanol, and rinsed in methanol. Guts were post fixed for 30 min 
at room temperature in the same fix solution and washed in PBS-0.1% Tween 20 (PBST). Samples were 
treated by proteinase K at room temperature, and the reaction was stopped by a 5 min treatment in 2mgl/ml 
glycine, followed by washes in cold PBST. Samples were incubated in the fix solution overnight at 4°C and 
washed in PBST. After 2 hrs pre-hybridization at 60°C in hybridization buffer (HB: 50% formamide, 2X SSC, 
1 mg/ml Tortula RNA, 0.05mg/ml Heparin, 2% blocking reagent (Roche), 0.1% CHAPS, 5mM EDTA, 0.1% 
 Tween 20), guts were incubated overnight with svb anti-sense DIG-labeled RNA probe diluted in HB, at 
60°C. After several washes in HB and PBST and PBST-1% BSA (blocking solution), samples were 
incubated with sheep anti-DIG primary antibody conjugated to alkaline phosphatase (Roche), at 1:2,000 in 
blocking solution. After washes in PBST, in situ hybridization signals were developed by incubating samples 
in a fresh staining buffer containing NBT/BCIP stock solution (Sigma Aldrich) diluted at 1:50. Finally, 
samples were washed and mounted in 50% glycerol-PBS for analysis. 
X-gal staining assays 
Adult females were dissected in 1% PBS and guts were fixed in 1% glutaraldehyde-PBS for 15 min at room 
temperature. Samples were washed 3 times for 15 min each. The Staining Buffer (SB, 10mM Na2HPO4, 
1.6mM NaH2PO4, 150mM NaCl,1Mm MgCl2, 3.5Mm K3FeCN6, 3.5Mm K4FeCN6) was warmed up at 
37°C for 10 min, an 8% X-Gal solution (5-bromo-4-chloro-3-indoyl-ß-D-Galactopyranoside, Sigma Aldrich) 
was added (final concentration 2.5% X-gal in SB) and kept for an additional 10 min at 37°C, before 
centrifugation (5’ at 12,000g). Samples were incubated in staining solution overnight at 37°C, washed 3 
times for at least 15 min with PBS and mounted in 50% glycerol-PBS. Bright-field pictures were acquired 
using a Nikon Eclipse 90i microscope. 
 
QUANTIFICATION AND STATISTICAL ANALYSIS 
Images were analyzed by using ImageJ, with automated macros we developed for quantification of 
indicated cell types (codes are available upon request). Briefly, images were acquired with same setting 
and transformed into multilayered TIFF files. To count the number of cells positive for a given marker (e.g. 
GFP), the corresponding channel was used to generate a ROI mask in which DAPI-labelled nuclei were 
automatically segmented and the number, size and morphometric features of each object was recorded in 
and xls file for further analysis. A similar analysis was performed for ReDDM assays, quantifying the number 
of nuclei in GFP+/RFP+ progenitors versus in GFP-/RFP+ differentiated cells. Data of at least three 
independent experiments were combined. Statistical analyses were carried out with Prism 8 (Graphpad), 
using nonparametric Mann-Whitney tests for comparison between two samples, and ANOVA Kruskal-
Wallis tests with Dunn’s correction for comparison between three or more samples. In each figure, graphs 
show all individual points. Images were processed and figures drawn using Adobe Photoshop CC. 
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 KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Mouse monoclonal anti-GFP (1: 500) Sigma-Aldrich Cat# 11814460001, 
RRID:AB_390913 
Rabbit anti-GFP (1: 500) Torrey Pines Biolabs Cat# TP401 071519, 
RRID:AB_10013661 
Rabbit anti-β-galactosidase (1:500) MP Biomedicals Cat# 559761, 
RRID:AB_2687418 
Mouse monoclonal anti-β-galactosidase (1:1,000) Promega Cat# 53781,  
Rabbit anti-Dyl antibody (1:400) Fernandes et al., 
2010 
N/A 
Rabbit anti-Min antibody (1:200) Chanut et al., 2006 N/A 
Rat monoclonal antibody to Red Fluorescent Proteins 
(1:800) 
Chromotek GmbH Cat# 5f8-100, 
RRID:AB_2336064 
Cleaved Drosophila Dcp-1 (Asp216) antibody (1:100) Cell Signaling 
Technology 
Cat# 9578, 
RRID:AB_2721060 
Mouse anti-Cora antibody (1:100)  DSHB Cat# C615.16, 
RRID:AB_1161644 
Mouse anti-Prospero (1:100) DSHB Cat# MR1A, 
RRID:AB_528440 
Biotinylated goat anti-rabbit IgG antibody (1:1,000)  Vector Laboratories Cat# BA-1000, 
RRID:AB_2313606 
Rabbit polyclonal anti-Tsp2a antibody (1:1,000) Izumi et al., 2016 N/A 
Rabbit polyclonal anti-Scribble antibody (1:1,000) Chen et al, 2018 N/A 
Rabbit polyclonal Anti-phospho-Histone H3 (Ser10) 
(1:1,000) 
Millipore Cat# 06-570, 
RRID:AB_310177 
Sheep Anti-Digoxigenin Fab fragments antibody, Alkaline 
Phosphatase conjugated (1:2,000) 
Roche Cat# 11093274910, 
RRID:AB_51449 
Goat anti-Rabbit IgG (H+L) Secondary Antibody, 
AlexaFluor-488 conjugate (1:500) 
Thermo Fisher 
Scientific 
Cat# A-11034, 
RRID:AB_2576217 
Goat anti mouse IgG (H+L) secondary antibody, 
AlexaFluor-488 (1:500) 
Quantum Dot 
Corporation 
Cat# 1100-1, 
RRID:AB_346865 
Goat anti-rabbit IgG (H+L) secondary antibody, 
AlexaFluor-555 (1:500) 
Molecular Probes Cat# A-21428, 
RRID:AB_141784 
Goat anti-mouse IgG (H+L) secondary antibody, 
AlexaFluor-555 (1:500) 
Molecular Probes Cat# A-21422, 
RRID:AB_141822 
Goat anti-rat IgG (H+L) secondary antibody, AlexaFluor-
555 (1:500) 
Molecular Probes Cat# A-21434, 
RRID:AB_141733 
Chemicals, Peptides, and Recombinant Proteins 
Sucrose, BioXtra, >=99.5% (GC)  Sigma-Aldrich Cat# 57-50-1 
DAPI (4′,6-diamidino-2-phenylindole) Thermo Fisher 
Scientific 
Cat# D1306 
X-Gal (5-bromo-4-chloro-3-indoyl-ß-D-Galactopyranoside) Biosolve Cat# 7240-90-6 
NBT/BCIP (C40H30Cl2N10O6 / C8H6NO4BrClP x C7H9N) Sigma Aldrich Cat# 11681451001 
16% Paraformaldehyde, methanol free Electron microscopy 
Sciences 
Cat# 30525-89-4 
Formaldehyde Electron microscopy 
Sciences 
Cat# 50-00-0 
Blocking Reagent for nucleic acid hybridization and 
detection 
Roche Cat# 11096176001 
Phalloidin conjugated to Rhodamin (1:500) Thermo Fisher 
Scientific 
Cat# R415, 
RRID:AB_2572408 
 VECTASHIELD Mounting Medium antibody Vector Laboratories Cat# H-1000, 
RRID:AB_2336789 
VECTASHIELD Mounting Medium with DAPI antibody Vector Laboratories Cat# H-1200, 
RRID:AB_2336790 
XhoI New England 
Biolabs  
Cat# R0146L 
NotI New England 
Biolabs  
Cat# R0189L 
Phusion High-Fidelity PCR Master Mix with HF Buffer Thermo Fisher 
Scientific 
Cat# F531L 
Phusion High-Fidelity DNA Polymerase  Thermo Fisher 
Scientific 
Cat# F530L 
Critical Commercial Assays 
VECTASTAIN ABC-Peroxidase Kit Vector Laboratories Cat# PK-4001, 
RRID:AB_2336810 
Qiaquick PCR Purification kit  Qiagen Cat# 28104 
QIAmp DNA Micro Kit Qiagen Cat# 56304 
In-Fusion® HD Cloning Plus Takara Cat# 638920 
DIG RNA Labeling Kit (SP6/T7) ROCHE Cat# 11 175 025 910 
Experimental Models: Organisms/strains  
D. melanogaster: esg-LacZ:  
y1 w67c23; P{w+mC=lacW}esgk00606/CyO 
BDSC BDSC Cat# 10359, 
RRID:BDSC_10359 
D. melanogaster: Su(H)GBE-LacZ Furriols and Bray, 
2001 
N/A 
ry506 P{ry+t7.2=PZ}Dl05151/TM3, ryRK Sb1 Ser1 BDSC BDSC Cat# 11651, 
RRID:BDSC_11651 
D. melanogaster: UAS-w-RNAi 
y1 v1; P{y+t7.7 v+t1.8=TRiP.JF01545}attP2 
BDSC BDSC Cat# 28980 
RRID:BDSC_28980 
D. melanogaster: UAS-mCherry-RNAi 
y1 sc* v1 sev21; P{y+t7.7 v+t1.8=VALIUM20-mCherry}attP2 
BDSC BDSC Cat# 35785 
RRID:BDSC_35785 
D. melanogaster: UAS-svb-RNAi 
w1118; P{GD9026}v41584 
VDRC Cat# FBst0464178, 
RRID:FlyBase_FBst
0464178 
D. melanogaster: UAS-ubr3-RNAi: 
w1118; P{GD12698}v22901 
VDRC Cat# FBst0454736, 
RRID:FlyBase_FBst
0454736 
D. melanogaster: UAS-Notch-RNAi:  
w*; P{w+mC=UAS-N.dsRNA.P}9G 
BDSC BDSC Cat# 7077,  
RRID:BDSC_7077 
D. melanogaster: UAS-STAT92E-RNAi: 
y1 sc* v1 sev21; P{y+t7.7 v+t1.8=TRiP.GL00437} attP40/ CyO  
BDSC BDSC Cat# 35600,  
RRID:BDSC_35600 
D. melanogaster: UAS-pri-RNAi: 
P{UAS-tal.dsRNA} 
Galindo et al.,2007 FBtp0072543 
D. melanogaster: UAS-pri 
P{UAS-tal. }/CyO 
Galindo et al.,2007 N/A 
D. melanogaster: UAS-EcR-DN:  
w*; P{w+mC=UAS-EcR.B2.W650A}TP5 
BDSC BDSC Cat# 9449, 
RRID:BDSC_9449 
D. melanogaster: UAS-EcR-RNAi#1: 
y1 v1; P{y+t7.7 v+t1.8=TRiP.HMJ22371} attP40  
BDSC BDSC Cat# 58286, 
RRID:BDSC_58286 
D. melanogaster: UAS-EcR-RNAi#2: 
y1 v1; P{y+t7.7 v+t1.8=TRiP.JF02538}attP2 
BDSC BDSC Cat# 29374, 
RRID:BDSC_29374 
D. melanogaster: P{UAS-ovo.B2} Payre et al., 1999 FBtp0012383 
D. melanogaster: UAS-SvbREP Delon et al., 2003 N/A 
D. melanogaster: UAS-TCF-DN:  
y1 w1118; P{w+mC=UAS-pan.dTCFDeltaN}4  
BDSC BDSC Cat# 4784, 
RRID:BDSC_4784 
 D. melanogaster: UAS-ArmS10: 
P{w+mC=UAS-arm.S10}C, y1 w1118  
BDSC BDSC Cat# 4782, 
RRID:BDSC_4782 
D. melanogaster: UAS-EGFR-DN: 
y1 w*; P{w+mC=UAS-Egfr.DN.B}29-77-1; P{w+mC=UAS-
Egfr.DN.B}29-8-1 
BDSC BDSC Cat# 5364, 
RRID:BDSC_5364 
D. melanogaster: UAS-NICD: 
P{UAS-N.icd} 
Cooper and Bray, 
2000 
FBtp0013654 
D. melanogaster: UAS-Dl-DN: 
w*; P{w+mC=UAS-Dl.DN}TJ2/CyO  
BDSC BDSC Cat# 26697, 
RRID:BDSC_26697 
D. melanogaster: UAS-DIAP: 
P{UAS-DIAP1.H} 
BDSC BDSC Cat# 6657 
D. melanogaster: UAS-Wg BDSC BDSC Cat# 5919, 
RRID:BDSC_5919 
D. melanogaster: UAS-RasV12: 
w1118; P{w+mC=UAS-Ras85D.V12}TL1 
BDSC BDSC Cat# 4847,  
RRID:BDSC_4847 
D. melanogaster: esgts: 
esg-Gal4, UAS-GFP, tubP-Gal80ts 
Jiang et al.,2009 N/A 
D. melanogaster: NREts: 
Su(H)-GBE-Gal4, UAS-GFP; tubP-Gal80ts 
Zeng et al.,2010 N/A 
D. melanogaster: ISCts: 
esg-Gal4, UAS-GFP; Su(H)-GBE-GAL80, tubP-Gal80ts 
Wang et al.,2014 N /A 
D. melanogaster: esg-ReDDM: 
esg-Gal4, UAS-mCD8::GFP/Cyo; UAS-H2B::RFP, tubP-
Gal80ts/TM2 
Antonello et al.,2015 N /A 
D. melanogaster: Myo1Ats: 
Myo1A-Gal4, UAS-GFP, tubP-Gal80ts 
Jiang et al.,2009 N/A 
D. melanogaster: Voilats: 
tubP-Gal80ts; Voila-GAL4, UAS-GFP.nls 
Blakireva et al., 1998 N /A 
D. melanogaster: ActtsF/O: 
hs-FLP; actin<y+< Gal4; UAS–GFP 
Chanut-Delalande et 
al., 2014 
 
D. melanogaster: esgtsF/O: 
w; esg‐Gal4, UAS‐GFP, tubP-Gal80ts/CyO; UAS‐FLP, 
act>CD2>Gal4/TM6B 
Jiang et al., 2009 N/A 
D. melanogaster: Tal-Gal4:  
P{GaWB}talKG/TM3, Sb 
Galindo et al.,2007 N/A 
D. melanogaster: MARCM-19A 
P{ry+t7.2=hsFLP}1, P{w+mC=tubP-GAL80}LL1 w*, 
P{ry+t7.2=neoFRT}19A; P{w+mC=UAS-mCD8::GFP.L}LL5/ 
Cyo; P{w+mC=tubP-GAL4}LL7/TM6B,Tb 
N. Tapon  N/A 
D. melanogaster: svbR9 
y* w1118 svbR9, P{ry+t7.2=neoFRT}19A/FM0  
Delon et al., 2003 FBal0151651 
D. melanogaster: Ubr3B 
y1 w* Ubr3B P{ry+t7.2=neoFRT}19A/FM0 
Zanet et al., 2015 FBal0319860 
D. melanogaster: svbE6-lacZ Frankel et al., 2011 FBtp0085021 
D. melanogaster: PriA-LacZ Chanut-Delalande et 
al., 2014 
N/A 
D. melanogaster: PriH-LacZ Chanut-Delalande et 
al., 2014 
N/A 
D. melanogaster: PriJ-LacZ Chanut-Delalande et 
al., 2014 
N/A 
D. melanogaster: svbE3N-GFP This paper N/A 
D. melanogaster: svbE3N-LacZ Crocker et al., 2015 N/A 
D. melanogaster: svbE3N-Pnt-mt-LacZ This paper N/A 
D. melanogaster: svbE3N-TCF-mt-LacZ This paper N/A 
 D. melanogaster: E+7-svbP-svb-cDNA::GFP (pRSQ8)  Menoret et al.,2013 N/A 
D. melanogaster: E3N-svbP-svb-cDNA This paper  
D. melanogaster: E3N-TFC-mt-svbP-svb-cDNA This paper  
D. melanogaster: 9CJ2-LacZ This paper N/A 
D. melanogaster: 9CJ2-Pdm-mt-LacZ This paper N/A 
Oligonucleotides 
Primer: Fwd_9CJ2: 
CGGTACCCCGCGGCCGCCATATGTCAACG 
This paper N/A 
Primer: Rev_9CJ2: 
TCCGGCGCTCCTCGAGACTATTGGGATACC 
This paper N/A 
Primer: Fwd_E3-14: 
CGGTACCCCGCGGCCGCCATATGTCTTTTTTTTTATC
C 
This paper N/A 
Primer: Rev_E3-14:  
CCGGCGCTCCTCGAGGTAGGTTAGG 
This paper N/A 
Recombinant DNA 
Plasmid: placZAttB  DGRC Cat# 1421 
Plasmid: pRSQsvb Frankel et al., 2011 N/A 
Software and Algorithms 
ImageJ 1.52a https://imagej.net/ RRID:SCR_003070 
Fiji http://fiji.sc RRID:SCR_002285 
Prism 8 GraphPad  RRID:SCR_002798 
Photoshop CC Adobe RRID:SCR_014199 
FlyBase http://flybase.org/ RRID:SCR_006549 
Clustal Omega http://www.ebi.ac.uk/
Tools/msa/clustalo/ 
RRID:SCR_001591 
MUSCLE http://www.ebi.ac.uk/
Tools/msa/muscle/ 
RRID:SCR_011812 
JASPAR http://jaspar.genereg
.net 
RRID:SCR_003030 
Clone Manager Software http://www.scied.co
m/pr_cmbas.htm 
RRID:SCR_014521 
ZEN Digital Imaging for Light Microscopy http://www.zeiss.com
/microscopy/en_us/p
roducts/microscope-
software/zen.html 
RRID:SCR_013672 
Leica Application Suite https://www.nikoninst
ruments.com/Produc
ts/Software 
RRID:SCR_016555 
NIS-Elements https://www.nikoninst
ruments.com/Produc
ts/Software 
RRID:SCR_014329 
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The regulation of adult stem cell behavior is a key issue to insure organ homeostasis throughout 
the adult life and avoid illness. Since 2006 and the discovery of Intestinal Stem Cells (ISCs) in 
flies (Micchelli and Perrimon, 2006; Ohlstein and Spradling, 2006), Drosophila has become a 
fruitful model system to address this question (Jiang et al., 2016; Li and Jasper, 2016; Naszai 
et al., 2015; Parasram et al., 2018; Perochon et al., 2018). In the course of these investigations, 
it emerged that stemness and the differentiation of ISCs are controlled by a broad range of 
regulatory inputs. ISC behavior is regulated by many signaling pathways acting at different 
levels, from intrinsic cellular signals, extrinsic cues from the close micro-environment or niche, 
to the organismic level via systemic signals. Our studies on the function of Shavenbaby (Svb) 
in the Drosophila digestive track (gut and Malpighian tubules) now provide a fresh view of 
how these regulatory cues are integrated and mediated through Svb. 
The activity of the Svb transcription factor is regulated by its posttranslational processing, 
mediated by Pri smORF peptides (Chanut-Delalande et al., 2014; Kondo et al., 2010; Plaza et 
al., 2017; Zanet et al., 2015; Zanet et al., 2016). Svb is first transcribed as a long repressor form 
(SvbREP) and following the expression of Pri, cleaved into a shorter activator form (SvbACT). 
This, in turn, allows the transcription of a battery of target genes required for epithelial 
remodeling and trichome differentiation(Chanut-Delalande et al., 2006; Fernandes et al., 2010; 
Kondo et al., 2010; Menoret et al., 2013). While no specific function for SvbREP has been so 
far disclosed in epidermal derivatives where it mostly behaves as an inactive precursor of 
SvbACT, an additional outcome of this PhD is to provide first evidence of key and specific 
activities of both isoforms in the intestinal stem cell lineage. Our work shows that SvbACT is 
required in ISCs for their survival and to promote their self-renewal, while SvbREP is later 
indispensable for enterocyte differentiation and acts as a potent tumor suppressor.  
Svb belongs to the metazoan-specific family of Ovo-like transcription factors (Kumar et al., 
2012). In the light of recent data on the importance of these factors in epithelial/mesenchymal 
equilibrium (Bai et al., 2018; Biswas et al., 2019; Haensel et al., 2019; Hong et al., 2015; Jia et 
al., 2015; Lee et al., 2014; Liu et al., 2018; Wang et al., 2017; Watanabe et al., 2019; Watanabe 
et al., 2014) and related diseases (Davidson et al., 2016; Kitazawa et al., 2016), as well as in the 
metastatic potential of many cancers (Liu et al., 2018; Roca et al., 2013; Wang et al., 2017; 
Watanabe et al., 2014; Ye et al., 2016), we believe that besides improving fundamental 
knowledge our studies may have impacts in biomedical research. 
78 
 
 
 
As several aspects of our results have been discussed in the two presented papers, the aim of 
this final part is to present additional data and put our results in a more general frame.  
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1. Shavenbaby as a regulatory hub 
A key question to understand animal development and the homeostasis of adult functions is to 
decipher the mechanisms that shape the regulation of gene expression. Developmental genes 
contain cis-regulatory sequences, called enhancers, localized upstream or downstream of the 
transcribed region, and/or within introns, which plays a major role in directing specific patterns 
of gene expression (Furlong and Levine, 2018; Levine, 2010). Enhancers correspond to 
relatively short DNA regions comprising multiple binding sites for transcription factors (TFs). 
Depending on chromatin accessibility, enhancers are thus the landing platform of TFs that help 
recruiting general transcription complexes to initiate gene transcription. Unlike coding regions, 
the identification of enhancers still rely on tedious experimental assays of their activity that 
involve the generation of transgenic reporter lines. The general strategy is to hook putative 
enhancers to a minimal promoter and a reporter gene, the activity of which reflecting all or part 
of the endogenous gene expression profile. In collaboration with the lab of David Stern, our 
team has extensively used this approach, leading to the identification of 7 enhancers spread 
over 150 kb that collectively regulate svb expression to pattern epidermal cell differentiation 
(Stern and Frankel, 2013). Studies of svb enhancers has contributed to establish important 
concepts for the control of gene expression, including the developmental function and evolution 
of enhancers, how they participate to phenotypic robustness in the face of varying conditions, 
and their pleiotropic activity throughout successive stages of animal development (Lagha et al., 
2012; McGregor et al., 2007; Preger-Ben Noon et al., 2018; Stern and Frankel, 2013).  
In the mid 2000s, new approaches such as ChIPseq have helped predicting putative enhancers 
based on the genome-wide pattern of binding sites for a transcription factor. These data revealed 
that developmental genes often contain two or more prominent binding peaks for a transcription 
factor, suggesting that a same gene may comprise distinct enhancers that drive similar 
expression pattern (Zeitlinger et al., 2007). This idea of apparently redundant enhancers, 
sometime referred to as “shadow” enhancers (Hong et al., 2008), has rapidly received support 
from independent studies and is now viewed as a common feature of developmental regulators 
across animals. The question of the putative function of such shadow enhancers has however 
remained opened for a while. Functional assays of the activity of svb enhancers in building the 
pattern of epidermal differentiation have provided first insights into the role of this “redundant” 
cis-regulatory architecture (Frankel et al., 2010). 
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svb expression in subsets of dorsal embryonic epidermal cells is directly responsible for the 
formation of thin hairs, called quaternary trichomes. We had previously shown that the dorsal 
pattern of svb expression is driven by at least four distinct proximal and remote enhancers that 
display overlapping expression within corresponding epidermal cells (McGregor et al., 2007). 
Genomic engineering has allowed the deletion of two remote dorsal enhancers and thereby a 
direct assay of their developmental activity (Frankel et al., 2010). Puzzlingly, the lack of these 
remote enhancers has no detectable consequences on the pattern of dorsal trichomes when 
embryo develop under optimal conditions. However, when subjected to either environmental 
challenges (lower or higher temperature), or slight genetic alterations that do not produce by 
themselves any developmental defects (e.g., heterozygous recessive mutation), animals 
carrying the deletion of remote svb enhancers display a reduced number of dorsal trichomes. 
These results have led to the conclusion that shadow enhancers provide phenotypic robustness 
in the face of varying genetic or environmental conditions (Frankel et al., 2010). 
This conclusion rapidly received independent support from a work of M. Levine’s lab focusing 
on snail function during early development. snail encodes a transcription factor required for 
ventral furrow formation during gastrulation. Snail expression in the corresponding cell 
populations is driven by a proximal enhancer, as well as a more distant shadow enhancer. 
Inactivation of the proximal enhancer does not alter snail function in normal condition meaning 
that the activity of the two enhancers, the distant and the shadow, are redundant to ensure snail 
expression (Perry et al., 2010). However, in challenging conditions (extreme temperatures), 
there is a drastic reduction of snail expression associated with a defective gastrulation (Perry et 
al., 2010). This shows that the activity of the two enhancers is required in case of stress to 
ensure the robustness of snail expression. It also shows that there is no obvious functional 
hierarchy between “main” and “shadow” enhancers. 
In the course of our investigations to address the function of svb in adult stem cells, we 
identified two distinct enhancers that sustain the expression of svb in both ISCs and RNSCs. It 
is thus tempting to speculate that the collective activity of both svb enhancers may be required 
to protect ISCs from apoptosis and to support their proliferation, in particular under stress 
conditions. We have shown that the activity of one enhancer is directly dependent on both Wnt 
and EGFR signaling and we can speculate that the other can be regulated by the same and/or 
other cues such as JAK/STAT signaling pathway that is required for ISC proliferation 
specifically under stress conditions. 
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Moreover, changes in svb enhancers have collectively evolved the pattern of svb expression in 
various insect species, resulting in evolutionary diversification of embryonic morphologies 
(Delon and Payre, 2004; Sucena et al., 2003). For example, in Drosophila Sechellia, a closely 
related species to Drosophila melanogaster, naked cuticle replaces most of quaternary dorsal 
trichomes (McGregor et al., 2007; Sucena and Stern, 2000). It has been demonstrated that this 
evolutionary change was caused by multiple subtle modifications in svb enhancer sequences 
(Frankel et al., 2011; McGregor et al., 2007; Stern and Frankel, 2013). Further work has shown 
that a main svb dorsal enhancer contains binding sites for two transcriptional activators 
Arrowhead and Pannier. In Drosophila sechellia, four of Arrowhead binding sites were lost by 
point mutations, thus weakening svb expression. Moreover, the same enhancer in Sechellia has 
gained a binding site for a transcriptional repressor, Abrupt, leading to the loss of its activity in 
dorsal cells (Preger-Ben Noon et al., 2016). It will be interesting to further dissect the cis and 
trans regulatory mechanisms that control svb expression in adult stem cells. To address the 
question of the robustness of svb expression in ISCs, ongoing project in the lab aims at deleting 
by CRISPR-cas9 one or the other, or both, enhancers to test their function and possible 
redundancy regarding stem cells behavior.  
 
One outcome of my work was to identify that the expression of svb in stem cells and ECs is 
controlled by distinct enhancers and pathways, i.e., Wnt and EGFR and Pdm1, respectively. 
Interestingly, the two ISC enhancers in the adults display different activities in the embryo, 
while the EC enhancer shows overlapping epidermal pattern. These results reinforce the 
pleiotropy activity of svb enhancers first identified by (Preger-Ben Noon et al., 2018).  
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Figure 20 : svb's shadow enhancers ensure the robustness of the trichome formation program in 
extreme temperature variations conditions  
 (A)Respective domain of activity of the "pioneer" enhancers E3, E6 and A as well as the "shadow" 
enhancers Z and DG2 in the fourth dorsal abdominal segment (quaternary domain).(B)Schematic 
representation of the effect of temperature fluctuationon the trichome formation program of the fourth 
abdominal dorsal segment of wild Drosophila larvae (wild type shavenbaby)and those whose DG2 and 
Z shadow enhancers have been deleted (Deletion of DG2 and Z in the svb gene) that have developed 
under normal conditions (25°C) or exposed to extreme temperatures (17°C or 32°C) (Frankel, 2012) 
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2. Ovo/Svb as an EMT regulatory factor  
Epithelial-Mesenchymal Transitions (EMT) is the process by which epithelial cells become 
gradually transformed to mesenchymal cells, by passing through multiple intermediate and 
reversible states (Nieto et al., 2016). EMT is required for normal embryogenesis, including 
gastrulation, neural crest development, heart development, as well as for wound-healing in 
adults where epithelial cells dedifferentiate in order to replace lost cells. Deregulated EMT is 
also involved in various human pathologies such as fibrosis and cancers. EMT implicates a 
multitude of events that should be finely coordinated. First, cells need to lose their epithelial 
properties, including cell adhesion and cell polarity. Second, they need to acquire mesenchymal 
features such as motility, invasiveness and increased resistance to apoptosis. Of note, EMT is 
reversible by its reciprocal process the mesenchymal-epithelial transition (MET) supporting the 
fact that the EMT is not an all-or-not event. A conserved core of regulators (Snail/Slug, Zeb1/2 
and miR200s) is well known to induce EMT (Puisieux et al., 2014) in response to signaling 
pathways (BMP, Wnt, Egf-r, Notch)(Nieto, 2013; Nieto et al., 2016). Results from recent 
studies converge towards a key role of OvoL factors (the orthologues of Svb in vertebrates) as 
stabilization factors that counterbalance EMT (Jia et al., 2015), thereby providing a tunable 
stemness window in normal and tumor cells (Jolly et al., 2015). Indeed, OvoL factors have been 
implicated in the fate of various progenitor/stem cells (Aue et al., 2015; Kim et al., 2014; 
Kitazawa et al., 2016; Lee et al., 2014; Watanabe et al., 2014). In mammals, OvoL factors 
appear as critical protectors of the epithelial state by directly inhibiting the Snail/Slug, Zeb1/2 
and miR200s core of regulators. The majority of cancer cells that loose OvoL expression 
become extremely dangerous, with invasive characteristics and high metastatic potential (Hong 
et al., 2015; Ricketts et al., 2012; Roca et al., 2014; Wang et al., 2017; Ye et al., 2016).  
In the fly gut, the Svb repressor (SvbREP) form likely fulfils a similar function within 
differentiated enterocytes (ECs) and is required to maintain their differentiated state. 
Conversely, Svb-Act induces ISC proliferation and disrupts epithelial organization when 
expressed within ECs. Interestingly, the germinal forms of Svb, OvoA and OvoB also acts 
antagonistically within germ cells (Andrews et al., 2000). OvoB is required to maintain 
germinal stem cells, whereas OvoA may favor full differentiation. In line with previous findings 
(Antonello et al., 2015), we find that the expression of the EMT inhibitor miR-8 (miR-200 in 
vertebrates) in ISC/EBs induces a complete loss of progenitors caused by premature 
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differentiation to ECs. Our unpublished results show that the concomitant expression of Svb-
ACT together with miR-8 is sufficient to overcome the miR-8 phenotype and to partially restore 
ISC/EBs. Thus, in contrast to epidermal derivatives, where Svb-Act seems to be the only active 
form, both Svb-ACT and Svb-REP are key regulators of the behavior of the adult intestinal 
stem cell lineage. SvbREP acts as a gatekeeper for epithelial state and Svb-Act acts together 
with EMT-TF to maintain stemness. Hence, the Drosophila gut is an attractive model system 
to study the distinct role/mode of action of the two isoforms of Svb. 
 
We have searched for Svb target genes within the ISC lineage. We started by profiling the 
activity of svb downstream target enhancers already identified in the embryonic epidermis 
(Chanut-Delalande et al., 2006; Menoret et al., 2013). Among this set of 22 validated enhancers, 
we observed a specific activity of three enhancers within small diploid duplet cells, thus very 
likely ISCS, ie: SnE1, an enhancer of singed encoding an actin binding protein, and two 
enhancers from uncharacterized genes CG4914 and CG31022. Thanks to tools available in the 
lab, we observed that mutations of Svb binding sites within the SnE1 enhancer reduce its 
activity within ISC/EBs compared to control. Thus, we have putative candidate target genes for 
Svb in the ISCs and further investigations of their putative role will require loss of function 
assays. So far, we only find few potential target genes of Svb in ISCs, and not in ECs. In order 
to find additional target genes, we are performing an unbiased approach using Dam-ID 
approach. This method consists of coupling the protein of interest, Svb in our case, to a DNA 
adeninemethylase (Dam) (van Steensel and Henikoff, 2000). The resulting chimeric protein 
binds to Svb target enhancers and methylates the adenine present in GATC Dam recognition 
sites; methylated sites are next quantitatively mapped to the Drosophila genome by next-gen. 
sequencing. This approach should unravel the different subset of genes activated by Svb-Rep 
vs Svb-Act forms in ISCs/EBs and ECs, respectively. This should also help us to delineate the 
function of Svb in the balance between stemness and differentiation. 
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Figure 21 : Svb-Act is required for the maintenance of ISC/EB undifferentiated state 
Confocal images of the posterior midgut of control female flies , flies expressing mir-8, OvoB or both in esg+ cells. Green 
is GFP, Red is armadillo, Blue is DAPI. Scale bar : 20 µm. 
 
 
 
Figure 22 : svb target genes in ISC  
 Representative images of three svb target genes expressed in adult ISC: CG4914, CG31022, SnE1  and SNE1 mutant for 
Svb binding sites. 
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3. Hormonal control of stem cells behavior  
Adapted stem cell comportment is regulated by a myriad of signals emanating from the 
surrounding environment. Both local and systemic signals can regulate stem cells behavior 
directly or through their niche. Accumulating evidences point to an important role of endocrine 
hormones in regulating stem cell establishment, maintenance, proliferation and differentiation 
(Gancz and Gilboa, 2013). In Drosophila, both insulin and the ecdysone hormone are required 
for primordial germ cells accumulation at embryonic stages and for their differentiation at larval 
stages. In adults, ecdysone is required for germinal stem cells (GSC) maintenance (Gancz et 
al., 2011). In addition, ecdysone is known to be required for the proliferation of progenitors 
(AMPs), responsible for adult midgut generation during metamorphosis (Micchelli et al., 2011). 
Although likely present at low levels, the ecdysone hormone is also detected in adults and its 
receptors EcR is expressed in various adult organs, within the central nervous system, gut, male 
and female reproductive apparatus and fat body among others (Schwedes and Carney, 2012). 
Interestingly, ecdysone inhibition in the adult can affect physiological functions including 
sexual behavior, sleep, nutrient, stress response as well as life span. 
In mice, the thyroid hormone T3 is crucial for intestinal crypt establishment and ISC 
proliferation by enhancing Wnt signaling (Flamant et al., 2002). In flies, the insulin hormone is 
required for ISC proliferation, symmetric stem cell division, as well as for their proper 
differentiation (Biteau et al., 2010; Choi et al., 2011; McLeod et al., 2010; O'Brien et al., 2011). 
In addition to ISCs, insulin and growth factors regulate hematopoietic stem cells self-renewal 
and expansion (Benmimoun et al., 2012). Evidence from our work supports that ecdysone is 
required to maintain ISC/EBs in the midgut and RNSCs in Malpighian tubules. Indeed, lack of 
Ecdysone signaling leads to a reduction of stem cell numbers, a phenotype that can be rescued 
by the re-expression of either Pri or Svb-Act. As a detailed study of the role of ecdysone in 
ISCs is ongoing in the lab of Bruce Edgar, we decided to restricted our study on the possible 
effect of this signaling on Pri expression. 
Work from our lab has demonstrated that the ecdysone hormone activates the expression of Pri 
throughout development (Chanut-Delalande et al., 2014). The active form of the hormone, 20 
hydroxyedsysone (20E) is synthesized from dietary cholesterol and well known to control the 
timing of developmental transitions, such as larval molting and metamorphosis. Chip-seq 
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analysis identified EcR binding sites in several enhancers of pri during pupal development, as 
well as in cultured S2 cells (Chanut-Delalande et al., 2014). We tested the effect of ecdysone 
on pri enhancer activity by depriving adult female flies bearing Pri-A , Pri-H or Pri-J from both 
food and water (desiccation). Interestingly, we observed an increase in the Pri-A enhancer 
activity. These data are in line with the findings of Azza Dib a former PhD student of the lab 
who identified EcR binding sites in Pri-A, but not in Pri-J or Pri-H. We have to confirm the 
increase in ecdysone levels by looking for Ecdysone responsive genes expression in desiccated 
flies compared to control (Figure 24). 
In Drosophila embryonic epidermis the binding of the 20E on its receptor EcR in association 
with the cofactor Ultraspiracle (USP) induces the expression of two subtypes of target genes, 
called “early” genes that then regulate the expression of a subset of genes called “late genes”. 
Thus, it will be interesting to test whether these target genes (or novel ecdysone target genes) 
are also required downstream of EcR in order to maintain ISC number. 
 
Figure 23 : The effect of desiccation on Pri-A and Pri-J activity in ISC 
Representative images of the Pri-A and Pri-J activities in normal (fed) or stressed conditions (starved), assessed by X-GAL 
assay. 
 
 
Conclusion  
We can then hypothesis that in Drosophila adult midgut, a systemic hormonal cue (Ecdysone) 
is sensed specifically within ISCs in order to activate the expression of Pri peptides. This 
activity is crucial to insure an efficient equilibrium between two isoforms of Svb and, 
consequently, to maintain adult midgut homeostasis. This ongoing work can shed light on the 
link between systemic signals and intrinsic genetic networks that control stem cell behavior.  
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Résumé 
L'intestin adulte est un organe très dynamique chargé des fonctions vitales. Bien que les cellules qui 
composent l'intestin soient quotidiennement perdues, l'homéostasie intestinale est maintenue tout au 
long de l'âge adulte grâce aux propriétés d'auto-renouvèlement et de différenciation des cellules souches 
intestinales (CSI). Dans ce travail nous montrons que le facteur de transcription OvoL/Shavenbaby (Svb) 
est nécessaire pour l'homéostasie intestinale des mouches adultes. Des travaux récents ont montré que 
Svb est d’abord traduit en tant qu’une longue protéine qui agit comme facteur répresseur de transcription 
(Svb-REP), puis post-traductionnellement transformé en facteur de transcription activateur plus court 
(Svb-ACT) en réponse aux petits peptides appelés Polished rice (Pri). Nous constatons que Svb est 
spécifiquement exprimé et transformé en isoforme activatrice dans les progéniteures intestinales adultes, 
c'est-à-dire les cellules souches intestinales et les entéroblastes (ISC/EB). Svb-ACT est nécessaire pour 
protéger les cellules souches de l'apoptose et suffisant pour favoriser leur prolifération. En effet, les tests 
d’épistasie génétiques révèlent que l'expression de Svb dans les CSI est activée par deux voies 
mitotiques principales, EGFR et Wnt. Nous avons identifié une région régulatrice de svb qui active son 
expression dans les CSI et les EB et démontré que son activité repose sur la liaison directe des effecteurs 
nucléaires des voies EGFR et Wnt. En outre, nous avons délimité un second enhancer de svb nécessaire 
pour l’induction de son expression dans les cellules différenciées absorbantes, les entérocytes (ECs). 
D’une manière intéressante on a constaté que c’est l'isoforme Svb-REP qui est exprimée et requise au 
sein des EC. Svb-REP induit la différenciation de l'EB en EC et est nécessaire pour maintenir la survie 
et la différenciation adéquate des ECs. Enfin, nous montrons que Svb-ACT est nécessaire à la croissance 
des tumeurs dérivées de la prolifération excessive des CSI et que Svb-REP est suffisant pour bloquer le 
comportement tumoral et conduire à la différenciation des CSI en EC. L'ensemble de nos données sur 
les mouches démontrent donc que l'expression contrôlée et la maturation du facteur de transcription 
OvoL/Svb jouent un rôle clé dans l'équilibre entre le maintien/prolifération des cellules souches et la 
différenciation des entérocytes dans l'intestin adulte. 
Abstract :  
The adult gut is a highly dynamic organ in charge of vital functions. Although cells that make up the 
gut are daily lost, intestinal homeostasis is maintained throughout adulthood due to self-renewal and 
differentiation properties of intestinal stem cells (ISCs). Here we show that the OvoL/Shavenbaby (Svb) 
transcription factor is required for adult gut homeostasis in flies. Recent work has shown that Svb is 
translated as a large sized repressor (Svb-REP), and then post-translationally processed in a shorter 
activator (Svb-ACT) in response to small peptides called Polished rice (Pri). We find that Svb is 
specifically expressed and processed into the activator isoform in adult gut progenitors, i.e. intestinal 
stem cells and enteroblats (ISC/EB). Svb-ACT is required to protect stem cells from apoptosis, and 
sufficient to promote their proliferation. Indeed, genetic assays reveal that Svb expression in ISCs is 
activated by two main mitogenic pathways, EGFR and Wnt. We identified an enhancer driving svb 
expression in gut progenitors and demonstrate that its activity relies on the direct binding of nuclear 
effectors of the EGFR and Wnt pathways. In addition, we delineated a second svb enhancer driving 
expression in differentiated enterocytes (ECs). Strikingly, we find that this is the Svb-REP isoform that 
is expressed and required within ECs. Svb-REP induces the differentiation of EB to EC and is required 
to maintain proper differentiation and survival of ECs. Finally, we show that Svb-ACT is required for 
the growth of ISC-derived tumors and that Svb-REP is sufficient to override deregulated signaling 
pathways, blocking tumorous behavior and leading to enterocyte differentiation. Taken together, our 
data in flies therefore demonstrate that controlled expression and maturation of the OvoL/Svb 
transcription factor plays a key role in the balance between stem cell maintenance/proliferation and 
enterocyte differentiation in the adult gut.  
 
